Pending: 31982D0426

Having regard to the Treaty establishing the European Economic Community, Having regard to Council Directive 72/462/EEC of 12 December 1972 on health and veterinary inspection problems upon importation of bovine animals and swine and fresh meat from third countries (1), as last amended by Directive 81/476/EEC (2), and in particular Article 16 thereof, Whereas, following a Community veterinary mission, it appears that the animal health situation in the United States of America is excellent, stable and completely controlled by well-structured and organized veterinary services, particularly as regards diseases transmissible through meat; Whereas, in addition, the responsible veterinary authorities of the United States of America have confirmed that the United States of America has for at least 12 months been free from rinderpest, foot-and-mouth disease, African swine fever, classical swine fever, contagious porcine paralysis (Teschen disease) and swine vesicular disease and that no vaccinations have been carried out against those diseases during that time; Whereas the responsible veterinary authorities of the United States of America have undertaken to notify the Commission and the Member States, by telex or telegram, within 24 hours, of the confirmation of the occurence of any of the abovementioned diseases or the adoption of a decision to vaccinate against them; Whereas it is possible, without risk of spread of disease, to accept meat of domestic solipeds where such animals have spent part of the residency period in a neighbouring country if that country is on the list of countries referred to in Council Decision 79/542/EEC (3), in respect of meat of domestic solipeds; Whereas animal health conditions and veterinary certification must be adopted according to the animal health situation of the non-member country concerned; Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee, HAS ADOPTED THIS DECISION:

Article 1
1. Member States shall authorize the importation from the United States of America of fresh meat of bovine animals, swine, sheep, goats and domestic solipeds conforming to the guarantees laid down in an animal health certificate which accords with the Annex hereto and which must accompany the consignment.
2. Member States shall not authorize imports of fresh meat from the United States of America other than those referred to in paragraph 1.

Article 2
This Decision shall not apply to imports of glands and organs authorized by the country of destination for pharmaceutical manufacturing purposes.

Article 3
This Decision shall apply from 1 January 1983.

Article 4
This Decision is addressed to the Member States.
Done at Brussels, 10 June 1982.
For the Commission
Poul DALSAGER
Member of the Commission
(1) OJ No L 302, 31. 12. 1972, p. 28.
(2) OJ No L 186, 8. 7. 1981, p. 20.
(3) OJ No L 146, 14. 6. 1979, p. 15.

Having regard to the Treaty establishing the European Economic Community, Having regard to Council Directive 72/462/EEC of 12 December 1972 on health and veterinary inspection problems upon importation of bovine animals and swine and fresh meat from third countries (1), as last amended by Directive 81/476/EEC (2), and in particular Article 16 thereof, Whereas, following a Community veterinary mission, it appears that the animal health situation in the United States of America is excellent, stable and completely controlled by well-structured and organized veterinary services, particularly as regards diseases transmissible through meat; Whereas, in addition, the responsible veterinary authorities of the United States of America have confirmed that the United States of America has for at least 12 months been free from rinderpest, foot-and-mouth disease, African swine fever, classical swine fever, contagious porcine paralysis (Teschen disease) and swine vesicular disease and that no vaccinations have been carried out against those diseases during that time; Whereas the responsible veterinary authorities of the United States of America have undertaken to notify the Commission and the Member States, by telex or telegram, within 24 hours, of the confirmation of the occurence of any of the abovementioned diseases or the adoption of a decision to vaccinate against them; Whereas it is possible, without risk of spread of disease, to accept meat of domestic solipeds where such animals have spent part of the residency period in a neighbouring country if that country is on the list of countries referred to in Council Decision 79/542/EEC (3), in respect of meat of domestic solipeds; Whereas animal health conditions and veterinary certification must be adopted according to the animal health situation of the non-member country concerned; Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee, HAS ADOPTED THIS DECISION:
1. Member States shall authorize the importation from the United States of America of fresh meat of bovine animals, swine, sheep, goats and domestic solipeds conforming to the guarantees laid down in an animal health certificate which accords with the Annex hereto and which must accompany the consignment.
2. Member States shall not authorize imports of fresh meat from the United States of America other than those referred to in paragraph 1.
This Decision shall not apply to imports of glands and organs authorized by the country of destination for pharmaceutical manufacturing purposes.
This Decision shall apply from 1 January 1983.
This Decision is addressed to the Member States.
Done at Brussels, 10 June 1982.
For the Commission
Poul DALSAGER
Member of the Commission
(1) OJ No L 302, 31. 12. 1972, p. 28.
(2) OJ No L 186, 8. 7. 1981, p. 20.
(3) OJ No L 146, 14. 6. 1979, p. 15.
ANIMAL HEALTH CERTIFICATE
for fresh meat (1) of bovine animals, swine, sheep, goats and domestic solipeds intended for consignment to the European Economic Community
Country of destination:
Reference number of the public health certificate (2):
Exporting country: United States of America
Department:
References:
I. Identification of meat
(Animal species)
Nature of cuts:
Nature of packaging:
Number of cuts or packages:
Net weight:
II. Origin of meat
Address(es) and veterinary approval number(s) (2) of the approved slaughterhouse(s) (2):
Address(es) and veterinary approval number(s) (2) of the approved cutting plant(s) (2):
III. Destination of meat
The meat will be sent from:
(Place of loading)
(Country and place of destination)
by the following means of transport (3):
Name and address of consignor:
Name and address of consignee:
IV. Attestation of health
I, the undersigned, official veterinarian, certify that the fresh meat described above has been obtained from:
– in the case of bovine animals, swine, sheep and goats, animals which have remained in the territory of the United States of America for at least three months before being slaughtered or since birth in the case of animals less than three months old,
– in the case of domestic solipeds, animals which have remained in the territory of the United States of America or a neighbouring country on the list referred to in Council Decision 79/542/EEC for meat of domestic solipeds, for at least three months before being slaughtered or since birth in the case of animals less than three months old,
– in the case of fresh meat from swine, animals which have not come from holdings which for health reasons are subject to prohibition as a result of an outbreak of porcine brucellosis during the previous six weeks,
– in the case of fresh meat from sheep and goats, animals which have not come from holdings which for health reasons are subject to prohibition as a result of an outbreak of ovine or caprine brucellosis during the previous six weeks.
Done at , on
(Signature of official veterinarian)
(1) Fresh meat means all parts of domestic animals of the bovine, ovine and caprine species and of domestic solipeds which are fit for human consumption and which have not undergone any preserving process, chilled and frozen meat being considered as fresh meat.
(2) Optional when the country of destination authorizes the importation of fresh meat for uses other than human consumption in application of Article 19 (a) of Directive 72/462/EEC.
(3) For railway wagons or lorries the registration number should be given, for aircraft the flight number and for ships the name.

Pending: 31980D0765

THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Economic Community, Having regard to Council Regulation (EEC) No 357/79 of 5 February 1979 on statistical surveys of areas under vines (1), and in particular Articles 5 (6) and Article 6 (7) thereof, Whereas Article 5 (6) of Regulation (EEC) No 357/79 provides that Member States which process the results of their basic surveys electronically shall submit the results in a machine-readable form; Whereas the equipment which the Commission has available for analyzing the results of the statistical surveys of the areas under vines and the need for its rational use require that a standard format be prescribed for the transcription of the data into a machine-readable form to be determined in accordance with the procedure laid down in Article 8 of the said Regulation; Whereas for practical reasons the Member States should forward the data referred to in Article 6 of Regulation (EEC) No 357/79 also in machine-readable form; Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Committee for Agricultural Statistics, HAS ADOPTED THIS DECISION:

Article 1
The machine-readable form for submission of the data provided for in Articles 5 and 6 of Regulation (EEC) No 357/79 by those Member States which process their survey results electronically shall be magnetic tape.

Article 2
The code and rules governing the transcription on to magnetic tape of the data provided for in Articles 5 and 6 of Regulation (EEC) No 357/79 shall be as set out in the Annexes hereto.

Article 3
This Decision is addressed to the Member States.
Done at Brussels, 8 July 1980.
For the Commission
François-Xavier ORTOLI
Vice-President (1)OJ No L 54, 5.3.1979, p. 124.

THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Economic Community, Having regard to Council Regulation (EEC) No 357/79 of 5 February 1979 on statistical surveys of areas under vines (1), and in particular Articles 5 (6) and Article 6 (7) thereof, Whereas Article 5 (6) of Regulation (EEC) No 357/79 provides that Member States which process the results of their basic surveys electronically shall submit the results in a machine-readable form; Whereas the equipment which the Commission has available for analyzing the results of the statistical surveys of the areas under vines and the need for its rational use require that a standard format be prescribed for the transcription of the data into a machine-readable form to be determined in accordance with the procedure laid down in Article 8 of the said Regulation; Whereas for practical reasons the Member States should forward the data referred to in Article 6 of Regulation (EEC) No 357/79 also in machine-readable form; Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Committee for Agricultural Statistics, HAS ADOPTED THIS DECISION:
The machine-readable form for submission of the data provided for in Articles 5 and 6 of Regulation (EEC) No 357/79 by those Member States which process their survey results electronically shall be magnetic tape.
The code and rules governing the transcription on to magnetic tape of the data provided for in Articles 5 and 6 of Regulation (EEC) No 357/79 shall be as set out in the Annexes hereto.
This Decision is addressed to the Member States.
Done at Brussels, 8 July 1980.
For the Commission
François-Xavier ORTOLI
Vice-President (1)OJ No L 54, 5.3.1979, p. 124.
GENERAL PROVISIONS
I. The information recorded in accordance with the characteristics referred to in Articles 5 and 6 of Regulation (EEC) No 357/79 is to be delivered to Eurostat in the following form by those Member States which process their information electronically: 1. The information shall refer to summaries of holdings if the survey is exhaustive (or to raised summaries of holdings if the survey is based on random sampling) and not to individual holdings.
2. The information shall be delivered on nine-track magnetic tape/1600 BPI (630 bytes/cm) standard label.
3. The information shall be of fixed record length consisting of 145 positions, and shall be recorded in EBCDIC.
4. The first two fields of each record shall contain information to permit identification. The first field (three positions) identifies the geographical unit, the codification of which is given in the detailed provisions and in Annex II.
5. The second field (two positions) identifies the table in the schedule of tables provided for in Council Regulation (EEC) No 357/79. The codification of these tables is given in the detailed provisions.
6. The number and size of the fields in each record vary according to the table. If all the 145 positions are not filled in the case of certain tables, the record shall be completed by blanks.
7. The information shall be entered right justified in each field and noughts added to fill in. If any optional information is not supplied the record shall be completed by blanks in the corresponding bytes.
8. Surface area data shall be given in areas, production data in hl.
9. Member States shall have a choice of blocking factor and shall inform Eurostat which blocking factor has been used.
10. The record shall be sorted according to geographical unit, table and changes in that order.
11. Standard administrative procedures governing the transmission of the magnetic tape files to Eurostat shall be established jointly by Eurostat and the Member States.
II. The following pages give for each table and for the various items of a record: (a) the codes which are to be used;
(b) the maximum number of digits required for the item in question;
(c) the consecutive numbering of the positions for the various items.
DETAILED PROVISIONS
The first two fields of each record contain the following information: >PIC FILE= “T0013529”>
>PIC FILE= “T0013530”>
>PIC FILE= “T0013531”>
>PIC FILE= “T0013532”>
>PIC FILE= “T0013533”> >PIC FILE= “T0013534”>

Pending: 32024D2132

Official Journalof the European Union ENL series
2024/2132 31.7.2024
(1) Infection with peste des petits ruminants virus is an infectious disease affecting caprine and ovine animals and can have a severe impact on the concerned animal population and the profitability of farming causing disturbance to movements of consignments of those animals and products thereof within the Union and exports to third countries.
(2) In the event of an outbreak of infection with peste des petits ruminants virus in caprine or ovine animals, there is a serious risk of the spread of that disease to other establishments of caprine or ovine animals.
(3) Commission Delegated Regulation (EU) 2020/687(2)supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C diseases in Commission Implementing Regulation (EU) 2018/1882(3). In particular, Articles 21 and 22 of Delegated Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category A disease, including infection with peste des petits ruminants virus, and for certain measures to be applied therein. In addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise a protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection and surveillance zones.
(4) Commission Implementing Decision (EU) 2024/2014(4)was adopted within the framework of Regulation (EU) 2016/429 and it lays down certain interim emergency measures relating to infection with peste des petits ruminants virus in Greece.
(5) More particularly, Implementing Decision (EU) 2024/2014 provides that the protection, surveillance and further restricted zones to be established by the Member State, following an outbreak of infection with peste des petits ruminants virus, in accordance with Delegated Regulation (EU) 2020/687, are to comprise at least the areas listed in the Annex to that Implementing Decision.
(6) Since the date of adoption of Implementing Decision (EU) 2024/2014, Greece notified the Commission of 14 further outbreaks of infection with peste des petits ruminants virus in establishments where ovine and/or caprine animals are kept, located in the regional units of Trikala and Larisa, in the region of Thessaly.
(7) In total, Greece has notified 15 outbreaks of infection with peste des petits ruminants virus that form at least two distinct clusters, one in the regional unit of Trikala and the other in the regional unit of Larisa. Ten of these outbreaks are located outside the restricted zones already established in the regional units of Trikala and Grevena.
(8) Therefore, the areas listed as protection, surveillance and further restricted zones for Greece in the Annex to Implementing Decision (EU) 2024/2014, should be further adjusted, spatially and/or temporally, in order to prevent further spread of the disease in Greece and the rest of the Union.
(9) The size of the zones and duration of the measures to apply in the protection, surveillance and further restricted zones should be based on the criteria set out in Article 64(1) of Regulation (EU) 2016/429 and the rules laid down in Delegated Regulation (EU) 2020/687, including the epidemiological situation as regards infection with peste des petits ruminants virus in the areas affected by that disease and the overall epidemiological situation of infection with peste des petits ruminants virus in the Member State concerned as well as the level of risk for the further spread of that disease. The duration of the measures should also take into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Health (WOAH). In the current situation, there is high risk of further spread of the disease, in particular due to the fact that, according to the information provided by the competent authority, the disease has spread within a few days as far as 84 kilometres from the first outbreak and the epidemiological information available suggest that the disease had been present in the area for a period of time before being diagnosed.
(10) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be set out in the Annex to this Decision and the duration of that regionalisation fixed.
(11) Due to the severity and urgency of the situation and in order to immediately limit the spread of the disease after this first occurrence in that Member State, it is necessary to ensure that animal movements from the protection, surveillance and further restricted zones to destinations outside the external perimeter of the further restricted zone do not take place, and to exclude possible derogations from the prohibition to move animals as foreseen in Delegated Regulation (EU) 2020/687, for a certain period of time, in order to prevent long distance spread of the disease.
(12) Given the urgency of the epidemiological situation in the Union as regards the spread of infection with peste des petits ruminants virus and the need to prevent the disease from spreading from the affected establishments in Greece to other parts of that Member State or to other Member States, the measures laid down in this Implementing Decision should apply as soon as possible.
(13) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be established immediately and listed in the Annex to this Decision and the duration of that regionalisation fixed and animal movements should be restricted.
(14) In addition, Implementing Decision (EU) 2024/2014 should be repealed and replaced by this Decision.
(15) Taking into account the current epidemiological situation in the Union as regards peste des petits ruminants virus, this Decision should apply until 30 November 2024.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
(a) the restricted zones which comprise protection and surveillance zones to be established by Greece, following outbreaks of infection with peste des petits ruminants virus in its territory, as well as a further restricted zone in accordance with Article 21 of Delegated Regulation (EU) 2020/687;
(b) the duration of the disease control measures to be applied in the protection zones, in accordance with Article 39 of Delegated Regulation (EU) 2020/687, in the surveillance zones in accordance with Article 55 of Delegated Regulation (EU) 2020/687 and in the further restricted zone in accordance with Article 21 of that Delegated Regulation.
(a) a restricted zone, which comprises a protection zone, a surveillance zone as well as a further restricted zone, is established immediately by the competent authority of that Member State in accordance with Article 21 of Delegated Regulation (EU) 2020/687, and under the conditions laid down in that Article;
(b) the protection, surveillance and further restricted zones referred to in point (a) comprise at least the areas listed in the Annex to this Decision;
(c) the measures required to be applied in the protection, surveillance and further restricted zones, are applied at least until the dates listed in the Annex to this Decision.
Regional unit and ADIS reference number of the outbreak Areas established as protection and surveillance zones, part of the restricted zone in Greece referred to in Article 1 Date until applicable
Regional unit of TrikalaGR-PPR-2024-00001GR-PPR-2024-00002GR-PPR-2024-00003GR-PPR-2024-00004GR-PPR-2024-00006GR-PPR-2024-00007GR-PPR-2024-000015 Protection zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15) 18.8.2024
Surveillance zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 10 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15), excluding the areas contained in the protection zone 27.8.2024
Surveillance zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15) 19.8.2024 – 27.8.2024
Regional unit of LarisaGR-PPR-2024-00005GR-PPR-2024-00008GR-PPR-2024-00009GR-PPR-2024-00010GR-PPR-2024-00011GR-PPR-2024-00012GR-PPR-2024-00013GR-PPR-2024-00014 Protection zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14) 18.8.2024
Surveillance zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 10 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14),excluding the areas contained in the protection zone 27.8.2024
Surveillance zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14) 19.8.2024 – 27.8.2024
Regional unit Areas included in the further restricted zone established in Greece as referred to in Article 1 Date until applicable
Regional unit of Trikala The following regional units:—Trikala—Larisa—Grevena—Karditsaexcluding the areas included in any protection or surveillance zone. — Trikala — Larisa — Grevena — Karditsaexcluding the areas included in any protection or surveillance zone. 27.8.2024
— Trikala
— Larisa
— Grevena
— Karditsaexcluding the areas included in any protection or surveillance zone.
The following regional units:—Trikala—Larisa—Grevena—Karditsa — Trikala — Larisa — Grevena — Karditsa 28.8.2024-26.9.2024
— Trikala
— Larisa
— Grevena
— Karditsa
— Trikala
— Larisa
— Grevena
— Karditsaexcluding the areas included in any protection or surveillance zone.
— Trikala
— Larisa
— Grevena
— Karditsa
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’)(1), and in particular Article 259(1) thereof,
(1) Infection with peste des petits ruminants virus is an infectious disease affecting caprine and ovine animals and can have a severe impact on the concerned animal population and the profitability of farming causing disturbance to movements of consignments of those animals and products thereof within the Union and exports to third countries.
(2) In the event of an outbreak of infection with peste des petits ruminants virus in caprine or ovine animals, there is a serious risk of the spread of that disease to other establishments of caprine or ovine animals.
(3) Commission Delegated Regulation (EU) 2020/687(2)supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C diseases in Commission Implementing Regulation (EU) 2018/1882(3). In particular, Articles 21 and 22 of Delegated Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category A disease, including infection with peste des petits ruminants virus, and for certain measures to be applied therein. In addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise a protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection and surveillance zones.
(4) Commission Implementing Decision (EU) 2024/2014(4)was adopted within the framework of Regulation (EU) 2016/429 and it lays down certain interim emergency measures relating to infection with peste des petits ruminants virus in Greece.
(5) More particularly, Implementing Decision (EU) 2024/2014 provides that the protection, surveillance and further restricted zones to be established by the Member State, following an outbreak of infection with peste des petits ruminants virus, in accordance with Delegated Regulation (EU) 2020/687, are to comprise at least the areas listed in the Annex to that Implementing Decision.
(6) Since the date of adoption of Implementing Decision (EU) 2024/2014, Greece notified the Commission of 14 further outbreaks of infection with peste des petits ruminants virus in establishments where ovine and/or caprine animals are kept, located in the regional units of Trikala and Larisa, in the region of Thessaly.
(7) In total, Greece has notified 15 outbreaks of infection with peste des petits ruminants virus that form at least two distinct clusters, one in the regional unit of Trikala and the other in the regional unit of Larisa. Ten of these outbreaks are located outside the restricted zones already established in the regional units of Trikala and Grevena.
(8) Therefore, the areas listed as protection, surveillance and further restricted zones for Greece in the Annex to Implementing Decision (EU) 2024/2014, should be further adjusted, spatially and/or temporally, in order to prevent further spread of the disease in Greece and the rest of the Union.
(9) The size of the zones and duration of the measures to apply in the protection, surveillance and further restricted zones should be based on the criteria set out in Article 64(1) of Regulation (EU) 2016/429 and the rules laid down in Delegated Regulation (EU) 2020/687, including the epidemiological situation as regards infection with peste des petits ruminants virus in the areas affected by that disease and the overall epidemiological situation of infection with peste des petits ruminants virus in the Member State concerned as well as the level of risk for the further spread of that disease. The duration of the measures should also take into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Health (WOAH). In the current situation, there is high risk of further spread of the disease, in particular due to the fact that, according to the information provided by the competent authority, the disease has spread within a few days as far as 84 kilometres from the first outbreak and the epidemiological information available suggest that the disease had been present in the area for a period of time before being diagnosed.
(10) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be set out in the Annex to this Decision and the duration of that regionalisation fixed.
(11) Due to the severity and urgency of the situation and in order to immediately limit the spread of the disease after this first occurrence in that Member State, it is necessary to ensure that animal movements from the protection, surveillance and further restricted zones to destinations outside the external perimeter of the further restricted zone do not take place, and to exclude possible derogations from the prohibition to move animals as foreseen in Delegated Regulation (EU) 2020/687, for a certain period of time, in order to prevent long distance spread of the disease.
(12) Given the urgency of the epidemiological situation in the Union as regards the spread of infection with peste des petits ruminants virus and the need to prevent the disease from spreading from the affected establishments in Greece to other parts of that Member State or to other Member States, the measures laid down in this Implementing Decision should apply as soon as possible.
(13) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be established immediately and listed in the Annex to this Decision and the duration of that regionalisation fixed and animal movements should be restricted.
(14) In addition, Implementing Decision (EU) 2024/2014 should be repealed and replaced by this Decision.
(15) Taking into account the current epidemiological situation in the Union as regards peste des petits ruminants virus, this Decision should apply until 30 November 2024.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:

Subject matter and scope
Article 1
This Decision establishes at Union level:
(a)
the restricted zones which comprise protection and surveillance zones to be established by Greece, following outbreaks of infection with peste des petits ruminants virus in its territory, as well as a further restricted zone in accordance with Article 21 of Delegated Regulation (EU) 2020/687;
(b)
the duration of the disease control measures to be applied in the protection zones, in accordance with Article 39 of Delegated Regulation (EU) 2020/687, in the surveillance zones in accordance with Article 55 of Delegated Regulation (EU) 2020/687 and in the further restricted zone in accordance with Article 21 of that Delegated Regulation.

Establishment of a restricted zone
Article 2
Greece shall ensure that:
(a)
a restricted zone, which comprises a protection zone, a surveillance zone as well as a further restricted zone, is established immediately by the competent authority of that Member State in accordance with Article 21 of Delegated Regulation (EU) 2020/687, and under the conditions laid down in that Article;
(b)
the protection, surveillance and further restricted zones referred to in point (a) comprise at least the areas listed in the Annex to this Decision;
(c)
the measures required to be applied in the protection, surveillance and further restricted zones, are applied at least until the dates listed in the Annex to this Decision.

Measures in the restricted zone
Article 3
Movements of sheep and goats from the protection, surveillance and further restricted zones to a destination located outside the external perimeter of the further restricted zone as provided for in Point B of the Annex to this Decision are prohibited until the dates listed for each zone in the Annex to this Decision.

Repeal of Implementing Decision (EU) 2024/2014
Article 4
Implementing Decision (EU) 2024/2014 is repealed.

Application
Article 5
This Decision shall apply until 30 November 2024.

Addressee
Article 6
This Decision is addressed to the Hellenic Republic.

THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’)(1), and in particular Article 259(1) thereof,
(1) Infection with peste des petits ruminants virus is an infectious disease affecting caprine and ovine animals and can have a severe impact on the concerned animal population and the profitability of farming causing disturbance to movements of consignments of those animals and products thereof within the Union and exports to third countries.
(2) In the event of an outbreak of infection with peste des petits ruminants virus in caprine or ovine animals, there is a serious risk of the spread of that disease to other establishments of caprine or ovine animals.
(3) Commission Delegated Regulation (EU) 2020/687(2)supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C diseases in Commission Implementing Regulation (EU) 2018/1882(3). In particular, Articles 21 and 22 of Delegated Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category A disease, including infection with peste des petits ruminants virus, and for certain measures to be applied therein. In addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise a protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection and surveillance zones.
(4) Commission Implementing Decision (EU) 2024/2014(4)was adopted within the framework of Regulation (EU) 2016/429 and it lays down certain interim emergency measures relating to infection with peste des petits ruminants virus in Greece.
(5) More particularly, Implementing Decision (EU) 2024/2014 provides that the protection, surveillance and further restricted zones to be established by the Member State, following an outbreak of infection with peste des petits ruminants virus, in accordance with Delegated Regulation (EU) 2020/687, are to comprise at least the areas listed in the Annex to that Implementing Decision.
(6) Since the date of adoption of Implementing Decision (EU) 2024/2014, Greece notified the Commission of 14 further outbreaks of infection with peste des petits ruminants virus in establishments where ovine and/or caprine animals are kept, located in the regional units of Trikala and Larisa, in the region of Thessaly.
(7) In total, Greece has notified 15 outbreaks of infection with peste des petits ruminants virus that form at least two distinct clusters, one in the regional unit of Trikala and the other in the regional unit of Larisa. Ten of these outbreaks are located outside the restricted zones already established in the regional units of Trikala and Grevena.
(8) Therefore, the areas listed as protection, surveillance and further restricted zones for Greece in the Annex to Implementing Decision (EU) 2024/2014, should be further adjusted, spatially and/or temporally, in order to prevent further spread of the disease in Greece and the rest of the Union.
(9) The size of the zones and duration of the measures to apply in the protection, surveillance and further restricted zones should be based on the criteria set out in Article 64(1) of Regulation (EU) 2016/429 and the rules laid down in Delegated Regulation (EU) 2020/687, including the epidemiological situation as regards infection with peste des petits ruminants virus in the areas affected by that disease and the overall epidemiological situation of infection with peste des petits ruminants virus in the Member State concerned as well as the level of risk for the further spread of that disease. The duration of the measures should also take into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Health (WOAH). In the current situation, there is high risk of further spread of the disease, in particular due to the fact that, according to the information provided by the competent authority, the disease has spread within a few days as far as 84 kilometres from the first outbreak and the epidemiological information available suggest that the disease had been present in the area for a period of time before being diagnosed.
(10) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be set out in the Annex to this Decision and the duration of that regionalisation fixed.
(11) Due to the severity and urgency of the situation and in order to immediately limit the spread of the disease after this first occurrence in that Member State, it is necessary to ensure that animal movements from the protection, surveillance and further restricted zones to destinations outside the external perimeter of the further restricted zone do not take place, and to exclude possible derogations from the prohibition to move animals as foreseen in Delegated Regulation (EU) 2020/687, for a certain period of time, in order to prevent long distance spread of the disease.
(12) Given the urgency of the epidemiological situation in the Union as regards the spread of infection with peste des petits ruminants virus and the need to prevent the disease from spreading from the affected establishments in Greece to other parts of that Member State or to other Member States, the measures laid down in this Implementing Decision should apply as soon as possible.
(13) Accordingly, the areas identified as protection, surveillance and further restricted zones in Greece should be established immediately and listed in the Annex to this Decision and the duration of that regionalisation fixed and animal movements should be restricted.
(14) In addition, Implementing Decision (EU) 2024/2014 should be repealed and replaced by this Decision.
(15) Taking into account the current epidemiological situation in the Union as regards peste des petits ruminants virus, this Decision should apply until 30 November 2024.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:

Subject matter and scope

This Decision establishes at Union level:
(a)
the restricted zones which comprise protection and surveillance zones to be established by Greece, following outbreaks of infection with peste des petits ruminants virus in its territory, as well as a further restricted zone in accordance with Article 21 of Delegated Regulation (EU) 2020/687;
(b)
the duration of the disease control measures to be applied in the protection zones, in accordance with Article 39 of Delegated Regulation (EU) 2020/687, in the surveillance zones in accordance with Article 55 of Delegated Regulation (EU) 2020/687 and in the further restricted zone in accordance with Article 21 of that Delegated Regulation.

Establishment of a restricted zone

Greece shall ensure that:
(a)
a restricted zone, which comprises a protection zone, a surveillance zone as well as a further restricted zone, is established immediately by the competent authority of that Member State in accordance with Article 21 of Delegated Regulation (EU) 2020/687, and under the conditions laid down in that Article;
(b)
the protection, surveillance and further restricted zones referred to in point (a) comprise at least the areas listed in the Annex to this Decision;
(c)
the measures required to be applied in the protection, surveillance and further restricted zones, are applied at least until the dates listed in the Annex to this Decision.

Measures in the restricted zone

Movements of sheep and goats from the protection, surveillance and further restricted zones to a destination located outside the external perimeter of the further restricted zone as provided for in Point B of the Annex to this Decision are prohibited until the dates listed for each zone in the Annex to this Decision.

Repeal of Implementing Decision (EU) 2024/2014

Implementing Decision (EU) 2024/2014 is repealed.

Application

This Decision shall apply until 30 November 2024.

Addressee

This Decision is addressed to the Hellenic Republic.

A.   Protection and surveillance zones established around the confirmed outbreak

ANNEX
Regional unit and ADIS reference number of the outbreak | Areas established as protection and surveillance zones, part of the restricted zone in Greece referred to in Article 1 | Date until applicable
Regional unit of TrikalaGR-PPR-2024-00001GR-PPR-2024-00002GR-PPR-2024-00003GR-PPR-2024-00004GR-PPR-2024-00006GR-PPR-2024-00007GR-PPR-2024-000015 | Protection zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15) | 18.8.2024
Surveillance zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 10 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15), excluding the areas contained in the protection zone | 27.8.2024
Surveillance zone:Those parts of the regional unit of Trikala, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.74240, Long. 21.5816 (2024/1), Lat. 39.74582, Long. 21.58346 (2024/2), Lat. 39.738997, Long. 21.58565 (2024/3), Lat. 39.73900 Long. 21.58565 (2024/4), Lat.39.74907, Long.21.58515 (2024/6), Lat. 39.73803, Long.21.58583 (2024/7), Lat.39.61299, Long.21.94638 (2024/15) | 19.8.2024 – 27.8.2024
Regional unit of LarisaGR-PPR-2024-00005GR-PPR-2024-00008GR-PPR-2024-00009GR-PPR-2024-00010GR-PPR-2024-00011GR-PPR-2024-00012GR-PPR-2024-00013GR-PPR-2024-00014 | Protection zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14) | 18.8.2024
Surveillance zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 10 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14),excluding the areas contained in the protection zone | 27.8.2024
Surveillance zone:Those parts of the regional unit of Larisa, contained within a circle of a radius of 3 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 39.80302, Long.22.09358 (2024/1), Lat.39.79371, Long 22.09587 (2024/8), Lat.39.78486, Long.22.09857(2014/9), Lat.39.78106, Long. 22.09151 (2014/10), Lat.39.78088, Long.22.09469 (2024/11), Lat.39.72800, Long.22.14268 (2024/12), Lat.39.71114, Long.22.56483 (2024/13), Lat.39.71725, Long.22.55791(2024/14) | 19.8.2024 – 27.8.2024B. Further restricted zone

Regional unit | Areas included in the further restricted zone established in Greece as referred to in Article 1 | Date until applicable
Regional unit of Trikala | The following regional units:—Trikala—Larisa—Grevena—Karditsaexcluding the areas included in any protection or surveillance zone. | — | Trikala | — | Larisa | — | Grevena | — | Karditsaexcluding the areas included in any protection or surveillance zone. | 27.8.2024
— | Trikala
— | Larisa
— | Grevena
— | Karditsaexcluding the areas included in any protection or surveillance zone.
The following regional units:—Trikala—Larisa—Grevena—Karditsa | — | Trikala | — | Larisa | — | Grevena | — | Karditsa | 28.8.2024-26.9.2024
— | Trikala
— | Larisa
— | Grevena
— | Karditsa

Pending: 32014D0178

29.3.2014 EN Official Journal of the European Union L 95/47
(1) Council Directive 2002/60/EC(4)lays down the minimum measures to be applied within the Union for the control of African swine fever, including the measures to be taken in the event of an outbreak of African swine fever and in cases where African swine fever is suspected or confirmed in feral pigs. Those measures include plans to be developed and implemented by Member States, and approved by the Commission, for the eradication of African swine fever from a feral pig population.
(2) Commission Decision 2005/363/EC(5)was adopted in response to the presence of African swine fever in Sardinia, Italy. That Decision lays down animal health rules on the movement, dispatch and marking of pigs and certain pig products from Sardinia, in order to prevent the spread of that disease to other areas of the Union.
(3) In addition, Commission Decision 2005/362/EC(6)approved a plan submitted by Italy to the Commission for the eradication of African swine fever in feral pigs in Sardinia.
(4) In 2014, cases of African swine fever in feral pigs, more specifically in wildboar, occurred in Lithuania and Poland due to the introduction of the African swine fever virus from neighbouring third countries where that disease is present. In order to focus the control measures and to prevent disease spread as well as to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade by third countries, a Union list of infected areas in those countries was urgently established in collaboration with the Member States concerned by means of Commission Implementing Decision 2014/93/EU(7)and Commission Implementing Decision 2014/134/EU(8)which both apply until 30 April 2014.
(5) African swine fever can be considered an endemic disease in the domestic and feral pig populations of certain third countries bordering the Union and represents a permanent threat for the Union.
(6) The disease situation is liable to endanger the pig herds in other regions of Lithuania, Italy and Poland and also in other Member States, notably in view of trade in commodities from porcine animals.
(7) Lithuania and Poland have taken measures to combat African swine fever within the framework of Directive 2002/60/EC and they are due to submit their plan for the eradication of African swine fever in feral pigs to the Commission for approval in accordance with Article 16 of that Directive.
(8) It is appropriate that the Member States and areas concerned are listed in an Annex differentiated by the level of risk considering the epidemiological situation of African swine fever and whether it concerns both pigs holdings and the feral pig population (Part III), only the feral pig population (Part II) or the risk is due to certain proximity to the infection in the feral population (Part I).
(9) In terms of risk of spread of African swine fever, movements of different porcine commodities pose different levels of risk. As a general rule the movement of live pigs, their semen, ova and embryos and animal by-products of porcine origin from infected areas pose higher risks in terms of exposure and consequences than the movement of meat, meat preparations and meat products as indicated in the Scientific Opinion of the European Food Safety Authority of 2010(9). Therefore, the dispatch of live pigs and their semen, ova and embryos, animal by-products of porcine origin as well as the dispatch of certain meat, meat preparations and meat products from designated zones of the Member States listed in the Annex to this Decision should be prohibited. This prohibition includes all suidae as referred to in Council Directive 92/65/EEC(10).
(10) In order to take account of the different risk levels depending on the type of porcine commodities and the epidemiological situation in the Member States concerned, it is appropriate to provide for certain derogations for each type of porcine commodity from the territories listed in the different Parts of the Annex hereto. Those derogations are also in line with the risk mitigation measures for importation as regards African swine fever indicated in the Terrestrial Animal Health Code of the World Organization for Animal Health. The additional safeguard measures and health requirements or treatments applicable for those derogations should also be provided for in this Decision.
(11) Council Directive 64/432/EEC(11)and Commission Decision 93/444/EEC(12)provide that health certificates are to accompany the movements of animals. Where derogations from the prohibition on the dispatch of live pigs from areas listed in the Annex to this Decision are applied to live pigs intended for intra-Union trade or for export to a third country, those health certificates should include a reference to this Decision so to ensure that adequeate and accurate health information is provided in the relevant certificates.
(12) Commission Regulation (EC) No 599/2004(13)provides that health certificates are to accompany the movements of certain products of animal origin. In order to prevent the spread of African swine fever to other areas of the Union, where a Member State is subject to a prohibition on the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing pigmeat from certain parts of its territory, certain requirements should be laid down, in particular as regards certification, for the dispatch of such meat, meat preparations and meat products from other areas of the territory of that Member State not subject to that prohibition and those health certificates should include a reference to this Decision.
(13) In addition, it is appropriate, in order to prevent the spread of African swine fever to other areas of the Union and to third countries, to provide that the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing meat of pigs from Member States with areas listed in the Annex, is subject to certain more stringent conditions. In particular, such fresh pigmeat, meat preparations and pigmeat products should be marked with special marks which cannot be confused with the the identification mark provided for in Regulation (EC) No 853/2004 of the European Parliament and of the Council(14)and with the health marks for pigmeat provided for in Regulation (EC) No 854/2004 of the European Parliament and of the Council(15).
(14) The period of application of the measures provided for in this Decision should take account of the epidemiology of African swine fever and the conditions to regain the African swine fever free status according to the Terrestrial Animal Health Code of the World Organization for Animal Health and therefore this period should last at least until 31 December 2017.
(15) Implementing Decisions 2014/93/EU and 2014/134/EU should be repealed and replaced by this Decision. Decision 2005/363/EC has been amended several times. Therefore, it is appropriate to repeal that Decision and replace it by this Decision.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
(a) the dispatch of live pigs from the areas listed in Parts II or III of the Annex;
(b) the dispatch of consignments of porcine semen, ova and embryos from the areas listed in Part III of the Annex;
(c) the dispatch of consignments of pig meat, pig meat preparations, pig meat products and any other products containing pig meat from the areas listed in Part III of the Annex;
(d) the dispatch of consignments of animal by-products from porcine animals from the areas listed in Part III of the Annex.
1. the pigs have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Commission Decision 2003/422/EC(16)on the date of shipment, or
2. the pigs come from a holding:(a)that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:(i)followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;(ii)included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;(iii)checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;(b)that implements bio-security requirements for African swine fever as establised by the competent authority.(c)in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1. (a) that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:(i)followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;(ii)included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;(iii)checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC; (i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC; (ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC; (iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC; (b) that implements bio-security requirements for African swine fever as establised by the competent authority. (c) in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1.
(a) that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:(i)followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;(ii)included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;(iii)checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC; (i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC; (ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC; (iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(b) that implements bio-security requirements for African swine fever as establised by the competent authority.
(c) in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1.
(a) that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:(i)followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;(ii)included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;(iii)checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC; (i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC; (ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC; (iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii) checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(b) that implements bio-security requirements for African swine fever as establised by the competent authority.
(c) in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1.
(a) derived from pigs which have been kept since birth in holdings located outside the areas listed in the Annex, and the pig meat, pig meat preparations and pig meat products consisting of, or containing such meat, have been produced, stored and processed in establishments approved in accordance with Article 10; or
(b) have been produced and processed in accordance with Article 4(1) of Directive 2002/99/EC.
(a) areas outside those listed in the Annex;
(b) a holding where no live pigs originating from the areas listed in the Annex have been introduced during a period of at least 30 days immediately prior to the date of dispatch.
(a) they have been resident for a period of at least 40 days or since birth on the holding and no live pigs have been introduced into that holding during the a period of at least 30 days prior to the date of the dispatch;
(b) they come from a holding which implements bio-security requirements for African swine fever as establised by the competent authority;
(c) they have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC on the date of shipment; or
(d) they come from a holding which has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:(i)followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;(ii)included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;(iii)checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC. (i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC; (ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC; (iii) checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC.
(i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii) checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC.
(i) followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii) included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii) checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC.
(a) Article 5(1) of Directive 64/432/EEC, or
(b) Article 3(1) of Decision 93/444/EEC:‘Pigs in compliance with Article 6(2) of Commission Implementing Decision 2014/178/EU(*1).(*1)OJ L 95, 29.3.2014, p. 48.’ "
(a) porcine semen, unless the semen originates from boars kept at an approved collection centre as referred to in Article 3(a) of Council Directive 90/429/EEC(18)and situated outside the areas listed in Part II and Part III of the Annex to this Decision;
(b) ova and embryos of animals of the porcine species, unless the ova and embryos originate from donor sows kept in holdings which comply with Article 6(2) and are situated outside the areas listed in Part II and III of the Annex and the embryos are conceived with semen in compliance with point (a).
(a) those by-products are have been subjected to a treatment which ensures that the derived product obtained from porcine animals poses no risks as regards African swine fever;
(b) the consignments are accompanied by a commercial document issued as referred in Chapter III of Annex VIII to Commission Regulation (EU) No 142/2011(19).
(a) have been produced and processed in compliance with Article 4(1) of Directive 2002/99/EC;
(b) are subjected to veterinary certification in accordance with Article 5 of Directive 2002/99/EC;
(c) are accompanied by the appropriate intra-Union trade health certificate as laid down by Regulation (EC) No 599/2004 of which Part II shall be completed by the following:‘Products in accordance with Commission Implementing Decision 2014/178/EU of 27 March 2014 concerning animal health control measures relating to African swine fever in certain Member States(*2).(*2)OJ L 95, 29.3.2014, p. 48.’ "
(a) no live feral pigs from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State;
(b) no consignments of fresh meat of feral pigs, meat preparations and meat products consisting of or containing such meat from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State.
(a) the identification mark for meat preparations and meat products consisting of, or containing pig meat, as set out in Section I of Annex II to Regulation (EC) No 853/2004;
(b) the health mark for fresh pig meat as set out in Chapter III of Section I of Annex I to Regulation (EC) No 854/2004.
(a) the conditions laid down in the second and the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC are applied in the pig holdings located within the areas listed in the Annex to this Decision;
(b) vehicles which have been used for the transport of pigs or animal by-products from porcine animals originating from holdings located within the areas listed in the Annex to this Decision are cleansed and disinfected immediately following each operation and the transporter provides proof of such cleansing and disinfection.
(a)in Vilnius county (apskritis): (a) in Vilnius county (apskritis): —part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103), — part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103),
(a) in Vilnius county (apskritis):
— part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103),
—Trakai district municipality and Elektrėnai municipality; — Trakai district municipality and Elektrėnai municipality;
— Trakai district municipality and Elektrėnai municipality;
(b)in Marijampolė county (apskritis): (b) in Marijampolė county (apskritis): —Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality; — Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality;
(b) in Marijampolė county (apskritis):
— Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality;
(c)in Kaunas county (apskritis): (c) in Kaunas county (apskritis): —Prienai district municipality and Birštonas municipality. — Prienai district municipality and Birštonas municipality.
(c) in Kaunas county (apskritis):
— Prienai district municipality and Birštonas municipality.
(a) in Vilnius county (apskritis):
— part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103),
— Trakai district municipality and Elektrėnai municipality;
(b) in Marijampolė county (apskritis):
— Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality;
(c) in Kaunas county (apskritis):
— Prienai district municipality and Birštonas municipality.
— the city of Suwałki;
— the city of Białystok;
— the municipalities of Suwałki, Szypliszki and Raczki in suwalski district;
— the municipalities of Augustów with the city of Augustów, Nowinka, Sztabin and Bargłów Kościelny in augustowski district;
— the municipalities of Krasnopol and Puńsk in sejneński district;
— the municipalities of Goniądz, Jasionówka, Jaświły, Knyszyn, Krypno and Mońki in moniecki district;
— the municipalities of Suchowola and Korycin in sokólski district;
— the municipalities of Choroszcz, Juchnowiec Kościelny, Suraż, Turośń Kościelna, Tykocin, Zabłudów and Dobrzyniewo Duże in białostocki district;
— the municipalities of Bielsk Podlaski with the city of Bielsk Podlaski, Orla and Wyszki in bielski district;
— the municipalities of Narew, Narewka, Białowieża, Czyże, Dubicze Cerkiewne and Hajnówka with the city of Hajnówka in hajnowski district.
(a)in Vilnius county (apskritis): (a) in Vilnius county (apskritis): —the Šalčininkai district municipality; — the Šalčininkai district municipality;
(a) in Vilnius county (apskritis):
— the Šalčininkai district municipality;
(b)in Alytus county (apskritis): (b) in Alytus county (apskritis): —the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality. — the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality.
(b) in Alytus county (apskritis):
— the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality.
(a) in Vilnius county (apskritis):
— the Šalčininkai district municipality;
(b) in Alytus county (apskritis):
— the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality.
— the municipalities of Giby and Sejny with the city of Sejny in sejneński district;
— the municipalities of Lipsk and Płaska in augustowski district;
— the municipalities of Czarna Białostocka, Gródek, Supraśl, Wasilków and Michałowo in białostocki district;
— the municipalities of Dąbrowa Białostocka, Janów, Krynki, Kuźnica, Nowy Dwór, Sidra, Sokółka and Szudziałowo in sokólski district.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Directive 89/662/EEC of 11 December 1989 concerning veterinary checks in intra-Community trade with a view to the completion of the internal market(1), and in particular Article 9(4) thereof,
Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animals and products with a view to the completion of the internal market(2), and in particular Article 10(4) thereof,
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption(3), and in particular Article 4(3) thereof,
(1) Council Directive 2002/60/EC(4)lays down the minimum measures to be applied within the Union for the control of African swine fever, including the measures to be taken in the event of an outbreak of African swine fever and in cases where African swine fever is suspected or confirmed in feral pigs. Those measures include plans to be developed and implemented by Member States, and approved by the Commission, for the eradication of African swine fever from a feral pig population.
(2) Commission Decision 2005/363/EC(5)was adopted in response to the presence of African swine fever in Sardinia, Italy. That Decision lays down animal health rules on the movement, dispatch and marking of pigs and certain pig products from Sardinia, in order to prevent the spread of that disease to other areas of the Union.
(3) In addition, Commission Decision 2005/362/EC(6)approved a plan submitted by Italy to the Commission for the eradication of African swine fever in feral pigs in Sardinia.
(4) In 2014, cases of African swine fever in feral pigs, more specifically in wildboar, occurred in Lithuania and Poland due to the introduction of the African swine fever virus from neighbouring third countries where that disease is present. In order to focus the control measures and to prevent disease spread as well as to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade by third countries, a Union list of infected areas in those countries was urgently established in collaboration with the Member States concerned by means of Commission Implementing Decision 2014/93/EU(7)and Commission Implementing Decision 2014/134/EU(8)which both apply until 30 April 2014.
(5) African swine fever can be considered an endemic disease in the domestic and feral pig populations of certain third countries bordering the Union and represents a permanent threat for the Union.
(6) The disease situation is liable to endanger the pig herds in other regions of Lithuania, Italy and Poland and also in other Member States, notably in view of trade in commodities from porcine animals.
(7) Lithuania and Poland have taken measures to combat African swine fever within the framework of Directive 2002/60/EC and they are due to submit their plan for the eradication of African swine fever in feral pigs to the Commission for approval in accordance with Article 16 of that Directive.
(8) It is appropriate that the Member States and areas concerned are listed in an Annex differentiated by the level of risk considering the epidemiological situation of African swine fever and whether it concerns both pigs holdings and the feral pig population (Part III), only the feral pig population (Part II) or the risk is due to certain proximity to the infection in the feral population (Part I).
(9) In terms of risk of spread of African swine fever, movements of different porcine commodities pose different levels of risk. As a general rule the movement of live pigs, their semen, ova and embryos and animal by-products of porcine origin from infected areas pose higher risks in terms of exposure and consequences than the movement of meat, meat preparations and meat products as indicated in the Scientific Opinion of the European Food Safety Authority of 2010(9). Therefore, the dispatch of live pigs and their semen, ova and embryos, animal by-products of porcine origin as well as the dispatch of certain meat, meat preparations and meat products from designated zones of the Member States listed in the Annex to this Decision should be prohibited. This prohibition includes all suidae as referred to in Council Directive 92/65/EEC(10).
(10) In order to take account of the different risk levels depending on the type of porcine commodities and the epidemiological situation in the Member States concerned, it is appropriate to provide for certain derogations for each type of porcine commodity from the territories listed in the different Parts of the Annex hereto. Those derogations are also in line with the risk mitigation measures for importation as regards African swine fever indicated in the Terrestrial Animal Health Code of the World Organization for Animal Health. The additional safeguard measures and health requirements or treatments applicable for those derogations should also be provided for in this Decision.
(11) Council Directive 64/432/EEC(11)and Commission Decision 93/444/EEC(12)provide that health certificates are to accompany the movements of animals. Where derogations from the prohibition on the dispatch of live pigs from areas listed in the Annex to this Decision are applied to live pigs intended for intra-Union trade or for export to a third country, those health certificates should include a reference to this Decision so to ensure that adequeate and accurate health information is provided in the relevant certificates.
(12) Commission Regulation (EC) No 599/2004(13)provides that health certificates are to accompany the movements of certain products of animal origin. In order to prevent the spread of African swine fever to other areas of the Union, where a Member State is subject to a prohibition on the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing pigmeat from certain parts of its territory, certain requirements should be laid down, in particular as regards certification, for the dispatch of such meat, meat preparations and meat products from other areas of the territory of that Member State not subject to that prohibition and those health certificates should include a reference to this Decision.
(13) In addition, it is appropriate, in order to prevent the spread of African swine fever to other areas of the Union and to third countries, to provide that the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing meat of pigs from Member States with areas listed in the Annex, is subject to certain more stringent conditions. In particular, such fresh pigmeat, meat preparations and pigmeat products should be marked with special marks which cannot be confused with the the identification mark provided for in Regulation (EC) No 853/2004 of the European Parliament and of the Council(14)and with the health marks for pigmeat provided for in Regulation (EC) No 854/2004 of the European Parliament and of the Council(15).
(14) The period of application of the measures provided for in this Decision should take account of the epidemiology of African swine fever and the conditions to regain the African swine fever free status according to the Terrestrial Animal Health Code of the World Organization for Animal Health and therefore this period should last at least until 31 December 2017.
(15) Implementing Decisions 2014/93/EU and 2014/134/EU should be repealed and replaced by this Decision. Decision 2005/363/EC has been amended several times. Therefore, it is appropriate to repeal that Decision and replace it by this Decision.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:

Subject matter and scope
Article 1
This Decision lays down animal health control measures in relation to African swine fever in the Member States or areas thereof as set out in the Annex (the Member States concerned).
It shall apply without prejudice to the plans for the eradication of African swine fever from feral pig populations in the Member State concerned, approved by the Commission in accordance with Article 16 of Directive 2002/60/EC.

Prohibition on the dispatch of live pigs, porcine semen, ova and embryo, pig meat, pig meat preparations, pig meat products and any other products containing pig meat as well as consignments of animal by-products from porcine animals from certain areas listed in the Annex
Article 2
The Member States concerned shall prohibit:
(a)
the dispatch of live pigs from the areas listed in Parts II or III of the Annex;
(b)
the dispatch of consignments of porcine semen, ova and embryos from the areas listed in Part III of the Annex;
(c)
the dispatch of consignments of pig meat, pig meat preparations, pig meat products and any other products containing pig meat from the areas listed in Part III of the Annex;
(d)
the dispatch of consignments of animal by-products from porcine animals from the areas listed in Part III of the Annex.

Derogation from the prohibition on the dispatch of live pigs from the areas listed in Part II of the Annex
Article 3
By way of derogation from the prohibition provided for in point (a) of Article 2, the Member States concerned may authorise the dispatch of live pigs from a holding located in the areas listed in Part II of the Annex to other areas in the territory of the same Member State provided that the pigs have been resident for a period of at least 30 days or since birth on the holding and no live pigs have been introduced into that holding during a period of at least 30 days prior to the date of the movement and
1.
the pigs have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Commission Decision 2003/422/EC(16)on the date of shipment, or
2.
the pigs come from a holding:
(a)
that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:
(i)
followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii)
included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii)
checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(b)
that implements bio-security requirements for African swine fever as establised by the competent authority.
(c)
in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1.

Derogation from the prohibition on the dispatch of consignments of pig meat, pig meat preparations, pig meat products and any other products consisting of or containing pig meat from the areas listed in Part III of the Annex
Article 4
By way of derogation from the prohibition provided for in point (c) of Article 2, the Member States concerned may authorise the dispatch of pig meat, pig meat preparations, pig meat products and any other products consisting of or containing pig meat, from the areas listed in Part III of the Annex provided they are either:
(a)
derived from pigs which have been kept since birth in holdings located outside the areas listed in the Annex, and the pig meat, pig meat preparations and pig meat products consisting of, or containing such meat, have been produced, stored and processed in establishments approved in accordance with Article 10; or
(b)
have been produced and processed in accordance with Article 4(1) of Directive 2002/99/EC.

Derogation from the prohibition on the dispatch of consignments of animal by-products from porcine animals from the areas listed in Part III of the Annex.
Article 5
By way of derogation from the prohibition provided for in point (d) of Article 2, the Member States concerned may authorise the dispatch of derived products as referred to in Article 3(2) of Regulation (EC) No 1069/2009 of the European Parliament and of the Council(17)obtained from animal by-products from porcine animals from the areas listed in Part III of the Annex provided that those by-products have been subjected to a treatment which ensures that the derived product pose no risks as regards African swine fever.

Prohibition on the dispatch to other Member States and third countries of live pigs from the areas listed in the Annex
Article 6
1. The Member States concerned shall ensure that live pigs are not dispatched from their territory to other Member States and third countries, except where those live pigs come from:
(a)
areas outside those listed in the Annex;
(b)
a holding where no live pigs originating from the areas listed in the Annex have been introduced during a period of at least 30 days immediately prior to the date of dispatch.
2. By way of derogation from paragraph 1, the Member States concerned may authorise the dispatch of live pigs from a holding located in the areas listed in the Part I of the Annex provided that those live pigs comply with the following conditions:
(a)
they have been resident for a period of at least 40 days or since birth on the holding and no live pigs have been introduced into that holding during the a period of at least 30 days prior to the date of the dispatch;
(b)
they come from a holding which implements bio-security requirements for African swine fever as establised by the competent authority;
(c)
they have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC on the date of shipment; or
(d)
they come from a holding which has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:
(i)
followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii)
included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii)
checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC.
3. For consignments of the live pigs referred to in this Article, the following additional wording shall be added to the corresponding health certificates referred to in:
(a)
Article 5(1) of Directive 64/432/EEC, or
(b)
Article 3(1) of Decision 93/444/EEC:
‘Pigs in compliance with Article 6(2) of Commission Implementing Decision 2014/178/EU(*1).

Prohibition on the dispatch to other Member States and third countries of consignments of porcine semen and ova and embryos of pigs from the areas listed in the Annex
Article 7
The Member State concerned shall ensure that no consignments of the following commodities are dispatched from their territory to other Member States and third countries:
(a)
porcine semen, unless the semen originates from boars kept at an approved collection centre as referred to in Article 3(a) of Council Directive 90/429/EEC(18)and situated outside the areas listed in Part II and Part III of the Annex to this Decision;
(b)
ova and embryos of animals of the porcine species, unless the ova and embryos originate from donor sows kept in holdings which comply with Article 6(2) and are situated outside the areas listed in Part II and III of the Annex and the embryos are conceived with semen in compliance with point (a).

Prohibition on the dispatch to other Member States and third countries of consignments of animal by-products from porcine animals from the areas listed in the Annex
Article 8
1. The Member State concerned shall ensure that no consignments of animal by-products from porcine animals are dispatched from their territory to other Member States and third countries, unless those porcine by-products originated from pigs originating in and coming from holdings located in the areas outside those listed in Parts II and III of the Annex.
2. By way of derogation from paragraph 1, the Member States concerned may authorise the dispatch of derived products obtained from animal by-products from porcine animals from the areas listed in Part II and Part III of the Annex to other Member States and third countries provided that:
(a)
those by-products are have been subjected to a treatment which ensures that the derived product obtained from porcine animals poses no risks as regards African swine fever;
(b)
the consignments are accompanied by a commercial document issued as referred in Chapter III of Annex VIII to Commission Regulation (EU) No 142/2011(19).

Prohibition on the dispatch to other Member States and third countries of fresh pig meat and of certain pig meat preparations and pig meat products from areas listed in the Annex
Article 9
1. The Member States concerned shall ensure that consignments of fresh pig meat from pigs originating from holdings located in the areas listed in the Annex, and pig meat preparations and pig meat products consisting of, or containing meat of those pigs are not dispatched to other Member States and third countries, except where such pig meat was produced from pigs originating in and coming from holdings not located in the areas listed in Parts II or III of the Annex.
2. By way of derogation from paragraph 1, the Member States concerned with areas listed in Part III of the Annex may authorise the dispatch of fresh pig meat referred to in paragraph 1 and pig meat preparations and pig meat products consisting of, or containing such pig meat, to other Member States provided that those pig meat preparations and pig meat products are derived from pigs which have been kept since birth in holdings located outside the areas listed in Part III of the Annex and the fresh pig meat, pig meat preparations and pig meat products are produced, stored and processed in establishments approved in accordance with Article 10.
3. By way of derogation from paragraph 1, the Member States concerned with areas listed in Part II of the Annex may authorise the dispatch of fresh pig meat referred to in paragraph 1 and pig meat preparations and pig meat products consisting of, or containing such pig meat, to other Member States provided that those pig meat preparations and pig meat products are derived from pigs that comply with the requirements laid down in paragraph 1 or 2 of Article 3.

Approval of slaughterhouses, cutting plants and meat processing establishments for the purposes of Article 4 and Article 9(2)
Article 10
The competent authority of the Member States concerned shall only approve slaughterhouses, cutting plants and meat processing establishments for the purposes of Article 4 and Article 9(2) in which the production, storage and processing of the fresh pig meat and pig meat preparations and pig meat products consisting of or containing such pig meat eligible for dispatch to other Member States and third countries in accordance with the derogations provided for in Article 4 and Article 9(2), is carried out separately from the production, storage and processing of other products consisting of or containing fresh pig meat and pig meat preparations and pig meat products consisting of or containing meat derived from pigs originating in or coming from holdings located in areas listed in the Annex other than those approved in accordance with this Article.

Derogation from the prohibition on the dispatch of fresh pig meat and of certain pig meat preparations and pig meat products from areas listed in the Annex
Article 11
By way of derogation from Article 9, the Member States concerned may authorise the dispatch of fresh pig meat, pig meat preparations and pig meat products consisting of or containing such meat from the areas listed in Part II or Part III of the Annex, to other Member States and third countries provided that the products in question:
(a)
have been produced and processed in compliance with Article 4(1) of Directive 2002/99/EC;
(b)
are subjected to veterinary certification in accordance with Article 5 of Directive 2002/99/EC;
(c)
are accompanied by the appropriate intra-Union trade health certificate as laid down by Regulation (EC) No 599/2004 of which Part II shall be completed by the following:
‘Products in accordance with Commission Implementing Decision 2014/178/EU of 27 March 2014 concerning animal health control measures relating to African swine fever in certain Member States(*2).

Information concerning Articles 9 to 11
Article 12
The Member States shall communicate to the Commission and the other Member States, every six months from the date of this Decision, the updated list of approved establishments referred to in Article 10 and any relevant information on the application of Articles 9, 10 and 11.

Measures relating to live feral pigs, fresh meat, meat preparations and meat products consisting of or containing meat from feral pigs
Article 13
1. The Member States concerned shall ensure that:
(a)
no live feral pigs from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State;
(b)
no consignments of fresh meat of feral pigs, meat preparations and meat products consisting of or containing such meat from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State.
2. By way of derogation from paragraph 1(b), the Member States concerned may authorise the dispatch of consignments of fresh meat of feral pigs, meat preparations and meat products consisting of or containing such meat from the areas listed in Part I of the Annex to other areas in the territory of the same Member State not listed in the Annex, provided that the feral pigs have been tested with negative results for African swine fever in accordance with the diagnostic procedures set out in Parts C and D of Chapter VI of the Annex to Decision 2003/422/EC.

Special health marks and certification requirements for fresh meat, meat preparations and meat products subject to prohibition referred to in Articles 2, 9 and 13
Article 14
The Member States concerned shall ensure that the fresh meat and meat preparations and meat products subject to the prohibitions provided for in Articles 2, 9 and 13 are marked with a special health mark that is not oval and cannot be confused with:
(a)
the identification mark for meat preparations and meat products consisting of, or containing pig meat, as set out in Section I of Annex II to Regulation (EC) No 853/2004;
(b)
the health mark for fresh pig meat as set out in Chapter III of Section I of Annex I to Regulation (EC) No 854/2004.

Requirements concerning holdings and transport vehicles in the areas listed in the Annex
Article 15
The Member States concerned shall ensure that:
(a)
the conditions laid down in the second and the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC are applied in the pig holdings located within the areas listed in the Annex to this Decision;
(b)
vehicles which have been used for the transport of pigs or animal by-products from porcine animals originating from holdings located within the areas listed in the Annex to this Decision are cleansed and disinfected immediately following each operation and the transporter provides proof of such cleansing and disinfection.

Information requirements of the Member States concerned
Article 16
The Member States concerned shall inform the Commission and the other Member States, in the framework of the Standing Committee on the Food Chain and Animal Health, of the results of the surveillance for African swine fever carried out in the areas listed in the Annex, as provided for in the plans for the eradication of African swine fever from feral pig populations approved by the Commission in accordance with Article 16 of Directive 2002/60/EC and referred to in the second paragraph of Article 1 of this Decision.

Compliance
Article 17
The Member States shall amend the measures they apply to trade so as to bring them into compliance with this Decision and they shall give immediate appropriate publicity to the measures adopted. They shall immediately inform the Commission thereof.

Repeal
Article 18
Decision 2005/363/EC, Implementing Decisions 2014/93/EU and 2014/134/EU are repealed.

Applicability
Article 19
This Decision shall apply until 31 December 2017.

Addressees
Article 20
This Decision is addressed to the Member States.

THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Directive 89/662/EEC of 11 December 1989 concerning veterinary checks in intra-Community trade with a view to the completion of the internal market(1), and in particular Article 9(4) thereof,
Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animals and products with a view to the completion of the internal market(2), and in particular Article 10(4) thereof,
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption(3), and in particular Article 4(3) thereof,
(1) Council Directive 2002/60/EC(4)lays down the minimum measures to be applied within the Union for the control of African swine fever, including the measures to be taken in the event of an outbreak of African swine fever and in cases where African swine fever is suspected or confirmed in feral pigs. Those measures include plans to be developed and implemented by Member States, and approved by the Commission, for the eradication of African swine fever from a feral pig population.
(2) Commission Decision 2005/363/EC(5)was adopted in response to the presence of African swine fever in Sardinia, Italy. That Decision lays down animal health rules on the movement, dispatch and marking of pigs and certain pig products from Sardinia, in order to prevent the spread of that disease to other areas of the Union.
(3) In addition, Commission Decision 2005/362/EC(6)approved a plan submitted by Italy to the Commission for the eradication of African swine fever in feral pigs in Sardinia.
(4) In 2014, cases of African swine fever in feral pigs, more specifically in wildboar, occurred in Lithuania and Poland due to the introduction of the African swine fever virus from neighbouring third countries where that disease is present. In order to focus the control measures and to prevent disease spread as well as to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade by third countries, a Union list of infected areas in those countries was urgently established in collaboration with the Member States concerned by means of Commission Implementing Decision 2014/93/EU(7)and Commission Implementing Decision 2014/134/EU(8)which both apply until 30 April 2014.
(5) African swine fever can be considered an endemic disease in the domestic and feral pig populations of certain third countries bordering the Union and represents a permanent threat for the Union.
(6) The disease situation is liable to endanger the pig herds in other regions of Lithuania, Italy and Poland and also in other Member States, notably in view of trade in commodities from porcine animals.
(7) Lithuania and Poland have taken measures to combat African swine fever within the framework of Directive 2002/60/EC and they are due to submit their plan for the eradication of African swine fever in feral pigs to the Commission for approval in accordance with Article 16 of that Directive.
(8) It is appropriate that the Member States and areas concerned are listed in an Annex differentiated by the level of risk considering the epidemiological situation of African swine fever and whether it concerns both pigs holdings and the feral pig population (Part III), only the feral pig population (Part II) or the risk is due to certain proximity to the infection in the feral population (Part I).
(9) In terms of risk of spread of African swine fever, movements of different porcine commodities pose different levels of risk. As a general rule the movement of live pigs, their semen, ova and embryos and animal by-products of porcine origin from infected areas pose higher risks in terms of exposure and consequences than the movement of meat, meat preparations and meat products as indicated in the Scientific Opinion of the European Food Safety Authority of 2010(9). Therefore, the dispatch of live pigs and their semen, ova and embryos, animal by-products of porcine origin as well as the dispatch of certain meat, meat preparations and meat products from designated zones of the Member States listed in the Annex to this Decision should be prohibited. This prohibition includes all suidae as referred to in Council Directive 92/65/EEC(10).
(10) In order to take account of the different risk levels depending on the type of porcine commodities and the epidemiological situation in the Member States concerned, it is appropriate to provide for certain derogations for each type of porcine commodity from the territories listed in the different Parts of the Annex hereto. Those derogations are also in line with the risk mitigation measures for importation as regards African swine fever indicated in the Terrestrial Animal Health Code of the World Organization for Animal Health. The additional safeguard measures and health requirements or treatments applicable for those derogations should also be provided for in this Decision.
(11) Council Directive 64/432/EEC(11)and Commission Decision 93/444/EEC(12)provide that health certificates are to accompany the movements of animals. Where derogations from the prohibition on the dispatch of live pigs from areas listed in the Annex to this Decision are applied to live pigs intended for intra-Union trade or for export to a third country, those health certificates should include a reference to this Decision so to ensure that adequeate and accurate health information is provided in the relevant certificates.
(12) Commission Regulation (EC) No 599/2004(13)provides that health certificates are to accompany the movements of certain products of animal origin. In order to prevent the spread of African swine fever to other areas of the Union, where a Member State is subject to a prohibition on the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing pigmeat from certain parts of its territory, certain requirements should be laid down, in particular as regards certification, for the dispatch of such meat, meat preparations and meat products from other areas of the territory of that Member State not subject to that prohibition and those health certificates should include a reference to this Decision.
(13) In addition, it is appropriate, in order to prevent the spread of African swine fever to other areas of the Union and to third countries, to provide that the dispatch of fresh pigmeat, meat preparations and meat products consisting of, or containing meat of pigs from Member States with areas listed in the Annex, is subject to certain more stringent conditions. In particular, such fresh pigmeat, meat preparations and pigmeat products should be marked with special marks which cannot be confused with the the identification mark provided for in Regulation (EC) No 853/2004 of the European Parliament and of the Council(14)and with the health marks for pigmeat provided for in Regulation (EC) No 854/2004 of the European Parliament and of the Council(15).
(14) The period of application of the measures provided for in this Decision should take account of the epidemiology of African swine fever and the conditions to regain the African swine fever free status according to the Terrestrial Animal Health Code of the World Organization for Animal Health and therefore this period should last at least until 31 December 2017.
(15) Implementing Decisions 2014/93/EU and 2014/134/EU should be repealed and replaced by this Decision. Decision 2005/363/EC has been amended several times. Therefore, it is appropriate to repeal that Decision and replace it by this Decision.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:

Subject matter and scope

This Decision lays down animal health control measures in relation to African swine fever in the Member States or areas thereof as set out in the Annex (the Member States concerned).
It shall apply without prejudice to the plans for the eradication of African swine fever from feral pig populations in the Member State concerned, approved by the Commission in accordance with Article 16 of Directive 2002/60/EC.

Prohibition on the dispatch of live pigs, porcine semen, ova and embryo, pig meat, pig meat preparations, pig meat products and any other products containing pig meat as well as consignments of animal by-products from porcine animals from certain areas listed in the Annex

The Member States concerned shall prohibit:
(a)
the dispatch of live pigs from the areas listed in Parts II or III of the Annex;
(b)
the dispatch of consignments of porcine semen, ova and embryos from the areas listed in Part III of the Annex;
(c)
the dispatch of consignments of pig meat, pig meat preparations, pig meat products and any other products containing pig meat from the areas listed in Part III of the Annex;
(d)
the dispatch of consignments of animal by-products from porcine animals from the areas listed in Part III of the Annex.

Derogation from the prohibition on the dispatch of live pigs from the areas listed in Part II of the Annex

By way of derogation from the prohibition provided for in point (a) of Article 2, the Member States concerned may authorise the dispatch of live pigs from a holding located in the areas listed in Part II of the Annex to other areas in the territory of the same Member State provided that the pigs have been resident for a period of at least 30 days or since birth on the holding and no live pigs have been introduced into that holding during a period of at least 30 days prior to the date of the movement and
1.
the pigs have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Commission Decision 2003/422/EC(16)on the date of shipment, or
2.
the pigs come from a holding:
(a)
that has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:
(i)
followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii)
included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii)
checked the effective application of the measures provided for in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC;
(b)
that implements bio-security requirements for African swine fever as establised by the competent authority.
(c)
in which the pigs over the age of 60 days have been subjected to the laboratory testing for African swine fever referred to in paragraph 1.

Derogation from the prohibition on the dispatch of consignments of pig meat, pig meat preparations, pig meat products and any other products consisting of or containing pig meat from the areas listed in Part III of the Annex

By way of derogation from the prohibition provided for in point (c) of Article 2, the Member States concerned may authorise the dispatch of pig meat, pig meat preparations, pig meat products and any other products consisting of or containing pig meat, from the areas listed in Part III of the Annex provided they are either:
(a)
derived from pigs which have been kept since birth in holdings located outside the areas listed in the Annex, and the pig meat, pig meat preparations and pig meat products consisting of, or containing such meat, have been produced, stored and processed in establishments approved in accordance with Article 10; or
(b)
have been produced and processed in accordance with Article 4(1) of Directive 2002/99/EC.

Derogation from the prohibition on the dispatch of consignments of animal by-products from porcine animals from the areas listed in Part III of the Annex.

By way of derogation from the prohibition provided for in point (d) of Article 2, the Member States concerned may authorise the dispatch of derived products as referred to in Article 3(2) of Regulation (EC) No 1069/2009 of the European Parliament and of the Council(17)obtained from animal by-products from porcine animals from the areas listed in Part III of the Annex provided that those by-products have been subjected to a treatment which ensures that the derived product pose no risks as regards African swine fever.

Prohibition on the dispatch to other Member States and third countries of live pigs from the areas listed in the Annex

1. The Member States concerned shall ensure that live pigs are not dispatched from their territory to other Member States and third countries, except where those live pigs come from:
(a)
areas outside those listed in the Annex;
(b)
a holding where no live pigs originating from the areas listed in the Annex have been introduced during a period of at least 30 days immediately prior to the date of dispatch.
2. By way of derogation from paragraph 1, the Member States concerned may authorise the dispatch of live pigs from a holding located in the areas listed in the Part I of the Annex provided that those live pigs comply with the following conditions:
(a)
they have been resident for a period of at least 40 days or since birth on the holding and no live pigs have been introduced into that holding during the a period of at least 30 days prior to the date of the dispatch;
(b)
they come from a holding which implements bio-security requirements for African swine fever as establised by the competent authority;
(c)
they have been subjected to laboratory testing for African swine fever carried out with negative results on samples taken in accordance with the sampling procedures as laid down in the plan for the eradication of African swine fever referred to in the second paragraph of Article 1 of this Decision within a period of 15 days prior to the date of the movement and a clinical examination for African swine fever has been carried out by an official veterinarian in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC on the date of shipment; or
(d)
they come from a holding which has been subjected at least twice a year, with an interval of at least 4 months, to inspections by the competent veterinary authority, which:
(i)
followed the guidelines and procedures laid down in Chapter IV of the Annex to Decision 2003/422/EC;
(ii)
included a clinical examination and sampling in accordance with the checking and sampling procedures laid down in Part A of Chapter IV of the Annex to Decision 2003/422/EC;
(iii)
checked the effective application of the measures provided for provisions laid down in the second indent and in the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC.
3. For consignments of the live pigs referred to in this Article, the following additional wording shall be added to the corresponding health certificates referred to in:
(a)
Article 5(1) of Directive 64/432/EEC, or
(b)
Article 3(1) of Decision 93/444/EEC:
‘Pigs in compliance with Article 6(2) of Commission Implementing Decision 2014/178/EU(*1).

Prohibition on the dispatch to other Member States and third countries of consignments of porcine semen and ova and embryos of pigs from the areas listed in the Annex

The Member State concerned shall ensure that no consignments of the following commodities are dispatched from their territory to other Member States and third countries:
(a)
porcine semen, unless the semen originates from boars kept at an approved collection centre as referred to in Article 3(a) of Council Directive 90/429/EEC(18)and situated outside the areas listed in Part II and Part III of the Annex to this Decision;
(b)
ova and embryos of animals of the porcine species, unless the ova and embryos originate from donor sows kept in holdings which comply with Article 6(2) and are situated outside the areas listed in Part II and III of the Annex and the embryos are conceived with semen in compliance with point (a).

Prohibition on the dispatch to other Member States and third countries of consignments of animal by-products from porcine animals from the areas listed in the Annex

1. The Member State concerned shall ensure that no consignments of animal by-products from porcine animals are dispatched from their territory to other Member States and third countries, unless those porcine by-products originated from pigs originating in and coming from holdings located in the areas outside those listed in Parts II and III of the Annex.
2. By way of derogation from paragraph 1, the Member States concerned may authorise the dispatch of derived products obtained from animal by-products from porcine animals from the areas listed in Part II and Part III of the Annex to other Member States and third countries provided that:
(a)
those by-products are have been subjected to a treatment which ensures that the derived product obtained from porcine animals poses no risks as regards African swine fever;
(b)
the consignments are accompanied by a commercial document issued as referred in Chapter III of Annex VIII to Commission Regulation (EU) No 142/2011(19).

Prohibition on the dispatch to other Member States and third countries of fresh pig meat and of certain pig meat preparations and pig meat products from areas listed in the Annex

1. The Member States concerned shall ensure that consignments of fresh pig meat from pigs originating from holdings located in the areas listed in the Annex, and pig meat preparations and pig meat products consisting of, or containing meat of those pigs are not dispatched to other Member States and third countries, except where such pig meat was produced from pigs originating in and coming from holdings not located in the areas listed in Parts II or III of the Annex.
2. By way of derogation from paragraph 1, the Member States concerned with areas listed in Part III of the Annex may authorise the dispatch of fresh pig meat referred to in paragraph 1 and pig meat preparations and pig meat products consisting of, or containing such pig meat, to other Member States provided that those pig meat preparations and pig meat products are derived from pigs which have been kept since birth in holdings located outside the areas listed in Part III of the Annex and the fresh pig meat, pig meat preparations and pig meat products are produced, stored and processed in establishments approved in accordance with Article 10.
3. By way of derogation from paragraph 1, the Member States concerned with areas listed in Part II of the Annex may authorise the dispatch of fresh pig meat referred to in paragraph 1 and pig meat preparations and pig meat products consisting of, or containing such pig meat, to other Member States provided that those pig meat preparations and pig meat products are derived from pigs that comply with the requirements laid down in paragraph 1 or 2 of Article 3.

Approval of slaughterhouses, cutting plants and meat processing establishments for the purposes of Article 4 and Article 9(2)

The competent authority of the Member States concerned shall only approve slaughterhouses, cutting plants and meat processing establishments for the purposes of Article 4 and Article 9(2) in which the production, storage and processing of the fresh pig meat and pig meat preparations and pig meat products consisting of or containing such pig meat eligible for dispatch to other Member States and third countries in accordance with the derogations provided for in Article 4 and Article 9(2), is carried out separately from the production, storage and processing of other products consisting of or containing fresh pig meat and pig meat preparations and pig meat products consisting of or containing meat derived from pigs originating in or coming from holdings located in areas listed in the Annex other than those approved in accordance with this Article.

Derogation from the prohibition on the dispatch of fresh pig meat and of certain pig meat preparations and pig meat products from areas listed in the Annex

By way of derogation from Article 9, the Member States concerned may authorise the dispatch of fresh pig meat, pig meat preparations and pig meat products consisting of or containing such meat from the areas listed in Part II or Part III of the Annex, to other Member States and third countries provided that the products in question:
(a)
have been produced and processed in compliance with Article 4(1) of Directive 2002/99/EC;
(b)
are subjected to veterinary certification in accordance with Article 5 of Directive 2002/99/EC;
(c)
are accompanied by the appropriate intra-Union trade health certificate as laid down by Regulation (EC) No 599/2004 of which Part II shall be completed by the following:
‘Products in accordance with Commission Implementing Decision 2014/178/EU of 27 March 2014 concerning animal health control measures relating to African swine fever in certain Member States(*2).

Information concerning Articles 9 to 11

The Member States shall communicate to the Commission and the other Member States, every six months from the date of this Decision, the updated list of approved establishments referred to in Article 10 and any relevant information on the application of Articles 9, 10 and 11.

Measures relating to live feral pigs, fresh meat, meat preparations and meat products consisting of or containing meat from feral pigs

1. The Member States concerned shall ensure that:
(a)
no live feral pigs from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State;
(b)
no consignments of fresh meat of feral pigs, meat preparations and meat products consisting of or containing such meat from the areas listed in the Annex are dispatched to other Member States or to other areas in the territory of the same Member State.
2. By way of derogation from paragraph 1(b), the Member States concerned may authorise the dispatch of consignments of fresh meat of feral pigs, meat preparations and meat products consisting of or containing such meat from the areas listed in Part I of the Annex to other areas in the territory of the same Member State not listed in the Annex, provided that the feral pigs have been tested with negative results for African swine fever in accordance with the diagnostic procedures set out in Parts C and D of Chapter VI of the Annex to Decision 2003/422/EC.

Special health marks and certification requirements for fresh meat, meat preparations and meat products subject to prohibition referred to in Articles 2, 9 and 13

The Member States concerned shall ensure that the fresh meat and meat preparations and meat products subject to the prohibitions provided for in Articles 2, 9 and 13 are marked with a special health mark that is not oval and cannot be confused with:
(a)
the identification mark for meat preparations and meat products consisting of, or containing pig meat, as set out in Section I of Annex II to Regulation (EC) No 853/2004;
(b)
the health mark for fresh pig meat as set out in Chapter III of Section I of Annex I to Regulation (EC) No 854/2004.

Requirements concerning holdings and transport vehicles in the areas listed in the Annex

The Member States concerned shall ensure that:
(a)
the conditions laid down in the second and the fourth to seventh indents of Article 15(2)(b) of Directive 2002/60/EC are applied in the pig holdings located within the areas listed in the Annex to this Decision;
(b)
vehicles which have been used for the transport of pigs or animal by-products from porcine animals originating from holdings located within the areas listed in the Annex to this Decision are cleansed and disinfected immediately following each operation and the transporter provides proof of such cleansing and disinfection.

Information requirements of the Member States concerned

The Member States concerned shall inform the Commission and the other Member States, in the framework of the Standing Committee on the Food Chain and Animal Health, of the results of the surveillance for African swine fever carried out in the areas listed in the Annex, as provided for in the plans for the eradication of African swine fever from feral pig populations approved by the Commission in accordance with Article 16 of Directive 2002/60/EC and referred to in the second paragraph of Article 1 of this Decision.

Compliance

The Member States shall amend the measures they apply to trade so as to bring them into compliance with this Decision and they shall give immediate appropriate publicity to the measures adopted. They shall immediately inform the Commission thereof.

Repeal

Decision 2005/363/EC, Implementing Decisions 2014/93/EU and 2014/134/EU are repealed.

Applicability

This Decision shall apply until 31 December 2017.

Addressees

This Decision is addressed to the Member States.

PART I

ANNEX1. Lithuania
The following areas in Lithuania:

(a)in Vilnius county (apskritis): | (a) | in Vilnius county (apskritis): | —part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103), | — | part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103),
(a) | in Vilnius county (apskritis):
— | part of Vilnius district municipality(southern part from the roads No A2 (E272) and No 103),
| —Trakai district municipality and Elektrėnai municipality; | — | Trakai district municipality and Elektrėnai municipality;
— | Trakai district municipality and Elektrėnai municipality;
(b)in Marijampolė county (apskritis): | (b) | in Marijampolė county (apskritis): | —Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality; | — | Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality;
(b) | in Marijampolė county (apskritis):
— | Marijampolė municipality, Kalvarija municipality and Kazlų Rūda municipality;
(c)in Kaunas county (apskritis): | (c) | in Kaunas county (apskritis): | —Prienai district municipality and Birštonas municipality. | — | Prienai district municipality and Birštonas municipality.
(c) | in Kaunas county (apskritis):
— | Prienai district municipality and Birštonas municipality.2. Poland
The following areas in Poland:
In podlaskie voivodship:

— | the city of Suwałki;
— | the city of Białystok;
— | the municipalities of Suwałki, Szypliszki and Raczki in suwalski district;
— | the municipalities of Augustów with the city of Augustów, Nowinka, Sztabin and Bargłów Kościelny in augustowski district;
— | the municipalities of Krasnopol and Puńsk in sejneński district;
— | the municipalities of Goniądz, Jasionówka, Jaświły, Knyszyn, Krypno and Mońki in moniecki district;
— | the municipalities of Suchowola and Korycin in sokólski district;
— | the municipalities of Choroszcz, Juchnowiec Kościelny, Suraż, Turośń Kościelna, Tykocin, Zabłudów and Dobrzyniewo Duże in białostocki district;
— | the municipalities of Bielsk Podlaski with the city of Bielsk Podlaski, Orla and Wyszki in bielski district;
— | the municipalities of Narew, Narewka, Białowieża, Czyże, Dubicze Cerkiewne and Hajnówka with the city of Hajnówka in hajnowski district.PART II1. Lithuania
The following areas in Lithuania:

(a)in Vilnius county (apskritis): | (a) | in Vilnius county (apskritis): | —the Šalčininkai district municipality; | — | the Šalčininkai district municipality;
(a) | in Vilnius county (apskritis):
— | the Šalčininkai district municipality;
(b)in Alytus county (apskritis): | (b) | in Alytus county (apskritis): | —the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality. | — | the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality.
(b) | in Alytus county (apskritis):
— | the Lazdijai district municipality, Varėna district municipality, Alytus district municipality, Alytus city municipality and the Druskininkai municipality.2. Poland
The following areas in Poland:
In podlaskie voivodship:

— | the municipalities of Giby and Sejny with the city of Sejny in sejneński district;
— | the municipalities of Lipsk and Płaska in augustowski district;
— | the municipalities of Czarna Białostocka, Gródek, Supraśl, Wasilków and Michałowo in białostocki district;
— | the municipalities of Dąbrowa Białostocka, Janów, Krynki, Kuźnica, Nowy Dwór, Sidra, Sokółka and Szudziałowo in sokólski district.PART III
Italy
The following areas in Italy:
All areas of Sardinia.

Pending: 32010D0565

22.9.2010 EN Official Journal of the European Union L 248/59
(1) On the basis of Joint Action 2005/355/CFSP(1), the European Union (EU) has been conducting, since 2 May 2005, a mission to provide advice and assistance for security sector reform in the Democratic Republic of the Congo (DRC) (EUSEC RD Congo). The current mandate of the mission is set out in Joint Action 2009/709/CFSP(2)and expires on 30 September 2010.
(2) The Secretary-General/High Representative for Common Foreign and Security Policy sent a letter to the President of the DRC dated 27 July 2009 stating the EU's renewed commitment. Following that letter, the mission statement was adapted as from 1 October 2009. The Congolese authorities transposed that letter into an action programme which was signed, on 21 January 2010, by the Minister for Defence and War Veterans and the Head of the EUSEC RD Congo mission.
(3) Following the ratification in 2005 of the Constitution of the Third Republic of the Congo, the elections held in the DRC in 2006 marked the end of the transition process and enabled a government to be formed in 2007, which has adopted a programme providing in particular for comprehensive reform of the security sector, the drawing up of a national plan, and priority reforms in the police, armed forces and judicial sectors. The Congolese authorities have demonstrated their interest in implementing the security sector reform (SSR) process in the DRC at operational level by developing a plan to reform the Armed Forces of the Democratic Republic of the Congo (FARDC) in three stages between 2009 and 2025, a plan which was approved by the President of the Republic at the end of May 2009 and presented to the representatives of the international community on 26 January 2010, and by taking over the role of coordinator of the work of the various actors supporting SSR in the DRC.
(4) The United Nations has reaffirmed its support for the transition process and SSR by means of several Security Council resolutions, and is conducting the United Nations Organisation Stabilisation Mission in the Democratic Republic of the Congo (MONUSCO), which is focusing on peacekeeping in the east of the country and on peace consolidation throughout the country. On 28 May 2010, the United Nations Security Council adopted Resolution 1925 (2010) extending MONUC's mandate until 30 June 2010 and renaming it the United Nations Organisation Stabilisation Mission in the DRC (MONUSCO) as from 1 July 2010 and allowing it to support, in close cooperation with other international partners, the efforts of the Congolese authorities to strengthen and reform security and judicial institutions.
(5) The EU has consistently supported SSR in the DRC, as one of the elements of a more general EU commitment to supporting development and democracy in the African Great Lakes Region, while taking care to promote policies compatible with human rights and international humanitarian law, democratic standards and the principles of good governance, transparency and respect for the rule of law.
(6) On 14 June 2010, the Council adopted Decision 2010/329/CFSP amending and extending for an additional period of three months Joint Action 2007/405/CFSP on the European Union police mission undertaken in the framework of SSR and its interface with the system of justice in the Democratic Republic of the Congo (EUPOL RD Congo)(3).
(7) In order to increase the coordination, consistency and complementarity of the EU's activities in the DRC, making maximum use of the new European institutional framework, there should be enhanced coordination of EU action between the two missions, between the European players in the DRC and between Brussels and Kinshasa.
(8) On 11 August 2010, the Council adopted Decision 2010/440/CFSP(4)extending the mandate of Mr Roeland VAN DE GEER as the EU Special Representative (EUSR) for the African Great Lakes Region.
(9) On 29 July 2010, the Council approved the crisis management concept for the commitment of common security and defence policy missions in support of security sector reform in the DRC.
(10) Third States should participate in the project in accordance with the general guidelines defined by the European Council.
(11) The current security situation in the DRC may deteriorate, with potentially serious repercussions for the process of strengthening democracy, the rule of law and international and regional security. A continued commitment of EU political effort and resources will help to embed stability in the region,
(a) maintaining support at strategic level;
(b) supporting the consolidation of the administration and the introduction of a human resources management system based on the work in progress;
(c) supporting the modernisation of logistics;
(d) supporting a relaunch of the training system, particularly for executive staff, mainly through support for the School of Administration and Military Academy project in Kananga and for studies for the School of Logistics in Kinshasa;
(e) pursuing activities relating to the campaign against impunity in the areas of respect for human rights, including sexual violence.
(a) a leadership;
(b) an administrative support and logistics department;
(c) a department of defence experts responsible for assisting and supporting the Congolese in carrying out specific actions in the areas of administration, human resources, logistics and training;
(d) an advice and assistance department, including advisers deployed in the east of the DRC and responsible for contributing to work on SSR carried out by the Congolese administration; and
(e) a planning cell.
(a) expenditure shall be managed in accordance with the EU rules and procedures applicable to the budget. Nationals of third States shall be allowed to tender for contracts;
(b) the Head of Mission shall report fully to, and be supervised by, the Commission regarding the activities undertaken in the framework of his contract.
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on European Union, and in particular Article 28 and Article 43 thereof,
(1) On the basis of Joint Action 2005/355/CFSP(1), the European Union (EU) has been conducting, since 2 May 2005, a mission to provide advice and assistance for security sector reform in the Democratic Republic of the Congo (DRC) (EUSEC RD Congo). The current mandate of the mission is set out in Joint Action 2009/709/CFSP(2)and expires on 30 September 2010.
(2) The Secretary-General/High Representative for Common Foreign and Security Policy sent a letter to the President of the DRC dated 27 July 2009 stating the EU’s renewed commitment. Following that letter, the mission statement was adapted as from 1 October 2009. The Congolese authorities transposed that letter into an action programme which was signed, on 21 January 2010, by the Minister for Defence and War Veterans and the Head of the EUSEC RD Congo mission.
(3) Following the ratification in 2005 of the Constitution of the Third Republic of the Congo, the elections held in the DRC in 2006 marked the end of the transition process and enabled a government to be formed in 2007, which has adopted a programme providing in particular for comprehensive reform of the security sector, the drawing up of a national plan, and priority reforms in the police, armed forces and judicial sectors. The Congolese authorities have demonstrated their interest in implementing the security sector reform (SSR) process in the DRC at operational level by developing a plan to reform the Armed Forces of the Democratic Republic of the Congo (FARDC) in three stages between 2009 and 2025, a plan which was approved by the President of the Republic at the end of May 2009 and presented to the representatives of the international community on 26 January 2010, and by taking over the role of coordinator of the work of the various actors supporting SSR in the DRC.
(4) The United Nations has reaffirmed its support for the transition process and SSR by means of several Security Council resolutions, and is conducting the United Nations Organisation Stabilisation Mission in the Democratic Republic of the Congo (MONUSCO), which is focusing on peacekeeping in the east of the country and on peace consolidation throughout the country. On 28 May 2010, the United Nations Security Council adopted Resolution 1925 (2010) extending MONUC’s mandate until 30 June 2010 and renaming it the United Nations Organisation Stabilisation Mission in the DRC (MONUSCO) as from 1 July 2010 and allowing it to support, in close cooperation with other international partners, the efforts of the Congolese authorities to strengthen and reform security and judicial institutions.
(5) The EU has consistently supported SSR in the DRC, as one of the elements of a more general EU commitment to supporting development and democracy in the African Great Lakes Region, while taking care to promote policies compatible with human rights and international humanitarian law, democratic standards and the principles of good governance, transparency and respect for the rule of law.
(6) On 14 June 2010, the Council adopted Decision 2010/329/CFSP amending and extending for an additional period of three months Joint Action 2007/405/CFSP on the European Union police mission undertaken in the framework of SSR and its interface with the system of justice in the Democratic Republic of the Congo (EUPOL RD Congo)(3).
(7) In order to increase the coordination, consistency and complementarity of the EU’s activities in the DRC, making maximum use of the new European institutional framework, there should be enhanced coordination of EU action between the two missions, between the European players in the DRC and between Brussels and Kinshasa.
(8) On 11 August 2010, the Council adopted Decision 2010/440/CFSP(4)extending the mandate of Mr Roeland VAN DE GEER as the EU Special Representative (EUSR) for the African Great Lakes Region.
(9) On 29 July 2010, the Council approved the crisis management concept for the commitment of common security and defence policy missions in support of security sector reform in the DRC.
(10) Third States should participate in the project in accordance with the general guidelines defined by the European Council.
(11) The current security situation in the DRC may deteriorate, with potentially serious repercussions for the process of strengthening democracy, the rule of law and international and regional security. A continued commitment of EU political effort and resources will help to embed stability in the region,
HAS ADOPTED THIS DECISION:

Mission
Article 1
1. The European Union (EU) is conducting a mission to provide advice and assistance for security sector reform (SSR) in the Democratic Republic of the Congo (DRC), hereinafter referred to as ‘EUSEC RD Congo’ or ‘the mission’, with the aim of assisting the Congolese authorities in setting up a defence apparatus capable of guaranteeing the security of the Congolese people, while respecting democratic standards, human rights and the rule of law, as well as the principles of good governance and transparency.
2. The mission shall operate in accordance with the mission statement set out in Article 2.

Mission statement
Article 2
1. The mission shall aim, in close cooperation and coordination with the other actors in the international community, in particular the United Nations and MONUSCO, and in pursuit of the objectives laid down in Article 1, to provide practical support in the field of SSR, creating conditions to facilitate the implementation in the short and medium term of activities and projects based on the guidelines adopted by the Congolese authorities in the plan for reform of the FARDC as set out in the mission action programme, including:
(a)
maintaining support at strategic level;
(b)
supporting the consolidation of the administration and the introduction of a human resources management system based on the work in progress;
(c)
supporting the modernisation of logistics;
(d)
supporting a relaunch of the training system, particularly for executive staff, mainly through support for the School of Administration and Military Academy project in Kananga and for studies for the School of Logistics in Kinshasa;
(e)
pursuing activities relating to the campaign against impunity in the areas of respect for human rights, including sexual violence.
2. The mission shall advise the Member States and shall coordinate and facilitate, under their responsibility, the implementation of their projects in fields which are of interest to the mission and in furtherance of its objectives.

Structure of the mission and deployment zone
Article 3
1. The mission shall have headquarters in Kinshasa consisting of:
(a)
a leadership;
(b)
an administrative support and logistics department;
(c)
a department of defence experts responsible for assisting and supporting the Congolese in carrying out specific actions in the areas of administration, human resources, logistics and training;
(d)
an advice and assistance department, including advisers deployed in the east of the DRC and responsible for contributing to work on SSR carried out by the Congolese administration; and
(e)
a planning cell.
2. The main deployment zone shall be Kinshasa. Seconded advisers might also be deployed in the military regions in the east of the DRC. Movements of experts and their temporary presence in the military regions might also prove necessary, on the instructions of the Head of Mission.

Planning
Article 4
The Head of Mission shall draw up an implementation plan (OPLAN) for the mission, to be submitted for approval by the Council. He shall be assisted in this task by the departments under the authority of the High Representative of the Union for Foreign Affairs and Security Policy (HR).

Head of Mission
Article 5
1. The Head of Mission shall assume day-to-day management of the mission and shall be responsible for staff and disciplinary matters.
2. All seconded staff shall remain under the full command of the national authorities of the sending State or the EU institution concerned. National authorities shall transfer operational control (OPCON) of their personnel to the Head of Mission.
3. The Head of Mission shall be responsible for disciplinary matters relating to staff. In the case of seconded staff, disciplinary action shall be exercised by the national authorities or EU institution concerned.
4. In the context of the mission statement as set out in Article 2, the Head of Mission shall be authorised to have recourse to financial contributions from the Member States to implement projects identified as supplementing in a consistent manner the mission’s other actions, in two specific cases: either the project is provided for in the financial statement relating to this Decision or it is incorporated in the course of the mission by amending the financial statement at the request of the Head of Mission.
The Head of Mission shall conclude an arrangement with the Member States concerned. This arrangement shall in particular cover the specific procedures for dealing with any complaint from third parties concerning damage caused as a result of acts or omissions by the Head of Mission in the use of the funds provided by the contributing Member States.
Under no circumstances may the EU or the HR be held liable by contributing Member States as a result of acts or omissions by the Head of Mission in the use of funds from those States.
5. The Head of Mission shall sign a contract with the Commission to execute the budget for the mission.
6. The Head of Mission shall collaborate closely, in his area of competence, with the Head of the EU Delegation, the heads of Member States’ missions in Kinshasa and the EU Special Representative (EUSR).

Staff
Article 6
1. Mission experts shall be seconded by Member States and by the EU institutions. Except for the Head of Mission, each Member State or institution shall bear the costs relating to the experts seconded, including travel expenses to and from the DRC, salaries, medical coverage and allowances other than daily allowances.
2. International civilian staff and local staff shall be recruited on a contractual basis by the mission as required.
3. All mission experts shall remain under the authority of the appropriate Member State or EU institution, and shall fulfil their duties and act in the interest of the mission. Both during and after the mission, mission experts shall exercise the greatest discretion with regard to all facts and information relating to the mission.

Chain of command
Article 7
1. The mission shall have a unified chain of command.
2. The Head of Mission shall lead the mission and assume its day-to-day management.
3. The Head of Mission shall report to the HR.

Political control and strategic direction
Article 8
1. Under the responsibility of the Council and the HR, the Political and Security Committee (PSC) shall exercise the political control and strategic direction of the mission. The Council hereby authorises the PSC to take the relevant decisions in accordance with Article 38(3) of the Treaty on European Union (TEU). This authorisation shall include the power to amend the implementation plan. It shall also include powers necessary to take decisions regarding the appointment of the Head of Mission. The power of decision with respect to the objectives and termination of the mission shall remain vested in the Council, assisted by the HR.
2. The PSC shall report to the Council at regular intervals.
3. The PSC shall receive reports by the Head of Mission at regular intervals, through the HR. The PSC may invite the Head of Mission to its meetings as appropriate.

Financial provisions
Article 9
1. The financial reference amount to cover expenditure relating to the mission shall be EUR 12 600 000 for the period from 1 October 2010 to 30 September 2011.
2. As regards expenditure financed out of the amount stipulated in paragraph 1, the following shall apply:
(a)
expenditure shall be managed in accordance with the EU rules and procedures applicable to the budget. Nationals of third States shall be allowed to tender for contracts;
(b)
the Head of Mission shall report fully to, and be supervised by, the Commission regarding the activities undertaken in the framework of his contract.
3. The financial arrangements shall respect the operational requirements of the mission, including compatibility of equipment.
4. The expenditure connected with the mission shall be eligible as from the entry into force of this Decision.

Participation by third States
Article 10
1. Without prejudice to the decision-making autonomy of the EU and the single institutional framework, the Council authorises the PSC to invite third States to propose to contribute to the mission, provided that they bear the cost of the staff seconded by them, including salaries, all risks insurance cover, daily allowances and travel expenses to and from the DRC, and that they contribute to the running costs of the mission, as appropriate.
2. Third States contributing to the mission shall have the same rights and obligations in terms of day-to-day management of the mission as Member States.
3. The Council hereby authorises the PSC to take the relevant decisions on acceptance of the contributions proposed and to establish a Committee of Contributors.
4. Detailed arrangements regarding the participation of third States shall be covered by agreements concluded pursuant to Article 37 of the TEU and in accordance with the procedure laid down in Article 218 of the Treaty on the Functioning of the European Union (TFEU) and additional technical arrangements if necessary. Where the EU and a third State have concluded an agreement establishing a framework for the third State’s participation in EU crisis-management operations, the provisions of that agreement shall apply in the context of the mission.

Implementation and consistency of the EU’s response
Article 11
1. The HR shall be responsible for the implementation of this Decision and shall also ensure that it is consistent with the EU’s external action as a whole, including the EU’s development programmes.
2. The Head of Mission shall assist the HR in implementing this Decision.

Coordination
Article 12
1. Arrangements for the coordination of the EU’s activities in the DRC shall be established in Kinshasa as well as in Brussels.
2. Without prejudice to the chain of command, the Head of the EUSEC RD Congo mission and the Head of the EUPOL RD Congo mission shall coordinate their activities closely and shall seek synergies between the two missions, particularly as regards the horizontal aspects of SSR in the DRC, and as regards the sharing of functions between the two missions, particularly in relation to crosscutting areas.
3. The Head of Mission shall ensure that EUSEC RD Congo closely coordinates its activities in support of the reform of the FARDC with the Government of the DRC, the United Nations, via the MONUSCO mission, and the third States involved in the defence area of the SSR process in the DRC.
4. The Head of the EU delegation in Kinshasa shall provide local political guidelines for the EUSEC RD Congo mission within the general framework defined by the planning documents, without prejudice to the EUSR’s brief.
5. The Head of the EU delegation and the Head of the EUSEC RD Congo mission shall establish the appropriate arrangements for information/consultation, particularly as regards the political aspects which may have an impact on the conduct of the mission. Likewise, the Head of the EUSEC RD Congo mission shall inform the Head of the EU delegation of all contacts at his level which may have a political impact.
6. The Head of the EUSEC RD Congo mission (or his representative) shall also act as defence adviser to the Head of the delegation, without prejudice to each player’s existing chains of command. In that context, there shall be constant contact between the mission and the EU delegation.
7. As part of his brief, the EUSR shall, where necessary, provide the EUSEC RD Congo mission with political advice on the regional dimension, particularly as regards the Nairobi, Goma and Juba processes.

Release of classified information
Article 13
1. The HR shall be authorised to release to third States associated with this Decision EU classified information and documents up to the level ‘CONFIDENTIEL UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations(5).
2. The HR shall be authorised to release to the United Nations, in accordance with the operational needs of the mission, EU classified information and documents up to the level ‘RESTREINT UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations. Local arrangements shall be established for this purpose.
3. In the event of a specific and immediate operational need, the HR shall also be authorised to release to the host State EU classified information and documents up to the level ‘RESTREINT UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations. In all other cases, such information and documents shall be released to the host State in accordance with procedures appropriate to the host State’s level of cooperation with the EU.
4. The HR shall be authorised to release to third States associated with this Decision EU non-classified documents relating to the deliberations of the Council with regard to the operation and covered by the obligation of professional secrecy pursuant to Article 6(1) of the Council’s Rules of Procedure(6).

Status of the mission and of its staff
Article 14
1. The status of mission staff, including where appropriate the privileges, immunities and any further guarantees necessary for the completion and smooth functioning of the mission, shall be agreed pursuant to Article 37 of the TEU and in accordance with the procedure laid down in Article 218(3) of the TFEU.
2. The State or EU institution having seconded a staff member shall be responsible for dealing with any complaints linked to the secondment, from or concerning the staff member. The State or EU institution in question shall be responsible for bringing any action against the person seconded.
3. The conditions of employment and the rights and obligations of international and local civilian personnel shall be set out in a contract concluded between the Head of Mission and the staff member.

Security
Article 15
1. The Head of Mission shall be responsible for the security of the EUSEC RD Congo mission.
2. The Head of Mission shall exercise this responsibility in accordance with EU directives on the security of staff deployed outside EU territory in an operational mission decided on pursuant to Title V, Chapter 2, of the TEU and related documents.
3. The Head of Mission shall be assisted by a Mission Security Officer (MSO) who shall report to him and shall also have a functional link with the Council Security Office.
4. Appropriate training in security measures shall be provided for all staff, in accordance with the OPLAN. A reminder of security instructions shall be given regularly by the MSO.

Review of the mission
Article 16
On the basis of an evaluation report drafted by the departments under the authority of the HR halfway through the mission and presented in June 2011 at the latest, the PSC shall approve recommendations to the Council with a view to reviewing the progress of the reform of the FARDC and evaluating the impact of the mission on the implementation of specific measures to support the plan for reform of the FARDC. The evaluation shall be based, inter alia, on progress indicators and on specific operational indicators detailed in the OPLAN.

Entry into force and duration
Article 17
This Decision shall enter into force on 1 October 2010.
It shall apply until 30 September 2012.

THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on European Union, and in particular Article 28 and Article 43 thereof,
(1) On the basis of Joint Action 2005/355/CFSP(1), the European Union (EU) has been conducting, since 2 May 2005, a mission to provide advice and assistance for security sector reform in the Democratic Republic of the Congo (DRC) (EUSEC RD Congo). The current mandate of the mission is set out in Joint Action 2009/709/CFSP(2)and expires on 30 September 2010.
(2) The Secretary-General/High Representative for Common Foreign and Security Policy sent a letter to the President of the DRC dated 27 July 2009 stating the EU’s renewed commitment. Following that letter, the mission statement was adapted as from 1 October 2009. The Congolese authorities transposed that letter into an action programme which was signed, on 21 January 2010, by the Minister for Defence and War Veterans and the Head of the EUSEC RD Congo mission.
(3) Following the ratification in 2005 of the Constitution of the Third Republic of the Congo, the elections held in the DRC in 2006 marked the end of the transition process and enabled a government to be formed in 2007, which has adopted a programme providing in particular for comprehensive reform of the security sector, the drawing up of a national plan, and priority reforms in the police, armed forces and judicial sectors. The Congolese authorities have demonstrated their interest in implementing the security sector reform (SSR) process in the DRC at operational level by developing a plan to reform the Armed Forces of the Democratic Republic of the Congo (FARDC) in three stages between 2009 and 2025, a plan which was approved by the President of the Republic at the end of May 2009 and presented to the representatives of the international community on 26 January 2010, and by taking over the role of coordinator of the work of the various actors supporting SSR in the DRC.
(4) The United Nations has reaffirmed its support for the transition process and SSR by means of several Security Council resolutions, and is conducting the United Nations Organisation Stabilisation Mission in the Democratic Republic of the Congo (MONUSCO), which is focusing on peacekeeping in the east of the country and on peace consolidation throughout the country. On 28 May 2010, the United Nations Security Council adopted Resolution 1925 (2010) extending MONUC’s mandate until 30 June 2010 and renaming it the United Nations Organisation Stabilisation Mission in the DRC (MONUSCO) as from 1 July 2010 and allowing it to support, in close cooperation with other international partners, the efforts of the Congolese authorities to strengthen and reform security and judicial institutions.
(5) The EU has consistently supported SSR in the DRC, as one of the elements of a more general EU commitment to supporting development and democracy in the African Great Lakes Region, while taking care to promote policies compatible with human rights and international humanitarian law, democratic standards and the principles of good governance, transparency and respect for the rule of law.
(6) On 14 June 2010, the Council adopted Decision 2010/329/CFSP amending and extending for an additional period of three months Joint Action 2007/405/CFSP on the European Union police mission undertaken in the framework of SSR and its interface with the system of justice in the Democratic Republic of the Congo (EUPOL RD Congo)(3).
(7) In order to increase the coordination, consistency and complementarity of the EU’s activities in the DRC, making maximum use of the new European institutional framework, there should be enhanced coordination of EU action between the two missions, between the European players in the DRC and between Brussels and Kinshasa.
(8) On 11 August 2010, the Council adopted Decision 2010/440/CFSP(4)extending the mandate of Mr Roeland VAN DE GEER as the EU Special Representative (EUSR) for the African Great Lakes Region.
(9) On 29 July 2010, the Council approved the crisis management concept for the commitment of common security and defence policy missions in support of security sector reform in the DRC.
(10) Third States should participate in the project in accordance with the general guidelines defined by the European Council.
(11) The current security situation in the DRC may deteriorate, with potentially serious repercussions for the process of strengthening democracy, the rule of law and international and regional security. A continued commitment of EU political effort and resources will help to embed stability in the region,
HAS ADOPTED THIS DECISION:

Mission

1. The European Union (EU) is conducting a mission to provide advice and assistance for security sector reform (SSR) in the Democratic Republic of the Congo (DRC), hereinafter referred to as ‘EUSEC RD Congo’ or ‘the mission’, with the aim of assisting the Congolese authorities in setting up a defence apparatus capable of guaranteeing the security of the Congolese people, while respecting democratic standards, human rights and the rule of law, as well as the principles of good governance and transparency.
2. The mission shall operate in accordance with the mission statement set out in Article 2.

Mission statement

1. The mission shall aim, in close cooperation and coordination with the other actors in the international community, in particular the United Nations and MONUSCO, and in pursuit of the objectives laid down in Article 1, to provide practical support in the field of SSR, creating conditions to facilitate the implementation in the short and medium term of activities and projects based on the guidelines adopted by the Congolese authorities in the plan for reform of the FARDC as set out in the mission action programme, including:
(a)
maintaining support at strategic level;
(b)
supporting the consolidation of the administration and the introduction of a human resources management system based on the work in progress;
(c)
supporting the modernisation of logistics;
(d)
supporting a relaunch of the training system, particularly for executive staff, mainly through support for the School of Administration and Military Academy project in Kananga and for studies for the School of Logistics in Kinshasa;
(e)
pursuing activities relating to the campaign against impunity in the areas of respect for human rights, including sexual violence.
2. The mission shall advise the Member States and shall coordinate and facilitate, under their responsibility, the implementation of their projects in fields which are of interest to the mission and in furtherance of its objectives.

Structure of the mission and deployment zone

1. The mission shall have headquarters in Kinshasa consisting of:
(a)
a leadership;
(b)
an administrative support and logistics department;
(c)
a department of defence experts responsible for assisting and supporting the Congolese in carrying out specific actions in the areas of administration, human resources, logistics and training;
(d)
an advice and assistance department, including advisers deployed in the east of the DRC and responsible for contributing to work on SSR carried out by the Congolese administration; and
(e)
a planning cell.
2. The main deployment zone shall be Kinshasa. Seconded advisers might also be deployed in the military regions in the east of the DRC. Movements of experts and their temporary presence in the military regions might also prove necessary, on the instructions of the Head of Mission.

Planning

The Head of Mission shall draw up an implementation plan (OPLAN) for the mission, to be submitted for approval by the Council. He shall be assisted in this task by the departments under the authority of the High Representative of the Union for Foreign Affairs and Security Policy (HR).

Head of Mission

1. The Head of Mission shall assume day-to-day management of the mission and shall be responsible for staff and disciplinary matters.
2. All seconded staff shall remain under the full command of the national authorities of the sending State or the EU institution concerned. National authorities shall transfer operational control (OPCON) of their personnel to the Head of Mission.
3. The Head of Mission shall be responsible for disciplinary matters relating to staff. In the case of seconded staff, disciplinary action shall be exercised by the national authorities or EU institution concerned.
4. In the context of the mission statement as set out in Article 2, the Head of Mission shall be authorised to have recourse to financial contributions from the Member States to implement projects identified as supplementing in a consistent manner the mission’s other actions, in two specific cases: either the project is provided for in the financial statement relating to this Decision or it is incorporated in the course of the mission by amending the financial statement at the request of the Head of Mission.
The Head of Mission shall conclude an arrangement with the Member States concerned. This arrangement shall in particular cover the specific procedures for dealing with any complaint from third parties concerning damage caused as a result of acts or omissions by the Head of Mission in the use of the funds provided by the contributing Member States.
Under no circumstances may the EU or the HR be held liable by contributing Member States as a result of acts or omissions by the Head of Mission in the use of funds from those States.
5. The Head of Mission shall sign a contract with the Commission to execute the budget for the mission.
6. The Head of Mission shall collaborate closely, in his area of competence, with the Head of the EU Delegation, the heads of Member States’ missions in Kinshasa and the EU Special Representative (EUSR).

Staff

1. Mission experts shall be seconded by Member States and by the EU institutions. Except for the Head of Mission, each Member State or institution shall bear the costs relating to the experts seconded, including travel expenses to and from the DRC, salaries, medical coverage and allowances other than daily allowances.
2. International civilian staff and local staff shall be recruited on a contractual basis by the mission as required.
3. All mission experts shall remain under the authority of the appropriate Member State or EU institution, and shall fulfil their duties and act in the interest of the mission. Both during and after the mission, mission experts shall exercise the greatest discretion with regard to all facts and information relating to the mission.

Chain of command

1. The mission shall have a unified chain of command.
2. The Head of Mission shall lead the mission and assume its day-to-day management.
3. The Head of Mission shall report to the HR.

Political control and strategic direction

1. Under the responsibility of the Council and the HR, the Political and Security Committee (PSC) shall exercise the political control and strategic direction of the mission. The Council hereby authorises the PSC to take the relevant decisions in accordance with Article 38(3) of the Treaty on European Union (TEU). This authorisation shall include the power to amend the implementation plan. It shall also include powers necessary to take decisions regarding the appointment of the Head of Mission. The power of decision with respect to the objectives and termination of the mission shall remain vested in the Council, assisted by the HR.
2. The PSC shall report to the Council at regular intervals.
3. The PSC shall receive reports by the Head of Mission at regular intervals, through the HR. The PSC may invite the Head of Mission to its meetings as appropriate.

Financial provisions

1. The financial reference amount to cover expenditure relating to the mission shall be EUR 12 600 000 for the period from 1 October 2010 to 30 September 2011.
2. As regards expenditure financed out of the amount stipulated in paragraph 1, the following shall apply:
(a)
expenditure shall be managed in accordance with the EU rules and procedures applicable to the budget. Nationals of third States shall be allowed to tender for contracts;
(b)
the Head of Mission shall report fully to, and be supervised by, the Commission regarding the activities undertaken in the framework of his contract.
3. The financial arrangements shall respect the operational requirements of the mission, including compatibility of equipment.
4. The expenditure connected with the mission shall be eligible as from the entry into force of this Decision.

Participation by third States

1. Without prejudice to the decision-making autonomy of the EU and the single institutional framework, the Council authorises the PSC to invite third States to propose to contribute to the mission, provided that they bear the cost of the staff seconded by them, including salaries, all risks insurance cover, daily allowances and travel expenses to and from the DRC, and that they contribute to the running costs of the mission, as appropriate.
2. Third States contributing to the mission shall have the same rights and obligations in terms of day-to-day management of the mission as Member States.
3. The Council hereby authorises the PSC to take the relevant decisions on acceptance of the contributions proposed and to establish a Committee of Contributors.
4. Detailed arrangements regarding the participation of third States shall be covered by agreements concluded pursuant to Article 37 of the TEU and in accordance with the procedure laid down in Article 218 of the Treaty on the Functioning of the European Union (TFEU) and additional technical arrangements if necessary. Where the EU and a third State have concluded an agreement establishing a framework for the third State’s participation in EU crisis-management operations, the provisions of that agreement shall apply in the context of the mission.

Implementation and consistency of the EU's response

1. The HR shall be responsible for the implementation of this Decision and shall also ensure that it is consistent with the EU’s external action as a whole, including the EU’s development programmes.
2. The Head of Mission shall assist the HR in implementing this Decision.

Coordination

1. Arrangements for the coordination of the EU’s activities in the DRC shall be established in Kinshasa as well as in Brussels.
2. Without prejudice to the chain of command, the Head of the EUSEC RD Congo mission and the Head of the EUPOL RD Congo mission shall coordinate their activities closely and shall seek synergies between the two missions, particularly as regards the horizontal aspects of SSR in the DRC, and as regards the sharing of functions between the two missions, particularly in relation to crosscutting areas.
3. The Head of Mission shall ensure that EUSEC RD Congo closely coordinates its activities in support of the reform of the FARDC with the Government of the DRC, the United Nations, via the MONUSCO mission, and the third States involved in the defence area of the SSR process in the DRC.
4. The Head of the EU delegation in Kinshasa shall provide local political guidelines for the EUSEC RD Congo mission within the general framework defined by the planning documents, without prejudice to the EUSR’s brief.
5. The Head of the EU delegation and the Head of the EUSEC RD Congo mission shall establish the appropriate arrangements for information/consultation, particularly as regards the political aspects which may have an impact on the conduct of the mission. Likewise, the Head of the EUSEC RD Congo mission shall inform the Head of the EU delegation of all contacts at his level which may have a political impact.
6. The Head of the EUSEC RD Congo mission (or his representative) shall also act as defence adviser to the Head of the delegation, without prejudice to each player’s existing chains of command. In that context, there shall be constant contact between the mission and the EU delegation.
7. As part of his brief, the EUSR shall, where necessary, provide the EUSEC RD Congo mission with political advice on the regional dimension, particularly as regards the Nairobi, Goma and Juba processes.

Release of classified information

1. The HR shall be authorised to release to third States associated with this Decision EU classified information and documents up to the level ‘CONFIDENTIEL UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations(5).
2. The HR shall be authorised to release to the United Nations, in accordance with the operational needs of the mission, EU classified information and documents up to the level ‘RESTREINT UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations. Local arrangements shall be established for this purpose.
3. In the event of a specific and immediate operational need, the HR shall also be authorised to release to the host State EU classified information and documents up to the level ‘RESTREINT UE’ generated for the purposes of the operation, in accordance with the Council’s security regulations. In all other cases, such information and documents shall be released to the host State in accordance with procedures appropriate to the host State’s level of cooperation with the EU.
4. The HR shall be authorised to release to third States associated with this Decision EU non-classified documents relating to the deliberations of the Council with regard to the operation and covered by the obligation of professional secrecy pursuant to Article 6(1) of the Council’s Rules of Procedure(6).

Status of the mission and of its staff

1. The status of mission staff, including where appropriate the privileges, immunities and any further guarantees necessary for the completion and smooth functioning of the mission, shall be agreed pursuant to Article 37 of the TEU and in accordance with the procedure laid down in Article 218(3) of the TFEU.
2. The State or EU institution having seconded a staff member shall be responsible for dealing with any complaints linked to the secondment, from or concerning the staff member. The State or EU institution in question shall be responsible for bringing any action against the person seconded.
3. The conditions of employment and the rights and obligations of international and local civilian personnel shall be set out in a contract concluded between the Head of Mission and the staff member.

Security

1. The Head of Mission shall be responsible for the security of the EUSEC RD Congo mission.
2. The Head of Mission shall exercise this responsibility in accordance with EU directives on the security of staff deployed outside EU territory in an operational mission decided on pursuant to Title V, Chapter 2, of the TEU and related documents.
3. The Head of Mission shall be assisted by a Mission Security Officer (MSO) who shall report to him and shall also have a functional link with the Council Security Office.
4. Appropriate training in security measures shall be provided for all staff, in accordance with the OPLAN. A reminder of security instructions shall be given regularly by the MSO.

Review of the mission

On the basis of an evaluation report drafted by the departments under the authority of the HR halfway through the mission and presented in June 2011 at the latest, the PSC shall approve recommendations to the Council with a view to reviewing the progress of the reform of the FARDC and evaluating the impact of the mission on the implementation of specific measures to support the plan for reform of the FARDC. The evaluation shall be based, inter alia, on progress indicators and on specific operational indicators detailed in the OPLAN.

Entry into force and duration

This Decision shall enter into force on 1 October 2010.
It shall apply until 30 September 2012.

Pending: 32010D0320

11.6.2010 EN Official Journal of the European Union L 145/6
(1) Article 136(1)(a) TFEU foresees the possibility of adopting measures specific to the Member States whose currency is the euro with a view to strengthening the coordination and surveillance of their budgetary discipline.
(2) Article 126 TFEU establishes that Member States are to avoid excessive government deficits and sets out the excessive deficit procedure to that effect. The Stability and Growth Pact, which in its corrective arm implements the excessive deficit procedure, provides the framework supporting government policies for a prompt return to sound budgetary positions taking account of the economic situation.
(3) On 27 April 2009, the Council decided, in accordance with Article 104(6) of the Treaty establishing the European Community (TEC), that an excessive deficit existed in Greece and issued recommendations to correct that deficit by 2010 at the latest, in accordance with Article 104(7) (TEC) and Article 3(4) of Council Regulation (EC) No 1467/97 of 7 July 1997 on speeding up and clarifying the implementation of the excessive deficit procedure(1). The Council also set a deadline of 27 October 2009 for Greece to take effective action. On 30 November 2009, the Council established, in accordance with Article 126(8) TFEU, that Greece had not taken effective action; consequently, on 16 February 2010, the Council gave notice to Greece in accordance with Article 126(9) TFEU to take measures to correct the excessive deficit by 2012 at the latest (hereinafter ‘the Council Decision pursuant to Article 126(9)’). The Council also set a deadline of 15 May 2010 for effective action to be taken.
(4) According to Article 5(2) of Regulation (EC) No 1467/97, if effective action has been taken in compliance with Article 126(9) TFEU and unexpected adverse economic events with major unfavourable consequences for government finances occur after the adoption of that notice, the Council may decide, on a recommendation from the Commission, to adopt a revised notice pursuant to Article 126(9) TFEU.
(5) According to the Commission services’ autumn 2009 forecasts, which provided the basis for the initial notice addressed to Greece, GDP was expected to contract by ¼ % in 2010, and recover as from 2011, when the economy was forecast to grow by 0,7 %. A sharp fall in real GDP is now expected for 2010, followed by a further contraction in 2011. A gradual resumption of growth is expected thereafter. This marked worsening of the economic scenario implies a corresponding deterioration of the outlook for public finances at unchanged policy. To this should be added the upward revision of the government deficit outcome for 2009 (from an estimated 12,7 % of GDP at the time of the Council Decision pursuant to Article 126(9) to 13,6 % of GDP according to the fiscal notification submitted by Greece on 1 April 2010), with the risk of a further upward revision (of the order of 0,3 to 0,5 % of GDP) following completion of the investigations that Eurostat is undertaking with the Greek Statistical Authorities(2). Lastly, concerns in the markets for the public finances outlook have been reflected in a sharp rise in risk premia on government debt, compounding the difficulties in controlling the path of government deficit and debt. According to the preliminary assessment carried out by the Commission in March 2010, Greece was implementing, as requested, the fiscal measures meant to ensure the achievement of the planned deficit target for 2010. However, the abrupt change in the economic scenario means that those plans can no longer be considered valid, requiring even more drastic action in the course of the current year. At the same time, the depth of the contraction in the economy that can now be expected makes the achievement of the initial deficit reduction path unfeasible. Unexpected adverse economic events with major unfavourable consequences for government finances can be considered to have occurred in Greece and revised recommendations pursuant to Article 136 and Article 126(9) TFEU are therefore justified.
(6) In the light of the above considerations, it appears that the deadline which was set in the Council Decision pursuant to Article 126(9) for the correction of the excessive deficit in Greece needs to be extended by two years to 2014.
(7) Gross public debt at the end of 2009 stood at 115,1 % of GDP. This is among the highest debt ratios in the EU, and is considerably higher than the 60 %-of-GDP reference value of the Treaty. Moreover, the figure risks being further revised upwards (by 5 to 7 percentage points) as a result of the ongoing statistical investigations. Achieving the deficit reduction path that is considered necessary and feasible in the light of the circumstances would imply that the increase in debt would be reversed from 2014. In addition to persistently high government deficits, the contribution of ‘below-the-line’ operations to the increase in debt has been large. This has contributed to undermining market confidence in the ability of the Greek Government to service the debt going forward. There is an extremely urgent need for Greece to take decisive action, on an unprecedented scale, on its deficit and on other factors contributing to the increase in debt, in order to reverse the increase in the debt-to-GDP ratio and allow it to return as soon as possible to market financing.
(8) The very severe deterioration of the financial situation of the Greek Government has led euro area Member States to decide to provide stability support to Greece, with a view to safeguarding the financial stability of the euro area as a whole, in conjunction with multilateral assistance provided by the International Monetary Fund. Support provided by the euro area Member States will take the form of a pooling of bilateral loans, coordinated by the Commission. The lenders have decided that their support shall be conditional on Greece respecting this Decision. In particular, Greece is expected to carry out the measures specified in this Decision in accordance with the calendar set out herein,
(a) a law introducing a progressive tax scale for all sources of income and a horizontally unified treatment of income generated by labour and capital assets;
(b) a law repealing all exemptions and autonomous taxation provisions in the tax system, including income from special allowances paid to civil servants;
(c) the cancellation of the budgetary appropriations in the contingency reserve, with the aim of saving EUR 700 million;
(d) the abolition of most of the budgetary appropriation for the solidarity allowance (except a part for poverty relief) with the aim of saving EUR 400 million;
(e) a reduction of the highest pensions with the aim of saving EUR 500 million for a full year (EUR 350 million for 2010);
(f) a reduction of the Easter, summer and Christmas bonuses and allowances paid to civil servants with the aim of saving EUR 1 500 million for a full year (EUR 1 100 million in 2010);
(g) the abolition of the Easter, summer and Christmas bonuses paid to pensioners, though protecting those receiving low pensions, with the aim of saving EUR 1 900 million for a full year (EUR 1 500 million in 2010);
(h) an increase in the VAT rate, with a yield of at least EUR 1 800 million for a full year (EUR 800 million in 2010);
(i) an increase in excises for fuel, tobacco and alcohol, with a yield of at least EUR 1 050 million for a full year (EUR 450 million in 2010);
(j) legislation implementing the Services Directive(3);
(k) a law reforming and simplifying public administration at local level with the aim of reducing operating costs;
(l) the establishment of a task force aiming at improving the absorption rate of structural and cohesion funds;
(m) a law to simplify the start-up of new businesses;
(n) a reduction of public investment by EUR 500 million compared to plans;
(o) the channelling of the budgetary appropriations for the co-financing of structural and cohesion funds to a special central account that cannot be used for any other purpose;
(p) the establishment of an independent financial stability fund to deal with potential capital shortfalls and preserve the soundness of the financial sector, by providing equity support to banks as needed;
(q) the reinforced supervision of banks, with increased human resources, more frequent reporting and quarterly stress tests.
(a) an inclusion in the draft budget for 2011 of fiscal consolidation measures amounting to at least 3 % of GDP (4,1 % of GDP if carryovers from measures implemented in 2010 are considered). The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): a reduction in intermediate consumption of the general government by at least EUR 300 million compared to the 2010 level (in addition to savings stemming from the reform, referred to in this paragraph, of public administration and of local government); a freeze in the indexation of pensions (with the aim of saving EUR 100 million); a temporary crisis levy on highly profitable firms (yielding at least EUR 600 million in additional revenue per year in 2011, 2012 and 2013); the presumptive taxation of professionals (with a yield of at least EUR 400 million in 2011 and increasing returns in 2012 and 2013); a broadening of the VAT base to include certain services currently exempted and moving 30 % of goods and services from the reduced rate to the main rate (with a yield of EUR 1 billion); a phased-in green tax on CO2emissions (with a yield of at least EUR 300 million in 2011); the implementation by the Greek Government of legislation reforming public administration and reorganising local government (with the aim of reducing costs by at least EUR 500 million in 2011, and 500 additional EUR million each year in 2012 and 2013); a reduction in domestically-financed investments (by at least EUR 1 billion) by giving priority to investment projects financed by EU structural funds; incentives to regularise land-use violations (yielding at least EUR 1 500 million from 2011 to 2013, of which at least EUR 500 million in 2011); a collection of revenue from the licensing of gaming (at least EUR 500 million in sales of licences and EUR 200 million in royalties); a broadening of the real estate tax base by updating asset values (to yield at least EUR 500 million additional revenue); an increased taxation of wages in kind, including by taxing car lease payments (by at least EUR 150 million); an increased taxation of luxury goods (by at least EUR 100 million); a special tax on unauthorised establishments (to yield at least EUR 800 million per year); and a replacement of only 20 % of retiring employees in the public sector (central government, municipalities, public companies, local governments, state agencies and other public institutions);
(b) a law reforming the pension system with a view to ensuring its medium and long-term sustainability. The law should, in particular, introduce: a unified statutory retirement age of 65 years (including for women); a merger of the existing pension funds in three funds and a unified new pension system for all current and future employees (applicable as of 1 January 2013); a reduction of the upper limit on pensions; a gradual increase in the minimum contributory period for retirement on a full benefit from 37 to 40 years (by 2015); a minimum retirement age of 60 years by 1 January 2011 (including for workers in heavy and arduous professions and those with 40 years of contributions); the abolition of the special rules applicable to persons insured before 1993 (while retaining acquired rights); a substantial narrowing of the list of heavy and arduous professions; a reduction of pension benefits (by 6 % per year) for people entering retirement between the ages of 60 and 65 with a contributory period of less than 40 years; the creation of an automatic adjustment mechanism linking the retirement age with the increase in life expectancy (as of 2020); the creation of a means-tested minimum guaranteed income for elderly people above the statutory retirement age; stricter conditions and the regular re-examination of eligibility for disability pensions; an amendment of the pension award formula in the contributory based scheme to strengthen the link between contributions paid and benefits received (with accrual rate limited to an average annual rate of 1,2 %); and an extension of the calculation of the pensionable earnings to entire lifetime earnings (while retaining acquired rights). The implementation of this law should reduce the projected increase in the pension expenditure to GDP ratio to below the euro area average over the next decades and should limit the increase of public sector spending on pensions over the period 2010-2060 to less than 2,5 % of GDP;
(c) a reinforcement of the role and resources of the general accounting office and the establishment of safeguards against possible political interference in data projection and accounting;
(d) a draft reform of wage legislation in the public sector, including, in particular, the creation of a Single Payment Authority for the payment of wages, the introduction of unified principles and a timetable to establish a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies;
(e) legislation to improve the efficiency of the tax administration and controls;
(f) the launch of an independent review of public administration and of existing social programmes;
(g) the publication of monthly statistics (on a cash basis) on revenue, expenditure, financing and spending arrears for the ‘available general government’ and its sub entities;
(h) an action plan to improve the collection and processing of general government data, in particular by enhancing the control mechanisms of statistical authorities and of the general accounting office and ensuring effective personal responsibility for cases of misreporting, in order to ensure the prompt supply of high quality general government data required by Regulations (EC) No 2223/96(4), (EC) No 264/2000(5), (EC) No 1221/2002(6), (EC) No 501/2004(7), (EC) No 1222/2004(8), (EC) No 1161/2005(9), (EC) No 223/2009(10)and (EC) No 479/2009(11);
(i) the regular publication of information on the financial position of public undertakings and other public entities not classified as part of the general government (including detailed income statements, balance sheets and data on employment and the wage bill).
(a) the final adoption of the measures referred to in paragraphs 2(a) and (d);
(b) draft legislation strengthening the fiscal framework. This should, in particular, include the establishment of a medium-term fiscal framework, the creation of a compulsory contingency reserve in the budget corresponding to 10 % of total appropriations, the creation of stronger expenditure monitoring mechanisms and the establishment of an independent fiscal agency providing advice and expert scrutiny on fiscal issues;
(c) a law to reform the wage bargaining system in the private sector, which should provide for a reduction in pay rates for overtime work, enhanced flexibility in the management of working time and allow local territorial pacts to set wage growth below sectoral agreements;
(d) a law on minimum wages to introduce sub-minima for groups at risk such as the young and long-term unemployed, and put measures in place to guarantee that current minimum wages remain fixed in nominal terms for three years;
(e) a reform of employment protection legislation to extend the probationary period for new jobs to one year, reduce the overall level of severance payments and ensure that the same severance payment conditions apply to blue and white collar workers, raise the minimum threshold for the rules on collective dismissals to apply, especially for larger companies, and facilitate a greater use of temporary contracts;
(f) a significant increase in the absorption rate of structural and cohesion funds;
(g) the introduction of a new system for the management of drugs favouring the use of generic medicines;
(h) the establishment of a unified public procurement system with a central procurement authority, ensuring, in particular, robust tendering procedures, and ex ante and ex post controls;
(i) legislation simplifying and accelerating the process of licensing undertakings, industrial activities and professions;
(j) a modification of the institutional framework of the Hellenic competition authority (HCC) with a view to increasing its independence, establishing reasonable deadlines for the investigation and issue of decisions and entrusting it with the power to reject complaints;
(k) a better management of public assets, with the aim of raising at least EUR 1 billion per year during the period 2011-2013;
(l) measures aiming at removing existing restrictions on the freedom to provide services.
(a) the final adoption of the measures referred to in paragraph 3(b).
(a) a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies, with remunerations reflecting productivity and tasks;
(b) measures implementing the findings of the external and independent functional review of public administrations;
(c) a reinforcement of the labour inspectorate, which shall be fully resourced with qualified staff and have quantitative targets on the number of controls to be carried out.
(a) the inclusion in the draft budget for 2012 of fiscal consolidation measures amounting to at least 2,2 % of GDP. The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): further broaden the VAT base by moving goods and services from a reduced to a normal rate (with the aim of collecting at least an additional EUR 300 million); reduce public employment in addition to the rule of one recruitment for every five retirements in the public sector (with the aim of saving at least EUR 600 million); establish excise duties for non-alcoholic beverages (for a total amount of at least EUR 300 million); expand the real estate tax by updating asset values (in order to create at least EUR 200 million in extra revenue); reorganise sub-central governments (aiming at generating at least EUR 500 million in savings); reduce the intermediate consumption of the general government (by at least EUR 300 million compared to the level in 2011); introduce a nominal freeze on pensions; increase efficiency of the presumptive taxation of professionals (with the aim of collecting at least EUR 100 million); reduce transfers to public undertakings (by at least EUR 800 million) following their restructuring; make unemployment benefits means-tested (with the aim of saving EUR 500 million); and collect further revenues from the licensing of gaming (at least EUR 225 million in the sale of licences and EUR 400 million in royalties);
(b) a mitigation of tax obstacles to mergers and acquisitions;
(c) a simplification of the custom clearing process for exports and imports;
(d) a further increase in the absorption rates of structural and cohesion funds;
(e) the full implementation of the Better Regulation agenda with a view to reducing administrative burdens by 20 % (compared with 2008).
(a) the final adoption of the measures referred to in paragraph 6(a);
(b) a reinforcement of the managerial capacity of all managing authorities and intermediate bodies of operational programmes under the framework of the national strategy reference framework 2007-2013 and their ISO 9001:2008 (quality management) certification.
(a) concrete measures implemented by the date of the report in order to comply with this Decision, including their quantified budgetary impact;
(b) concrete measures planned to be implemented after the date of the report in order to comply with this Decision, their implementation calendar and an estimation of their budgetary impact;
(c) the monthly State budget execution;
(d) infra-annual budgetary implementation by social security, local government and extra budgetary funds;
(e) government debt issue and reimbursement;
(f) permanent and temporary public sector employment developments;
(g) government expenditure pending payment (cumulated arrears);
(h) the financial position of public undertakings and other public entities.
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union (TFEU), and in particular Article 126(9) and Article 136 thereof,
Having regard to the recommendation from the Commission,
(1) Article 136(1)(a) TFEU foresees the possibility of adopting measures specific to the Member States whose currency is the euro with a view to strengthening the coordination and surveillance of their budgetary discipline.
(2) Article 126 TFEU establishes that Member States are to avoid excessive government deficits and sets out the excessive deficit procedure to that effect. The Stability and Growth Pact, which in its corrective arm implements the excessive deficit procedure, provides the framework supporting government policies for a prompt return to sound budgetary positions taking account of the economic situation.
(3) On 27 April 2009, the Council decided, in accordance with Article 104(6) of the Treaty establishing the European Community (TEC), that an excessive deficit existed in Greece and issued recommendations to correct that deficit by 2010 at the latest, in accordance with Article 104(7) (TEC) and Article 3(4) of Council Regulation (EC) No 1467/97 of 7 July 1997 on speeding up and clarifying the implementation of the excessive deficit procedure(1). The Council also set a deadline of 27 October 2009 for Greece to take effective action. On 30 November 2009, the Council established, in accordance with Article 126(8) TFEU, that Greece had not taken effective action; consequently, on 16 February 2010, the Council gave notice to Greece in accordance with Article 126(9) TFEU to take measures to correct the excessive deficit by 2012 at the latest (hereinafter ‘the Council Decision pursuant to Article 126(9)’). The Council also set a deadline of 15 May 2010 for effective action to be taken.
(4) According to Article 5(2) of Regulation (EC) No 1467/97, if effective action has been taken in compliance with Article 126(9) TFEU and unexpected adverse economic events with major unfavourable consequences for government finances occur after the adoption of that notice, the Council may decide, on a recommendation from the Commission, to adopt a revised notice pursuant to Article 126(9) TFEU.
(5) According to the Commission services’ autumn 2009 forecasts, which provided the basis for the initial notice addressed to Greece, GDP was expected to contract by ¼ % in 2010, and recover as from 2011, when the economy was forecast to grow by 0,7 %. A sharp fall in real GDP is now expected for 2010, followed by a further contraction in 2011. A gradual resumption of growth is expected thereafter. This marked worsening of the economic scenario implies a corresponding deterioration of the outlook for public finances at unchanged policy. To this should be added the upward revision of the government deficit outcome for 2009 (from an estimated 12,7 % of GDP at the time of the Council Decision pursuant to Article 126(9) to 13,6 % of GDP according to the fiscal notification submitted by Greece on 1 April 2010), with the risk of a further upward revision (of the order of 0,3 to 0,5 % of GDP) following completion of the investigations that Eurostat is undertaking with the Greek Statistical Authorities(2). Lastly, concerns in the markets for the public finances outlook have been reflected in a sharp rise in risk premia on government debt, compounding the difficulties in controlling the path of government deficit and debt. According to the preliminary assessment carried out by the Commission in March 2010, Greece was implementing, as requested, the fiscal measures meant to ensure the achievement of the planned deficit target for 2010. However, the abrupt change in the economic scenario means that those plans can no longer be considered valid, requiring even more drastic action in the course of the current year. At the same time, the depth of the contraction in the economy that can now be expected makes the achievement of the initial deficit reduction path unfeasible. Unexpected adverse economic events with major unfavourable consequences for government finances can be considered to have occurred in Greece and revised recommendations pursuant to Article 136 and Article 126(9) TFEU are therefore justified.
(6) In the light of the above considerations, it appears that the deadline which was set in the Council Decision pursuant to Article 126(9) for the correction of the excessive deficit in Greece needs to be extended by two years to 2014.
(7) Gross public debt at the end of 2009 stood at 115,1 % of GDP. This is among the highest debt ratios in the EU, and is considerably higher than the 60 %-of-GDP reference value of the Treaty. Moreover, the figure risks being further revised upwards (by 5 to 7 percentage points) as a result of the ongoing statistical investigations. Achieving the deficit reduction path that is considered necessary and feasible in the light of the circumstances would imply that the increase in debt would be reversed from 2014. In addition to persistently high government deficits, the contribution of ‘below-the-line’ operations to the increase in debt has been large. This has contributed to undermining market confidence in the ability of the Greek Government to service the debt going forward. There is an extremely urgent need for Greece to take decisive action, on an unprecedented scale, on its deficit and on other factors contributing to the increase in debt, in order to reverse the increase in the debt-to-GDP ratio and allow it to return as soon as possible to market financing.
(8) The very severe deterioration of the financial situation of the Greek Government has led euro area Member States to decide to provide stability support to Greece, with a view to safeguarding the financial stability of the euro area as a whole, in conjunction with multilateral assistance provided by the International Monetary Fund. Support provided by the euro area Member States will take the form of a pooling of bilateral loans, coordinated by the Commission. The lenders have decided that their support shall be conditional on Greece respecting this Decision. In particular, Greece is expected to carry out the measures specified in this Decision in accordance with the calendar set out herein,
HAS ADOPTED THIS DECISION:

Article 1
1. Greece shall put an end to the present excessive deficit situation as rapidly as possible and, at the latest, by the deadline of 2014.
2. The adjustment path towards the correction of the excessive deficit shall aim to achieve a general government deficit not exceeding EUR 18 508 million (8,0 % of GDP) in 2010, EUR 17 065 million (7,6 % of GDP) in 2011, EUR 14 916 million (6,5 % of GDP) in 2012, EUR 11 399 million (4,9 % of GDP) in 2013 and EUR 6 385 million (2,6 % of GDP) in 2014. To this aim, an improvement in the structural balance of at least 10 % of GDP will have to be achieved over the period 2009-2014.
3. The adjustment path referred to in paragraph 2 requires that the annual change in the general government consolidated gross debt does not exceed EUR 34 058 million in 2010, EUR 17 365 million in 2011, EUR 15 016 million in 2012, EUR 11 599 million in 2013 and EUR 7 885 million in 2014. Based on current GDP projections, the corresponding path for the debt-to-GDP ratio would be 133,2 % in 2010, 145,2 % in 2011, 148,8 % in 2012, 149,6 % in 2013 and 148,4 % in 2014.

Article 2
1. Greece shall adopt the following measures before the end of June 2010:
(a)
a law introducing a progressive tax scale for all sources of income and a horizontally unified treatment of income generated by labour and capital assets;
(b)
a law repealing all exemptions and autonomous taxation provisions in the tax system, including income from special allowances paid to civil servants;
(c)
the cancellation of the budgetary appropriations in the contingency reserve, with the aim of saving EUR 700 million;
(d)
the abolition of most of the budgetary appropriation for the solidarity allowance (except a part for poverty relief) with the aim of saving EUR 400 million;
(e)
a reduction of the highest pensions with the aim of saving EUR 500 million for a full year (EUR 350 million for 2010);
(f)
a reduction of the Easter, summer and Christmas bonuses and allowances paid to civil servants with the aim of saving EUR 1 500 million for a full year (EUR 1 100 million in 2010);
(g)
the abolition of the Easter, summer and Christmas bonuses paid to pensioners, though protecting those receiving low pensions, with the aim of saving EUR 1 900 million for a full year (EUR 1 500 million in 2010);
(h)
an increase in the VAT rate, with a yield of at least EUR 1 800 million for a full year (EUR 800 million in 2010);
(i)
an increase in excises for fuel, tobacco and alcohol, with a yield of at least EUR 1 050 million for a full year (EUR 450 million in 2010);
(j)
legislation implementing the Services Directive(3);
(k)
a law reforming and simplifying public administration at local level with the aim of reducing operating costs;
(l)
the establishment of a task force aiming at improving the absorption rate of structural and cohesion funds;
(m)
a law to simplify the start-up of new businesses;
(n)
a reduction of public investment by EUR 500 million compared to plans;
(o)
the channelling of the budgetary appropriations for the co-financing of structural and cohesion funds to a special central account that cannot be used for any other purpose;
(p)
the establishment of an independent financial stability fund to deal with potential capital shortfalls and preserve the soundness of the financial sector, by providing equity support to banks as needed;
(q)
the reinforced supervision of banks, with increased human resources, more frequent reporting and quarterly stress tests.
2. Greece shall adopt the following measures by the end of September 2010:
(a)
an inclusion in the draft budget for 2011 of fiscal consolidation measures amounting to at least 3 % of GDP (4,1 % of GDP if carryovers from measures implemented in 2010 are considered). The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): a reduction in intermediate consumption of the general government by at least EUR 300 million compared to the 2010 level (in addition to savings stemming from the reform, referred to in this paragraph, of public administration and of local government); a freeze in the indexation of pensions (with the aim of saving EUR 100 million); a temporary crisis levy on highly profitable firms (yielding at least EUR 600 million in additional revenue per year in 2011, 2012 and 2013); the presumptive taxation of professionals (with a yield of at least EUR 400 million in 2011 and increasing returns in 2012 and 2013); a broadening of the VAT base to include certain services currently exempted and moving 30 % of goods and services from the reduced rate to the main rate (with a yield of EUR 1 billion); a phased-in green tax on CO2emissions (with a yield of at least EUR 300 million in 2011); the implementation by the Greek Government of legislation reforming public administration and reorganising local government (with the aim of reducing costs by at least EUR 500 million in 2011, and 500 additional EUR million each year in 2012 and 2013); a reduction in domestically-financed investments (by at least EUR 1 billion) by giving priority to investment projects financed by EU structural funds; incentives to regularise land-use violations (yielding at least EUR 1 500 million from 2011 to 2013, of which at least EUR 500 million in 2011); a collection of revenue from the licensing of gaming (at least EUR 500 million in sales of licences and EUR 200 million in royalties); a broadening of the real estate tax base by updating asset values (to yield at least EUR 500 million additional revenue); an increased taxation of wages in kind, including by taxing car lease payments (by at least EUR 150 million); an increased taxation of luxury goods (by at least EUR 100 million); a special tax on unauthorised establishments (to yield at least EUR 800 million per year); and a replacement of only 20 % of retiring employees in the public sector (central government, municipalities, public companies, local governments, state agencies and other public institutions);
(b)
a law reforming the pension system with a view to ensuring its medium and long-term sustainability. The law should, in particular, introduce: a unified statutory retirement age of 65 years (including for women); a merger of the existing pension funds in three funds and a unified new pension system for all current and future employees (applicable as of 1 January 2013); a reduction of the upper limit on pensions; a gradual increase in the minimum contributory period for retirement on a full benefit from 37 to 40 years (by 2015); a minimum retirement age of 60 years by 1 January 2011 (including for workers in heavy and arduous professions and those with 40 years of contributions); the abolition of the special rules applicable to persons insured before 1993 (while retaining acquired rights); a substantial narrowing of the list of heavy and arduous professions; a reduction of pension benefits (by 6 % per year) for people entering retirement between the ages of 60 and 65 with a contributory period of less than 40 years; the creation of an automatic adjustment mechanism linking the retirement age with the increase in life expectancy (as of 2020); the creation of a means-tested minimum guaranteed income for elderly people above the statutory retirement age; stricter conditions and the regular re-examination of eligibility for disability pensions; an amendment of the pension award formula in the contributory based scheme to strengthen the link between contributions paid and benefits received (with accrual rate limited to an average annual rate of 1,2 %); and an extension of the calculation of the pensionable earnings to entire lifetime earnings (while retaining acquired rights). The implementation of this law should reduce the projected increase in the pension expenditure to GDP ratio to below the euro area average over the next decades and should limit the increase of public sector spending on pensions over the period 2010-2060 to less than 2,5 % of GDP;
(c)
a reinforcement of the role and resources of the general accounting office and the establishment of safeguards against possible political interference in data projection and accounting;
(d)
a draft reform of wage legislation in the public sector, including, in particular, the creation of a Single Payment Authority for the payment of wages, the introduction of unified principles and a timetable to establish a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies;
(e)
legislation to improve the efficiency of the tax administration and controls;
(f)
the launch of an independent review of public administration and of existing social programmes;
(g)
the publication of monthly statistics (on a cash basis) on revenue, expenditure, financing and spending arrears for the ‘available general government’ and its sub entities;
(h)
an action plan to improve the collection and processing of general government data, in particular by enhancing the control mechanisms of statistical authorities and of the general accounting office and ensuring effective personal responsibility for cases of misreporting, in order to ensure the prompt supply of high quality general government data required by Regulations (EC) No 2223/96(4), (EC) No 264/2000(5), (EC) No 1221/2002(6), (EC) No 501/2004(7), (EC) No 1222/2004(8), (EC) No 1161/2005(9), (EC) No 223/2009(10)and (EC) No 479/2009(11);
(i)
the regular publication of information on the financial position of public undertakings and other public entities not classified as part of the general government (including detailed income statements, balance sheets and data on employment and the wage bill).
3. Greece shall adopt the following measures by the end of December 2010:
(a)
the final adoption of the measures referred to in paragraphs 2(a) and (d);
(b)
draft legislation strengthening the fiscal framework. This should, in particular, include the establishment of a medium-term fiscal framework, the creation of a compulsory contingency reserve in the budget corresponding to 10 % of total appropriations, the creation of stronger expenditure monitoring mechanisms and the establishment of an independent fiscal agency providing advice and expert scrutiny on fiscal issues;
(c)
a law to reform the wage bargaining system in the private sector, which should provide for a reduction in pay rates for overtime work, enhanced flexibility in the management of working time and allow local territorial pacts to set wage growth below sectoral agreements;
(d)
a law on minimum wages to introduce sub-minima for groups at risk such as the young and long-term unemployed, and put measures in place to guarantee that current minimum wages remain fixed in nominal terms for three years;
(e)
a reform of employment protection legislation to extend the probationary period for new jobs to one year, reduce the overall level of severance payments and ensure that the same severance payment conditions apply to blue and white collar workers, raise the minimum threshold for the rules on collective dismissals to apply, especially for larger companies, and facilitate a greater use of temporary contracts;
(f)
a significant increase in the absorption rate of structural and cohesion funds;
(g)
the introduction of a new system for the management of drugs favouring the use of generic medicines;
(h)
the establishment of a unified public procurement system with a central procurement authority, ensuring, in particular, robust tendering procedures, and ex ante and ex post controls;
(i)
legislation simplifying and accelerating the process of licensing undertakings, industrial activities and professions;
(j)
a modification of the institutional framework of the Hellenic competition authority (HCC) with a view to increasing its independence, establishing reasonable deadlines for the investigation and issue of decisions and entrusting it with the power to reject complaints;
(k)
a better management of public assets, with the aim of raising at least EUR 1 billion per year during the period 2011-2013;
(l)
measures aiming at removing existing restrictions on the freedom to provide services.
4. Greece shall adopt the following measures by the end of March 2011:
(a)
the final adoption of the measures referred to in paragraph 3(b).
5. Greece shall adopt the following measures by the end of June 2011:
(a)
a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies, with remunerations reflecting productivity and tasks;
(b)
measures implementing the findings of the external and independent functional review of public administrations;
(c)
a reinforcement of the labour inspectorate, which shall be fully resourced with qualified staff and have quantitative targets on the number of controls to be carried out.
6. Greece shall adopt the following measures by the end of September 2011:
(a)
the inclusion in the draft budget for 2012 of fiscal consolidation measures amounting to at least 2,2 % of GDP. The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): further broaden the VAT base by moving goods and services from a reduced to a normal rate (with the aim of collecting at least an additional EUR 300 million); reduce public employment in addition to the rule of one recruitment for every five retirements in the public sector (with the aim of saving at least EUR 600 million); establish excise duties for non-alcoholic beverages (for a total amount of at least EUR 300 million); expand the real estate tax by updating asset values (in order to create at least EUR 200 million in extra revenue); reorganise sub-central governments (aiming at generating at least EUR 500 million in savings); reduce the intermediate consumption of the general government (by at least EUR 300 million compared to the level in 2011); introduce a nominal freeze on pensions; increase efficiency of the presumptive taxation of professionals (with the aim of collecting at least EUR 100 million); reduce transfers to public undertakings (by at least EUR 800 million) following their restructuring; make unemployment benefits means-tested (with the aim of saving EUR 500 million); and collect further revenues from the licensing of gaming (at least EUR 225 million in the sale of licences and EUR 400 million in royalties);
(b)
a mitigation of tax obstacles to mergers and acquisitions;
(c)
a simplification of the custom clearing process for exports and imports;
(d)
a further increase in the absorption rates of structural and cohesion funds;
(e)
the full implementation of the Better Regulation agenda with a view to reducing administrative burdens by 20 % (compared with 2008).
7. Greece shall adopt the following measures by the end of December 2011:
(a)
the final adoption of the measures referred to in paragraph 6(a);
(b)
a reinforcement of the managerial capacity of all managing authorities and intermediate bodies of operational programmes under the framework of the national strategy reference framework 2007-2013 and their ISO 9001:2008 (quality management) certification.

Article 3
Greece shall fully cooperate with the Commission and transmit without delay, upon a reasoned request from the latter, any data or document required in order to monitor compliance with this Decision.

Article 4
1. Greece shall submit to the Council and the Commission a report outlining the policy measures taken to comply with this Decision on a quarterly basis.
2. The reports referred to in paragraph 1 should contain detailed information on:
(a)
concrete measures implemented by the date of the report in order to comply with this Decision, including their quantified budgetary impact;
(b)
concrete measures planned to be implemented after the date of the report in order to comply with this Decision, their implementation calendar and an estimation of their budgetary impact;
(c)
the monthly State budget execution;
(d)
infra-annual budgetary implementation by social security, local government and extra budgetary funds;
(e)
government debt issue and reimbursement;
(f)
permanent and temporary public sector employment developments;
(g)
government expenditure pending payment (cumulated arrears);
(h)
the financial position of public undertakings and other public entities.
3. The Commission and the Council shall analyse the reports with a view to assessing Greece’s compliance with this Decision. In the context of those assessments, the Commission may indicate the measures needed to respect the adjustment path set by this Decision for the correction of the excessive deficit.

Article 5
This Decision shall take effect on the day of its notification.

Article 6
This Decision is addressed to the Hellenic Republic.

THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union (TFEU), and in particular Article 126(9) and Article 136 thereof,
Having regard to the recommendation from the Commission,
(1) Article 136(1)(a) TFEU foresees the possibility of adopting measures specific to the Member States whose currency is the euro with a view to strengthening the coordination and surveillance of their budgetary discipline.
(2) Article 126 TFEU establishes that Member States are to avoid excessive government deficits and sets out the excessive deficit procedure to that effect. The Stability and Growth Pact, which in its corrective arm implements the excessive deficit procedure, provides the framework supporting government policies for a prompt return to sound budgetary positions taking account of the economic situation.
(3) On 27 April 2009, the Council decided, in accordance with Article 104(6) of the Treaty establishing the European Community (TEC), that an excessive deficit existed in Greece and issued recommendations to correct that deficit by 2010 at the latest, in accordance with Article 104(7) (TEC) and Article 3(4) of Council Regulation (EC) No 1467/97 of 7 July 1997 on speeding up and clarifying the implementation of the excessive deficit procedure(1). The Council also set a deadline of 27 October 2009 for Greece to take effective action. On 30 November 2009, the Council established, in accordance with Article 126(8) TFEU, that Greece had not taken effective action; consequently, on 16 February 2010, the Council gave notice to Greece in accordance with Article 126(9) TFEU to take measures to correct the excessive deficit by 2012 at the latest (hereinafter ‘the Council Decision pursuant to Article 126(9)’). The Council also set a deadline of 15 May 2010 for effective action to be taken.
(4) According to Article 5(2) of Regulation (EC) No 1467/97, if effective action has been taken in compliance with Article 126(9) TFEU and unexpected adverse economic events with major unfavourable consequences for government finances occur after the adoption of that notice, the Council may decide, on a recommendation from the Commission, to adopt a revised notice pursuant to Article 126(9) TFEU.
(5) According to the Commission services’ autumn 2009 forecasts, which provided the basis for the initial notice addressed to Greece, GDP was expected to contract by ¼ % in 2010, and recover as from 2011, when the economy was forecast to grow by 0,7 %. A sharp fall in real GDP is now expected for 2010, followed by a further contraction in 2011. A gradual resumption of growth is expected thereafter. This marked worsening of the economic scenario implies a corresponding deterioration of the outlook for public finances at unchanged policy. To this should be added the upward revision of the government deficit outcome for 2009 (from an estimated 12,7 % of GDP at the time of the Council Decision pursuant to Article 126(9) to 13,6 % of GDP according to the fiscal notification submitted by Greece on 1 April 2010), with the risk of a further upward revision (of the order of 0,3 to 0,5 % of GDP) following completion of the investigations that Eurostat is undertaking with the Greek Statistical Authorities(2). Lastly, concerns in the markets for the public finances outlook have been reflected in a sharp rise in risk premia on government debt, compounding the difficulties in controlling the path of government deficit and debt. According to the preliminary assessment carried out by the Commission in March 2010, Greece was implementing, as requested, the fiscal measures meant to ensure the achievement of the planned deficit target for 2010. However, the abrupt change in the economic scenario means that those plans can no longer be considered valid, requiring even more drastic action in the course of the current year. At the same time, the depth of the contraction in the economy that can now be expected makes the achievement of the initial deficit reduction path unfeasible. Unexpected adverse economic events with major unfavourable consequences for government finances can be considered to have occurred in Greece and revised recommendations pursuant to Article 136 and Article 126(9) TFEU are therefore justified.
(6) In the light of the above considerations, it appears that the deadline which was set in the Council Decision pursuant to Article 126(9) for the correction of the excessive deficit in Greece needs to be extended by two years to 2014.
(7) Gross public debt at the end of 2009 stood at 115,1 % of GDP. This is among the highest debt ratios in the EU, and is considerably higher than the 60 %-of-GDP reference value of the Treaty. Moreover, the figure risks being further revised upwards (by 5 to 7 percentage points) as a result of the ongoing statistical investigations. Achieving the deficit reduction path that is considered necessary and feasible in the light of the circumstances would imply that the increase in debt would be reversed from 2014. In addition to persistently high government deficits, the contribution of ‘below-the-line’ operations to the increase in debt has been large. This has contributed to undermining market confidence in the ability of the Greek Government to service the debt going forward. There is an extremely urgent need for Greece to take decisive action, on an unprecedented scale, on its deficit and on other factors contributing to the increase in debt, in order to reverse the increase in the debt-to-GDP ratio and allow it to return as soon as possible to market financing.
(8) The very severe deterioration of the financial situation of the Greek Government has led euro area Member States to decide to provide stability support to Greece, with a view to safeguarding the financial stability of the euro area as a whole, in conjunction with multilateral assistance provided by the International Monetary Fund. Support provided by the euro area Member States will take the form of a pooling of bilateral loans, coordinated by the Commission. The lenders have decided that their support shall be conditional on Greece respecting this Decision. In particular, Greece is expected to carry out the measures specified in this Decision in accordance with the calendar set out herein,
HAS ADOPTED THIS DECISION:
1. Greece shall put an end to the present excessive deficit situation as rapidly as possible and, at the latest, by the deadline of 2014.
2. The adjustment path towards the correction of the excessive deficit shall aim to achieve a general government deficit not exceeding EUR 18 508 million (8,0 % of GDP) in 2010, EUR 17 065 million (7,6 % of GDP) in 2011, EUR 14 916 million (6,5 % of GDP) in 2012, EUR 11 399 million (4,9 % of GDP) in 2013 and EUR 6 385 million (2,6 % of GDP) in 2014. To this aim, an improvement in the structural balance of at least 10 % of GDP will have to be achieved over the period 2009-2014.
3. The adjustment path referred to in paragraph 2 requires that the annual change in the general government consolidated gross debt does not exceed EUR 34 058 million in 2010, EUR 17 365 million in 2011, EUR 15 016 million in 2012, EUR 11 599 million in 2013 and EUR 7 885 million in 2014. Based on current GDP projections, the corresponding path for the debt-to-GDP ratio would be 133,2 % in 2010, 145,2 % in 2011, 148,8 % in 2012, 149,6 % in 2013 and 148,4 % in 2014.
1. Greece shall adopt the following measures before the end of June 2010:
(a)
a law introducing a progressive tax scale for all sources of income and a horizontally unified treatment of income generated by labour and capital assets;
(b)
a law repealing all exemptions and autonomous taxation provisions in the tax system, including income from special allowances paid to civil servants;
(c)
the cancellation of the budgetary appropriations in the contingency reserve, with the aim of saving EUR 700 million;
(d)
the abolition of most of the budgetary appropriation for the solidarity allowance (except a part for poverty relief) with the aim of saving EUR 400 million;
(e)
a reduction of the highest pensions with the aim of saving EUR 500 million for a full year (EUR 350 million for 2010);
(f)
a reduction of the Easter, summer and Christmas bonuses and allowances paid to civil servants with the aim of saving EUR 1 500 million for a full year (EUR 1 100 million in 2010);
(g)
the abolition of the Easter, summer and Christmas bonuses paid to pensioners, though protecting those receiving low pensions, with the aim of saving EUR 1 900 million for a full year (EUR 1 500 million in 2010);
(h)
an increase in the VAT rate, with a yield of at least EUR 1 800 million for a full year (EUR 800 million in 2010);
(i)
an increase in excises for fuel, tobacco and alcohol, with a yield of at least EUR 1 050 million for a full year (EUR 450 million in 2010);
(j)
legislation implementing the Services Directive(3);
(k)
a law reforming and simplifying public administration at local level with the aim of reducing operating costs;
(l)
the establishment of a task force aiming at improving the absorption rate of structural and cohesion funds;
(m)
a law to simplify the start-up of new businesses;
(n)
a reduction of public investment by EUR 500 million compared to plans;
(o)
the channelling of the budgetary appropriations for the co-financing of structural and cohesion funds to a special central account that cannot be used for any other purpose;
(p)
the establishment of an independent financial stability fund to deal with potential capital shortfalls and preserve the soundness of the financial sector, by providing equity support to banks as needed;
(q)
the reinforced supervision of banks, with increased human resources, more frequent reporting and quarterly stress tests.
2. Greece shall adopt the following measures by the end of September 2010:
(a)
an inclusion in the draft budget for 2011 of fiscal consolidation measures amounting to at least 3 % of GDP (4,1 % of GDP if carryovers from measures implemented in 2010 are considered). The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): a reduction in intermediate consumption of the general government by at least EUR 300 million compared to the 2010 level (in addition to savings stemming from the reform, referred to in this paragraph, of public administration and of local government); a freeze in the indexation of pensions (with the aim of saving EUR 100 million); a temporary crisis levy on highly profitable firms (yielding at least EUR 600 million in additional revenue per year in 2011, 2012 and 2013); the presumptive taxation of professionals (with a yield of at least EUR 400 million in 2011 and increasing returns in 2012 and 2013); a broadening of the VAT base to include certain services currently exempted and moving 30 % of goods and services from the reduced rate to the main rate (with a yield of EUR 1 billion); a phased-in green tax on CO2emissions (with a yield of at least EUR 300 million in 2011); the implementation by the Greek Government of legislation reforming public administration and reorganising local government (with the aim of reducing costs by at least EUR 500 million in 2011, and 500 additional EUR million each year in 2012 and 2013); a reduction in domestically-financed investments (by at least EUR 1 billion) by giving priority to investment projects financed by EU structural funds; incentives to regularise land-use violations (yielding at least EUR 1 500 million from 2011 to 2013, of which at least EUR 500 million in 2011); a collection of revenue from the licensing of gaming (at least EUR 500 million in sales of licences and EUR 200 million in royalties); a broadening of the real estate tax base by updating asset values (to yield at least EUR 500 million additional revenue); an increased taxation of wages in kind, including by taxing car lease payments (by at least EUR 150 million); an increased taxation of luxury goods (by at least EUR 100 million); a special tax on unauthorised establishments (to yield at least EUR 800 million per year); and a replacement of only 20 % of retiring employees in the public sector (central government, municipalities, public companies, local governments, state agencies and other public institutions);
(b)
a law reforming the pension system with a view to ensuring its medium and long-term sustainability. The law should, in particular, introduce: a unified statutory retirement age of 65 years (including for women); a merger of the existing pension funds in three funds and a unified new pension system for all current and future employees (applicable as of 1 January 2013); a reduction of the upper limit on pensions; a gradual increase in the minimum contributory period for retirement on a full benefit from 37 to 40 years (by 2015); a minimum retirement age of 60 years by 1 January 2011 (including for workers in heavy and arduous professions and those with 40 years of contributions); the abolition of the special rules applicable to persons insured before 1993 (while retaining acquired rights); a substantial narrowing of the list of heavy and arduous professions; a reduction of pension benefits (by 6 % per year) for people entering retirement between the ages of 60 and 65 with a contributory period of less than 40 years; the creation of an automatic adjustment mechanism linking the retirement age with the increase in life expectancy (as of 2020); the creation of a means-tested minimum guaranteed income for elderly people above the statutory retirement age; stricter conditions and the regular re-examination of eligibility for disability pensions; an amendment of the pension award formula in the contributory based scheme to strengthen the link between contributions paid and benefits received (with accrual rate limited to an average annual rate of 1,2 %); and an extension of the calculation of the pensionable earnings to entire lifetime earnings (while retaining acquired rights). The implementation of this law should reduce the projected increase in the pension expenditure to GDP ratio to below the euro area average over the next decades and should limit the increase of public sector spending on pensions over the period 2010-2060 to less than 2,5 % of GDP;
(c)
a reinforcement of the role and resources of the general accounting office and the establishment of safeguards against possible political interference in data projection and accounting;
(d)
a draft reform of wage legislation in the public sector, including, in particular, the creation of a Single Payment Authority for the payment of wages, the introduction of unified principles and a timetable to establish a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies;
(e)
legislation to improve the efficiency of the tax administration and controls;
(f)
the launch of an independent review of public administration and of existing social programmes;
(g)
the publication of monthly statistics (on a cash basis) on revenue, expenditure, financing and spending arrears for the ‘available general government’ and its sub entities;
(h)
an action plan to improve the collection and processing of general government data, in particular by enhancing the control mechanisms of statistical authorities and of the general accounting office and ensuring effective personal responsibility for cases of misreporting, in order to ensure the prompt supply of high quality general government data required by Regulations (EC) No 2223/96(4), (EC) No 264/2000(5), (EC) No 1221/2002(6), (EC) No 501/2004(7), (EC) No 1222/2004(8), (EC) No 1161/2005(9), (EC) No 223/2009(10)and (EC) No 479/2009(11);
(i)
the regular publication of information on the financial position of public undertakings and other public entities not classified as part of the general government (including detailed income statements, balance sheets and data on employment and the wage bill).
3. Greece shall adopt the following measures by the end of December 2010:
(a)
the final adoption of the measures referred to in paragraphs 2(a) and (d);
(b)
draft legislation strengthening the fiscal framework. This should, in particular, include the establishment of a medium-term fiscal framework, the creation of a compulsory contingency reserve in the budget corresponding to 10 % of total appropriations, the creation of stronger expenditure monitoring mechanisms and the establishment of an independent fiscal agency providing advice and expert scrutiny on fiscal issues;
(c)
a law to reform the wage bargaining system in the private sector, which should provide for a reduction in pay rates for overtime work, enhanced flexibility in the management of working time and allow local territorial pacts to set wage growth below sectoral agreements;
(d)
a law on minimum wages to introduce sub-minima for groups at risk such as the young and long-term unemployed, and put measures in place to guarantee that current minimum wages remain fixed in nominal terms for three years;
(e)
a reform of employment protection legislation to extend the probationary period for new jobs to one year, reduce the overall level of severance payments and ensure that the same severance payment conditions apply to blue and white collar workers, raise the minimum threshold for the rules on collective dismissals to apply, especially for larger companies, and facilitate a greater use of temporary contracts;
(f)
a significant increase in the absorption rate of structural and cohesion funds;
(g)
the introduction of a new system for the management of drugs favouring the use of generic medicines;
(h)
the establishment of a unified public procurement system with a central procurement authority, ensuring, in particular, robust tendering procedures, and ex ante and ex post controls;
(i)
legislation simplifying and accelerating the process of licensing undertakings, industrial activities and professions;
(j)
a modification of the institutional framework of the Hellenic competition authority (HCC) with a view to increasing its independence, establishing reasonable deadlines for the investigation and issue of decisions and entrusting it with the power to reject complaints;
(k)
a better management of public assets, with the aim of raising at least EUR 1 billion per year during the period 2011-2013;
(l)
measures aiming at removing existing restrictions on the freedom to provide services.
4. Greece shall adopt the following measures by the end of March 2011:
(a)
the final adoption of the measures referred to in paragraph 3(b).
5. Greece shall adopt the following measures by the end of June 2011:
(a)
a streamlined and unified public sector wage grid to apply to the state sector, local authorities and other agencies, with remunerations reflecting productivity and tasks;
(b)
measures implementing the findings of the external and independent functional review of public administrations;
(c)
a reinforcement of the labour inspectorate, which shall be fully resourced with qualified staff and have quantitative targets on the number of controls to be carried out.
6. Greece shall adopt the following measures by the end of September 2011:
(a)
the inclusion in the draft budget for 2012 of fiscal consolidation measures amounting to at least 2,2 % of GDP. The budget shall, in particular, include the following measures (or in exceptional circumstances, measures yielding comparable savings): further broaden the VAT base by moving goods and services from a reduced to a normal rate (with the aim of collecting at least an additional EUR 300 million); reduce public employment in addition to the rule of one recruitment for every five retirements in the public sector (with the aim of saving at least EUR 600 million); establish excise duties for non-alcoholic beverages (for a total amount of at least EUR 300 million); expand the real estate tax by updating asset values (in order to create at least EUR 200 million in extra revenue); reorganise sub-central governments (aiming at generating at least EUR 500 million in savings); reduce the intermediate consumption of the general government (by at least EUR 300 million compared to the level in 2011); introduce a nominal freeze on pensions; increase efficiency of the presumptive taxation of professionals (with the aim of collecting at least EUR 100 million); reduce transfers to public undertakings (by at least EUR 800 million) following their restructuring; make unemployment benefits means-tested (with the aim of saving EUR 500 million); and collect further revenues from the licensing of gaming (at least EUR 225 million in the sale of licences and EUR 400 million in royalties);
(b)
a mitigation of tax obstacles to mergers and acquisitions;
(c)
a simplification of the custom clearing process for exports and imports;
(d)
a further increase in the absorption rates of structural and cohesion funds;
(e)
the full implementation of the Better Regulation agenda with a view to reducing administrative burdens by 20 % (compared with 2008).
7. Greece shall adopt the following measures by the end of December 2011:
(a)
the final adoption of the measures referred to in paragraph 6(a);
(b)
a reinforcement of the managerial capacity of all managing authorities and intermediate bodies of operational programmes under the framework of the national strategy reference framework 2007-2013 and their ISO 9001:2008 (quality management) certification.
Greece shall fully cooperate with the Commission and transmit without delay, upon a reasoned request from the latter, any data or document required in order to monitor compliance with this Decision.
1. Greece shall submit to the Council and the Commission a report outlining the policy measures taken to comply with this Decision on a quarterly basis.
2. The reports referred to in paragraph 1 should contain detailed information on:
(a)
concrete measures implemented by the date of the report in order to comply with this Decision, including their quantified budgetary impact;
(b)
concrete measures planned to be implemented after the date of the report in order to comply with this Decision, their implementation calendar and an estimation of their budgetary impact;
(c)
the monthly State budget execution;
(d)
infra-annual budgetary implementation by social security, local government and extra budgetary funds;
(e)
government debt issue and reimbursement;
(f)
permanent and temporary public sector employment developments;
(g)
government expenditure pending payment (cumulated arrears);
(h)
the financial position of public undertakings and other public entities.
3. The Commission and the Council shall analyse the reports with a view to assessing Greece’s compliance with this Decision. In the context of those assessments, the Commission may indicate the measures needed to respect the adjustment path set by this Decision for the correction of the excessive deficit.
This Decision shall take effect on the day of its notification.
This Decision is addressed to the Hellenic Republic.

Pending: 32009D0894

5.12.2009 EN Official Journal of the European Union L 320/23
(1) Under Regulation (EC) No 1980/2000, the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(4) Measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 17 of Regulation (EC) No 1980/2000,
(a) The product shall be made of at least 90 % w/w solid wood or wood-based materials. Glass, if easily replaceable in case of damage or breakage, may be excluded from the weight calculation as may technical equipment and fittings.
(b) The weight of any individual material, other than solid wood and wood-based materials, shall not exceed 3 % of the total weight of the product. The total combined weight of such materials shall not exceed 10 % of the total weight of the product.
— the use of materials produced in a more sustainable way;
— a reduction of the use of hazardous substances and of emissions of polluting substances;
— a product tested for durability
(i) Materials, other than solid wood and wood-based materials, and other than those covered by the criteria for surface treatment and for the assembly of furniture, which account for less than 3 % of the total weight of the eco-labelled product may be exempt from compliance with ‘wood and wood-based material requirements’.
(ii) Fixtures, such as screws and nails, and metal hardware for sliding doors and drawers are exempt from compliance with all criteria on materials.
a) No substances or preparations that are assigned, or may be assigned at the time of application, any of the following risk phrases (or combinations thereof) may be added to the wooden product:—R23: (toxic by inhalation),—R24: (toxic in contact with skin),—R25: (toxic if swallowed),—R26: (very toxic by inhalation),—R27: (very toxic in contact with skin),—R28: (very toxic if swallowed),—R39 (danger of very serious irreversible effects),—R40 (limited evidence of a carcinogenic effect),—R42 (May cause sensitisation by inhalation),—R43 (May cause sensitisation by skin contact),—R45 (may cause cancer),—R46 (may cause heritable genetic damage),—R48 (danger or serious damage to health by prolonged exposure),—R49 (may cause cancer by inhalation),—R50 (very toxic to aquatic organisms),—R51 (toxic to aquatic organisms),—R52 (harmful to aquatic organisms),—R53 (may cause long-term adverse effects in the aquatic environment),—R60 (may impair fertility),—R61 (may cause harm to the unborn child),—R62 (possible risk of impaired fertility),—R63 (possible risk of harm to the unborn child),—R68 (possible risk of irreversible effects),as laid down in Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances(1)(Dangerous Substances Directive) and its subsequent amendments, and considering Directive 1999/45/EC of the European Parliament and of the Council(2)(Dangerous Preparations Directive).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006(3). In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with and of the following hazard statements (or combinations thereof): H300, H301, H310, H311, H317 H330, H331, H334, H351, H350, H340, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341, H370, H372. — R23: (toxic by inhalation), — R24: (toxic in contact with skin), — R25: (toxic if swallowed), — R26: (very toxic by inhalation), — R27: (very toxic in contact with skin), — R28: (very toxic if swallowed), — R39 (danger of very serious irreversible effects), — R40 (limited evidence of a carcinogenic effect), — R42 (May cause sensitisation by inhalation), — R43 (May cause sensitisation by skin contact), — R45 (may cause cancer), — R46 (may cause heritable genetic damage), — R48 (danger or serious damage to health by prolonged exposure), — R49 (may cause cancer by inhalation), — R50 (very toxic to aquatic organisms), — R51 (toxic to aquatic organisms), — R52 (harmful to aquatic organisms), — R53 (may cause long-term adverse effects in the aquatic environment), — R60 (may impair fertility), — R61 (may cause harm to the unborn child), — R62 (possible risk of impaired fertility), — R63 (possible risk of harm to the unborn child), — R68 (possible risk of irreversible effects),
— R23: (toxic by inhalation),
— R24: (toxic in contact with skin),
— R25: (toxic if swallowed),
— R26: (very toxic by inhalation),
— R27: (very toxic in contact with skin),
— R28: (very toxic if swallowed),
— R39 (danger of very serious irreversible effects),
— R40 (limited evidence of a carcinogenic effect),
— R42 (May cause sensitisation by inhalation),
— R43 (May cause sensitisation by skin contact),
— R45 (may cause cancer),
— R46 (may cause heritable genetic damage),
— R48 (danger or serious damage to health by prolonged exposure),
— R49 (may cause cancer by inhalation),
— R50 (very toxic to aquatic organisms),
— R51 (toxic to aquatic organisms),
— R52 (harmful to aquatic organisms),
— R53 (may cause long-term adverse effects in the aquatic environment),
— R60 (may impair fertility),
— R61 (may cause harm to the unborn child),
— R62 (possible risk of impaired fertility),
— R63 (possible risk of harm to the unborn child),
— R68 (possible risk of irreversible effects),
— R23: (toxic by inhalation),
— R24: (toxic in contact with skin),
— R25: (toxic if swallowed),
— R26: (very toxic by inhalation),
— R27: (very toxic in contact with skin),
— R28: (very toxic if swallowed),
— R39 (danger of very serious irreversible effects),
— R40 (limited evidence of a carcinogenic effect),
— R42 (May cause sensitisation by inhalation),
— R43 (May cause sensitisation by skin contact),
— R45 (may cause cancer),
— R46 (may cause heritable genetic damage),
— R48 (danger or serious damage to health by prolonged exposure),
— R49 (may cause cancer by inhalation),
— R50 (very toxic to aquatic organisms),
— R51 (toxic to aquatic organisms),
— R52 (harmful to aquatic organisms),
— R53 (may cause long-term adverse effects in the aquatic environment),
— R60 (may impair fertility),
— R61 (may cause harm to the unborn child),
— R62 (possible risk of impaired fertility),
— R63 (possible risk of harm to the unborn child),
— R68 (possible risk of irreversible effects),
(b) The product must not contain halogenated organic binding agents, azidirin and polyaziridins as well as pigments and additives based on:—lead, cadmium, chrome (VI), mercury and their compounds,—arsenic, boron and copper,—organic tin. — lead, cadmium, chrome (VI), mercury and their compounds, — arsenic, boron and copper, — organic tin.
— lead, cadmium, chrome (VI), mercury and their compounds,
— arsenic, boron and copper,
— organic tin.
— lead, cadmium, chrome (VI), mercury and their compounds,
— arsenic, boron and copper,
— organic tin.
(c) Only flame retardants that are chemically bound into the matrix/material or onto the matrix/material surface (reactive flame retardants) may be used in the product. If the flame retardants used have any of the R-phrases listed below, these reactive flame retardants should, on application, change their chemical nature to no longer warrant classification under any of these R-phrases. (Less than 0,1 % of the flame retardant on the matrix/material may remain in the form as before application.)—R40 (limited evidence of a carcinogenic effect),—R45 (may cause cancer),—R46 (may cause heritable genetic damage),—R49 (may cause cancer by inhalation),—R50 (very toxic to aquatic organisms),—R51 (toxic to aquatic organisms),—R52 (harmful to aquatic organisms),—R53 (may cause long-term adverse effects in the aquatic environment),—R60 (may impair fertility),—R61 (may cause harm to the unborn child),—R62 (possible risk of impaired fertility),—R63 (possible risk of harm to the unborn child),—R68 (possible risk of irreversible effects),as laid down in Directive 67/548/EEC, and its subsequent amendments.Flame retardants which are only physically mixed into the matrix/material are excluded (additive flame retardants).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008. In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, any of the following hazard statements (or combinations thereof): H351, H350, H340, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341.Assessment and verification: The applicant shall provide a declaration of compliance with this criterion, together with a list of ingredients and related documentation, such as Safety Data Sheets. — R40 (limited evidence of a carcinogenic effect), — R45 (may cause cancer), — R46 (may cause heritable genetic damage), — R49 (may cause cancer by inhalation), — R50 (very toxic to aquatic organisms), — R51 (toxic to aquatic organisms), — R52 (harmful to aquatic organisms), — R53 (may cause long-term adverse effects in the aquatic environment), — R60 (may impair fertility), — R61 (may cause harm to the unborn child), — R62 (possible risk of impaired fertility), — R63 (possible risk of harm to the unborn child), — R68 (possible risk of irreversible effects),
— R40 (limited evidence of a carcinogenic effect),
— R45 (may cause cancer),
— R46 (may cause heritable genetic damage),
— R49 (may cause cancer by inhalation),
— R50 (very toxic to aquatic organisms),
— R51 (toxic to aquatic organisms),
— R52 (harmful to aquatic organisms),
— R53 (may cause long-term adverse effects in the aquatic environment),
— R60 (may impair fertility),
— R61 (may cause harm to the unborn child),
— R62 (possible risk of impaired fertility),
— R63 (possible risk of harm to the unborn child),
— R68 (possible risk of irreversible effects),
— R40 (limited evidence of a carcinogenic effect),
— R45 (may cause cancer),
— R46 (may cause heritable genetic damage),
— R49 (may cause cancer by inhalation),
— R50 (very toxic to aquatic organisms),
— R51 (toxic to aquatic organisms),
— R52 (harmful to aquatic organisms),
— R53 (may cause long-term adverse effects in the aquatic environment),
— R60 (may impair fertility),
— R61 (may cause harm to the unborn child),
— R62 (possible risk of impaired fertility),
— R63 (possible risk of harm to the unborn child),
— R68 (possible risk of irreversible effects),
— Until 30 June 2011, for wooden products placed on the market bearing the Ecolabel, at least 50 % of any solid wood and 20 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materials.
— From 1 July 2011, until 31 December 2012 for wooden products placed on the market bearing the Ecolabel at least 60 % of any solid wood and 30 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materials
— From 1 January 2013, for wooden products placed on the market bearing the Ecolabel at least 70 % of any solid wood and 40 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materials
(i) Indoor furniture shall not be impregnated.For all other furniture, where impregnation or preservatives are used, they shall fulfil the requirements on hazardous substances (Section 2).
(ii) Solid wood, after logging, shall not be treated with substances or preparations containing substances that are included in any of the following lists:—WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),—WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous). — WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous), — WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
(i) Virgin wood shall not be treated with substances or preparations containing substances that are included in any of the following lists:—WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),—WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).Moreover, the treatment of wood shall be in accordance with the provisions of Directive 79/117/EEC and Directive 76/769/EEC. — WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous), — WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
(ii) The content of free formaldehyde in products or preparations used in the panels shall not exceed 0,3 % (w/w). The content of free formaldehyde in binding agents, adhesives, and glues for plywood panels or laminated wood panels shall not exceed 0,5 % (w/w).
(i) Particleboard: the emission of formaldehyde from particle boards in their raw state, i.e. prior to machining or coating, shall not exceed 50 % of the threshold value that would allow it to be classified as E1 according to standard EN 312.Assessment and verification: The applicant and/or his supplier shall provide evidence that the wood-based materials comply with this requirement according to the European standard EN 312-1
(ii) Fibreboard: The formaldehyde measured in any fibreboard used shall not exceed 50 % of the threshold value that would allow it to be classified as class A quality according to EN 622-1. However fibreboards classified as class A will be accepted if they do not represent more than 50 % of the total wood and wood-based materials used in the product.Assessment and verification: The applicant and/or his supplier shall provide evidence that the wood-based materials comply with this requirement according to the European standard EN 622-1.
— Chemical substances classified as harmful for the environment in accordance with Directive 1999/45/EC must not be added to substances and preparations for surface treatment. Nevertheless the products may contain up to 5 % volatile organic compounds (VOC) as defined in Council Directive 1999/13/EC(6)(VOC shall mean any organic compound having at 293,15 K a vapour pressure of 0,01 kPa or more, or having a corresponding volatility under the particular conditions of use.). If the product requires dilution, the contents of the diluted product must not exceed the aforementioned threshold values.
— The applied quantity (wet paint/varnish) of environmentally harmful substances in accordance with Directive 1999/45/EC shall not exceed 14 g/m2 surface area and applied quantity (wet paint/varnish) of VOC shall not exceed 35 g/m2.
— a complete recipe with designation of quantities and CAS numbers for constituent substances,
— the test method and test results for all substances present in the product, according to Directive 67/548/EEC,
— a declaration stating that all constituent substances have been disclosed,
— number of coats and quantity applied per coat per square meter of surface.
— Information on the fitness for purpose, on the basis of domestic or contract use (light or heavy, indoor or outdoor);
— Information on cleaning and care;
— Instruction for the replacement of glass (if any) upon request in case of damage or breakage from manufacturer or retailer;
— Instruction that the local authorities should be contacted on the best way to dispose of old furniture and materials;
— Instruction for assembly;
— Best use from an ergonomic point of view, where relevant;
— Name of the species of solid wood;
— Indicate any treatments or preservatives that have been used on outdoor products (chemical, biological or physical);
— Recommendation that the consumer use EU Ecolabelled products for future preservation of the furniture.
(i) Made out of one of the following:—easily recyclable material;—materials taken from renewable resources;—materials intended to be reusable, such as textile coverings. — easily recyclable material; — materials taken from renewable resources; — materials intended to be reusable, such as textile coverings.
— easily recyclable material;
— materials taken from renewable resources;
— materials intended to be reusable, such as textile coverings.
— easily recyclable material;
— materials taken from renewable resources;
— materials intended to be reusable, such as textile coverings.
(ii) All materials shall be easily separable by hand in recyclable parts consisting of one material (e.g. cardboard, paper, plastic, textiles).
— Wood from well managed forests;
— restricted hazardous substances;
— product tested for durability.
Elements and compounds Limit values(mg/kg recycled wood-based material)
Arsenic 25
Cadmium 50
Chromium 25
Copper 40
Lead 90
Mercury 25
Fluorine 100
Chlorine 1 000
Pentachlorophenol (PCP) 5
Tar oils (benzo(a)pyrene) 0,5
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1980/2000 of the European Parliament and of the Council of 17 July 2000 on a revised Community eco-label award scheme(1), and in particular the second subparagraph of Article 6(1) thereof,
After consulting the European Union Eco-labelling Board,
(1) Under Regulation (EC) No 1980/2000, the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(4) Measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 17 of Regulation (EC) No 1980/2000,
HAS ADOPTED THIS DECISION:

Article 1
The product group ‘wooden furniture’ shall comprise free-standing or built-in units, which are used for storing, hanging, lying, sitting, working and eating of domestic furniture, whether for indoor or outdoor use, or used indoors for business purposes. Business purposes shall include office and school furniture as well as furniture for restaurants and hotels.
The following conditions shall be fulfilled:
(a)
The product shall be made of at least 90 % w/w solid wood or wood-based materials. Glass, if easily replaceable in case of damage or breakage, may be excluded from the weight calculation as may technical equipment and fittings.
(b)
The weight of any individual material, other than solid wood and wood-based materials, shall not exceed 3 % of the total weight of the product. The total combined weight of such materials shall not exceed 10 % of the total weight of the product.

Article 2
In order to be awarded the Community eco-label under Regulation (EC) No 1980/2000, an item of wooden furniture must fall within the product group ‘wooden furniture’ as defined in Article 1 of this Decision and must comply with the ecological criteria set out in the Annex.

Article 3
The ecological criteria for the product group ‘wooden furniture’, as well as the related assessment and verification requirements, shall be valid for four years from the date of notification of this decision.

Article 4
For administrative purposes the code number assigned to the product group ‘wooden furniture’ shall be ‘36’.

Article 5
This Decision is addressed to the Member States.

THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1980/2000 of the European Parliament and of the Council of 17 July 2000 on a revised Community eco-label award scheme(1), and in particular the second subparagraph of Article 6(1) thereof,
After consulting the European Union Eco-labelling Board,
(1) Under Regulation (EC) No 1980/2000, the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(4) Measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 17 of Regulation (EC) No 1980/2000,
HAS ADOPTED THIS DECISION:
The product group ‘wooden furniture’ shall comprise free-standing or built-in units, which are used for storing, hanging, lying, sitting, working and eating of domestic furniture, whether for indoor or outdoor use, or used indoors for business purposes. Business purposes shall include office and school furniture as well as furniture for restaurants and hotels.
The following conditions shall be fulfilled:
(a)
The product shall be made of at least 90 % w/w solid wood or wood-based materials. Glass, if easily replaceable in case of damage or breakage, may be excluded from the weight calculation as may technical equipment and fittings.
(b)
The weight of any individual material, other than solid wood and wood-based materials, shall not exceed 3 % of the total weight of the product. The total combined weight of such materials shall not exceed 10 % of the total weight of the product.
In order to be awarded the Community eco-label under Regulation (EC) No 1980/2000, an item of wooden furniture must fall within the product group ‘wooden furniture’ as defined in Article 1 of this Decision and must comply with the ecological criteria set out in the Annex.
The ecological criteria for the product group ‘wooden furniture’, as well as the related assessment and verification requirements, shall be valid for four years from the date of notification of this decision.
For administrative purposes the code number assigned to the product group ‘wooden furniture’ shall be ‘36’.
This Decision is addressed to the Member States.

FRAMEWORK

ANNEX
The aims of the criteria
These criteria aim in particular at promoting a reduction of the impact of wooden furniture on the environment and on human health throughout its life cycle.
More specifically:

— | the use of materials produced in a more sustainable way;
— | a reduction of the use of hazardous substances and of emissions of polluting substances;
— | a product tested for durability
Assessment and verification requirements
The specific assessment and verification requirements are indicated within each criterion. Where appropriate, test methods other than those indicated for each criterion may be used if their equivalence is accepted by the Competent Body assessing the application.
Where the applicant is required to provide documentation, analyses test reports, or other evidence to show compliance with the criteria, it is understood that these may originate from the applicant and/or his supplier(s) and/or their supplier(s), etc., as appropriate.
Conformity assessment must be performed by appropriate accredited laboratories (where possible) that meet the general requirements of EN ISO 17025.
Where appropriate, Competent Bodies may require supporting documentation and may carry out independent verifications.
The Competent Bodies are recommended to take into account the implementation of recognised environmental management schemes, such as EMAS or ISO14001, and Environmental Product Declarations when assessing applications and monitoring compliance with the criteria (note: these declarations and management schemes are not required but encouraged).

CRITERIA

Exemptions
The following exemptions from certain of the criteria on materials shall apply:

(i) | Materials, other than solid wood and wood-based materials, and other than those covered by the criteria for surface treatment and for the assembly of furniture, which account for less than 3 % of the total weight of the eco-labelled product may be exempt from compliance with ‘wood and wood-based material requirements’.
(ii) | Fixtures, such as screws and nails, and metal hardware for sliding doors and drawers are exempt from compliance with all criteria on materials.Assessment and verification: Appropriate information shall be provided on those materials which are exempted from compliance with certain criteria. The calculation of the percentage of materials which may be exempted shall include the amount of such materials in composite materials, whatever the percentage of the composite material in the final Ecolabelled furniture. The calculation of the total weight shall not include the weight of fixtures.
1. Product Description
A description of the product shall be provided (functional description, product name or reference code; if various types of the same product are available a description of the subtypes to which the application applies). Information shall be provided on the total weight of the product, the materials used in the product, including fixtures and fittings, and their respective weight.
Assessment and verification: The applicant shall provide a product description to the Competent Body in which the above-described information is included.
2. Hazardous Substances

| a) | No substances or preparations that are assigned, or may be assigned at the time of application, any of the following risk phrases (or combinations thereof) may be added to the wooden product:—R23: (toxic by inhalation),—R24: (toxic in contact with skin),—R25: (toxic if swallowed),—R26: (very toxic by inhalation),—R27: (very toxic in contact with skin),—R28: (very toxic if swallowed),—R39 (danger of very serious irreversible effects),—R40 (limited evidence of a carcinogenic effect),—R42 (May cause sensitisation by inhalation),—R43 (May cause sensitisation by skin contact),—R45 (may cause cancer),—R46 (may cause heritable genetic damage),—R48 (danger or serious damage to health by prolonged exposure),—R49 (may cause cancer by inhalation),—R50 (very toxic to aquatic organisms),—R51 (toxic to aquatic organisms),—R52 (harmful to aquatic organisms),—R53 (may cause long-term adverse effects in the aquatic environment),—R60 (may impair fertility),—R61 (may cause harm to the unborn child),—R62 (possible risk of impaired fertility),—R63 (possible risk of harm to the unborn child),—R68 (possible risk of irreversible effects),as laid down in Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances(1)(Dangerous Substances Directive) and its subsequent amendments, and considering Directive 1999/45/EC of the European Parliament and of the Council(2)(Dangerous Preparations Directive).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006(3). In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with and of the following hazard statements (or combinations thereof): H300, H301, H310, H311, H317 H330, H331, H334, H351, H350, H340, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341, H370, H372. | — | R23: (toxic by inhalation), | — | R24: (toxic in contact with skin), | — | R25: (toxic if swallowed), | — | R26: (very toxic by inhalation), | — | R27: (very toxic in contact with skin), | — | R28: (very toxic if swallowed), | — | R39 (danger of very serious irreversible effects), | — | R40 (limited evidence of a carcinogenic effect), | — | R42 (May cause sensitisation by inhalation), | — | R43 (May cause sensitisation by skin contact), | — | R45 (may cause cancer), | — | R46 (may cause heritable genetic damage), | — | R48 (danger or serious damage to health by prolonged exposure), | — | R49 (may cause cancer by inhalation), | — | R50 (very toxic to aquatic organisms), | — | R51 (toxic to aquatic organisms), | — | R52 (harmful to aquatic organisms), | — | R53 (may cause long-term adverse effects in the aquatic environment), | — | R60 (may impair fertility), | — | R61 (may cause harm to the unborn child), | — | R62 (possible risk of impaired fertility), | — | R63 (possible risk of harm to the unborn child), | — | R68 (possible risk of irreversible effects),
— | R23: (toxic by inhalation),
— | R24: (toxic in contact with skin),
— | R25: (toxic if swallowed),
— | R26: (very toxic by inhalation),
— | R27: (very toxic in contact with skin),
— | R28: (very toxic if swallowed),
— | R39 (danger of very serious irreversible effects),
— | R40 (limited evidence of a carcinogenic effect),
— | R42 (May cause sensitisation by inhalation),
— | R43 (May cause sensitisation by skin contact),
— | R45 (may cause cancer),
— | R46 (may cause heritable genetic damage),
— | R48 (danger or serious damage to health by prolonged exposure),
— | R49 (may cause cancer by inhalation),
— | R50 (very toxic to aquatic organisms),
— | R51 (toxic to aquatic organisms),
— | R52 (harmful to aquatic organisms),
— | R53 (may cause long-term adverse effects in the aquatic environment),
— | R60 (may impair fertility),
— | R61 (may cause harm to the unborn child),
— | R62 (possible risk of impaired fertility),
— | R63 (possible risk of harm to the unborn child),
— | R68 (possible risk of irreversible effects),
| (b) | The product must not contain halogenated organic binding agents, azidirin and polyaziridins as well as pigments and additives based on:—lead, cadmium, chrome (VI), mercury and their compounds,—arsenic, boron and copper,—organic tin. | — | lead, cadmium, chrome (VI), mercury and their compounds, | — | arsenic, boron and copper, | — | organic tin.
— | lead, cadmium, chrome (VI), mercury and their compounds,
— | arsenic, boron and copper,
— | organic tin.
| (c) | Only flame retardants that are chemically bound into the matrix/material or onto the matrix/material surface (reactive flame retardants) may be used in the product. If the flame retardants used have any of the R-phrases listed below, these reactive flame retardants should, on application, change their chemical nature to no longer warrant classification under any of these R-phrases. (Less than 0,1 % of the flame retardant on the matrix/material may remain in the form as before application.)—R40 (limited evidence of a carcinogenic effect),—R45 (may cause cancer),—R46 (may cause heritable genetic damage),—R49 (may cause cancer by inhalation),—R50 (very toxic to aquatic organisms),—R51 (toxic to aquatic organisms),—R52 (harmful to aquatic organisms),—R53 (may cause long-term adverse effects in the aquatic environment),—R60 (may impair fertility),—R61 (may cause harm to the unborn child),—R62 (possible risk of impaired fertility),—R63 (possible risk of harm to the unborn child),—R68 (possible risk of irreversible effects),as laid down in Directive 67/548/EEC, and its subsequent amendments.Flame retardants which are only physically mixed into the matrix/material are excluded (additive flame retardants).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008. In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, any of the following hazard statements (or combinations thereof): H351, H350, H340, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341.Assessment and verification: The applicant shall provide a declaration of compliance with this criterion, together with a list of ingredients and related documentation, such as Safety Data Sheets. | — | R40 (limited evidence of a carcinogenic effect), | — | R45 (may cause cancer), | — | R46 (may cause heritable genetic damage), | — | R49 (may cause cancer by inhalation), | — | R50 (very toxic to aquatic organisms), | — | R51 (toxic to aquatic organisms), | — | R52 (harmful to aquatic organisms), | — | R53 (may cause long-term adverse effects in the aquatic environment), | — | R60 (may impair fertility), | — | R61 (may cause harm to the unborn child), | — | R62 (possible risk of impaired fertility), | — | R63 (possible risk of harm to the unborn child), | — | R68 (possible risk of irreversible effects),
— | R40 (limited evidence of a carcinogenic effect),
— | R45 (may cause cancer),
— | R46 (may cause heritable genetic damage),
— | R49 (may cause cancer by inhalation),
— | R50 (very toxic to aquatic organisms),
— | R51 (toxic to aquatic organisms),
— | R52 (harmful to aquatic organisms),
— | R53 (may cause long-term adverse effects in the aquatic environment),
— | R60 (may impair fertility),
— | R61 (may cause harm to the unborn child),
— | R62 (possible risk of impaired fertility),
— | R63 (possible risk of harm to the unborn child),
— | R68 (possible risk of irreversible effects),3. Wood and Wood-Based Material Requirements
(a) Sustainable Forest management
The producer shall have a policy for sustainable wood procurement and a system to trace and verify the origin of wood and tracking it from forest to the first reception point.
The origin of all wood shall be documented. The producer must ensure that all wood originate from legal sources. The wood shall not come from protected areas or areas in the official process of designation for protection, old growth forests and high conservation value forests defined in national stakeholder processes unless the purchases are clearly in line with the national conservation regulations.

— | Until 30 June 2011, for wooden products placed on the market bearing the Ecolabel, at least 50 % of any solid wood and 20 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materials.
— | From 1 July 2011, until 31 December 2012 for wooden products placed on the market bearing the Ecolabel at least 60 % of any solid wood and 30 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materials
— | From 1 January 2013, for wooden products placed on the market bearing the Ecolabel at least 70 % of any solid wood and 40 % wood-based materials must originate either from sustainably managed forests which have been certified by independent third party schemes fulfilling the criteria listed in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU and further development thereof, or from recycled materialsAssessment and verification: For meeting these conditions, the applicant shall demonstrate that any of their wooden Ecolabelled products, when first placed on the market after the dates shown in the criterion will meet the appropriate level of certified wood. If this cannot be demonstrated the competent body will only issue the Ecolabel licence for the period for which compliance can be demonstrated. The applicant shall provide appropriate documentation from the wood supplier indicating the types, quantities and precise origins of wood used in the production of furniture. The applicant shall provide appropriate certificate(s) showing that the certification scheme correctly fulfils the requirements as laid down in paragraph 15 of the Council Resolution of 15 December 1998 on a Forestry Strategy for the EU.
Definition: Wood-based materials means material made by binding with adhesives and/or glues one or more of the following materials: wood fibres, and/or stripped or sheared wood sheets, and/or wood residues from forest, plantations, sawn-wood, residues from pulp/paper industry, and/or recycled wood. Wood-based materials comprise: hardboard, fibreboard, medium density fibreboard, particleboard, OSB (Oriented Strand Board), plywood, and panels in solid wood. The term ‘wood-based material’ also refers to composite materials made from wood-based panels coated by plastics, or laminated plastics, or metals, or other coating materials and finished/semi-finished wood-based panels.
Finished or semi-finished wood-based materials, and wood-based materials coated by plastics, or laminated plastic, or metals, or other coating materials shall also comply with the criteria for surface treatment in addition to the criteria set under this section.
(b) Recycled wood fibres
Post consumer wood, chips or fibres applied in the production of wood-based materials (input), shall at least comply with the provisions in the EPF Industry standard, as reported in paragraph 6 of document ‘EPF Standard for delivery conditions of recycled wood’ of 24 October 2002. The reference standard table is also appended in the appendix.
Assessment and verification: A declaration shall be provided that post-consumer wood is applied in the production of wood-based materials. In addition, test results shall be provided to verify compliance with limit values as laid down in appendix 1.
(c) Impregnating substances and preservatives

(i) | Indoor furniture shall not be impregnated.For all other furniture, where impregnation or preservatives are used, they shall fulfil the requirements on hazardous substances (Section 2).
(ii) | Solid wood, after logging, shall not be treated with substances or preparations containing substances that are included in any of the following lists:—WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),—WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous). | — | WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous), | — | WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— | WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— | WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).Moreover, the treatment of wood shall be in accordance with the provisions of Council Directive 79/117/EEC(4)and Council Directive 76/769/EEC(5).
Assessment and verification: The applicant shall provide a declaration showing compliance to this criterion, a list of the substances which have been used and a data sheet for each of them.
(d) Use of hazardous substances and preparations in the production of wood-based materials
In addition to the requirements of Section 2 on hazardous substances, all substances and preparations used in the production of wood-based material shall fulfil the following:

(i) | Virgin wood shall not be treated with substances or preparations containing substances that are included in any of the following lists:—WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),—WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).Moreover, the treatment of wood shall be in accordance with the provisions of Directive 79/117/EEC and Directive 76/769/EEC. | — | WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous), | — | WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
— | WHO recommended classification of pesticides by hazard classified as class 1a (extremely hazardous),
— | WHO recommended classification of pesticides by hazard classified as class 1b (highly hazardous).
(ii) | The content of free formaldehyde in products or preparations used in the panels shall not exceed 0,3 % (w/w). The content of free formaldehyde in binding agents, adhesives, and glues for plywood panels or laminated wood panels shall not exceed 0,5 % (w/w).Assessment and verification: The applicant shall provide appropriate declarations verifying that the above requirements are met. For the chemical products used in the production of wood-based materials a Material Safety Data Sheet or equivalent documentation shall be presented containing information on health hazard classification.
(e) Formaldehyde emission from untreated raw wood-based materials
Wood-based materials are only allowed in a piece of furniture if they comply with the following requirements:

(i) | Particleboard: the emission of formaldehyde from particle boards in their raw state, i.e. prior to machining or coating, shall not exceed 50 % of the threshold value that would allow it to be classified as E1 according to standard EN 312.Assessment and verification: The applicant and/or his supplier shall provide evidence that the wood-based materials comply with this requirement according to the European standard EN 312-1
(ii) | Fibreboard: The formaldehyde measured in any fibreboard used shall not exceed 50 % of the threshold value that would allow it to be classified as class A quality according to EN 622-1. However fibreboards classified as class A will be accepted if they do not represent more than 50 % of the total wood and wood-based materials used in the product.Assessment and verification: The applicant and/or his supplier shall provide evidence that the wood-based materials comply with this requirement according to the European standard EN 622-1.(f) Genetically modified wood
The product shall not contain GMO wood.
Assessment and Verification: the applicant shall provide a declaration that no GMO wood has been used.
4. Criteria for Surface Treatments
Surface treatment refers to the surface treatment process either of single parts/components of furniture or of the furniture as a whole.
(a) Surface treatment with plastic and metals
Plastics and metal shall be allowed in a percentage up to 2 % of the total weight of the piece of furniture. They must comply with the general requirements on hazardous substances stated in Section 2.
Assessment and verification: The applicant shall provide appropriate documentation to show compliance with these criteria.
(b) Other surface treatments than plastics and metals
This criterion is linked to the coating of the furniture and wood materials.
(i) Hazardous substances and preparations (including VOC content)All materials, substances and preparation used must comply with the requirements on hazardous substances set out in section 2.
Assessment and verification: The applicant shall provide a declaration of compliance with this criterion, together with a list of ingredients and related documentation, such as Material and Safety Data Sheets.
In addition, chemical substances classified as harmful for the environment by the chemical manufacturer/supplier in accordance with Community classification system (28th Amendment to Directive 67/548/EEC) shall comply with one of the 2 following limits:

— | Chemical substances classified as harmful for the environment in accordance with Directive 1999/45/EC must not be added to substances and preparations for surface treatment. Nevertheless the products may contain up to 5 % volatile organic compounds (VOC) as defined in Council Directive 1999/13/EC(6)(VOC shall mean any organic compound having at 293,15 K a vapour pressure of 0,01 kPa or more, or having a corresponding volatility under the particular conditions of use.). If the product requires dilution, the contents of the diluted product must not exceed the aforementioned threshold values.
— | The applied quantity (wet paint/varnish) of environmentally harmful substances in accordance with Directive 1999/45/EC shall not exceed 14 g/m2 surface area and applied quantity (wet paint/varnish) of VOC shall not exceed 35 g/m2.Assessment and verification: The applicant shall provide a declaration of compliance with this criterion, together with documents to support this declaration, including:

— | a complete recipe with designation of quantities and CAS numbers for constituent substances,
— | the test method and test results for all substances present in the product, according to Directive 67/548/EEC,
— | a declaration stating that all constituent substances have been disclosed,
— | number of coats and quantity applied per coat per square meter of surface.Method of application:
The following standard degrees of effectiveness are used for the purpose of calculating the consumption of surface treatment product and of the applied quantity: Spraying device without recycling 50 %, spraying device with recycling 70 %, electrostatic spraying 65 %, spraying, bell/disk 80 %, roller coating 95 %, blanket coating 95 %, vacuum coating 95 %, dipping 95 %, rinsing 95 %.
(c) Formaldehyde
Formaldehyde emissions from substances and preparations for surface treatment liberating formaldehyde shall be less than 0,05 ppm.
Assessment and verification: The applicant and/or his supplier shall provide a declaration that the above requirement is met, together with information on the formulation of the surface treatment (e.g. Material safety data sheets).
(d) Plasticizers
If any plasticizer substance in the manufacturing process is applied, phthalates must comply with the requirements on hazardous substances set out in section 2.
Additionally DNOP (di-n-octyl phthalate), DINP (di-isononyl phthalate), DIDP (di-isodecyl phthalate) are not permitted in the product.
Assessment and verification: The applicant shall provide a declaration of compliance with this criterion.
(e) Biocides
Only biocidal products containing biocidal active substances included in Annex IA to Directive 98/8/EC of the European Parliament and of the Council(7), and authorised for use in furniture, shall be allowed for use.
Assessment and verification: The applicant shall provide a declaration that the requirements of this criterion have been met along with a list of biocidal products used.
5. Criteria for the Assembly of Furniture
This criterion is linked to the gluing of components included in the assembly of furniture. i.e. adhesives.
(a) Hazardous substances in additives and binding agents
They must comply with the requirements set out in section 2 on hazardous substances.
Assessment and verification: The applicant shall provide appropriate declarations verifying that the above requirements are met. For each chemical product used in the assembly of furniture, a Safety Data Sheet or equivalent documentation shall be presented containing information on health hazard classification. Test reports or a declaration from the supplier shall be provided for the free formaldehyde content.
(b) VOC
The VOC content of adhesives used in the assembly of furniture shall not exceed 5 % (w/w). (VOC shall mean any organic compound having at 293,15 K a vapour pressure of 0,01 kPa or more, or having a corresponding volatility under the particular conditions of use).
Assessment and verification: A declaration shall be provided by the applicant indicating all adhesives used in the assembly of furniture, as well as compliance with this criterion.
6. Criteria for the Final Product
(a) Durability and safety
The product shall fulfil the requirements on durability, strength, safety and stability in EN standards applicable to the usage of the product. If no EN standard exists, the requirements in ISO standards shall be used. If no EN or ISO standard exists, an evaluation of the product*s durability, strength, safety and stability on the basis of the design and choice of materials shall be performed by an independent test institution.
The user manual will provide the list of norms and standards which shall be used for the durability assessment.
Given the importance of the durability criterion and in order to improve the durability assessment of a product, an initiative will be taken by the EUEB to promote the adoption of EN durability standards which will have to be available for the next revision of the present criteria.
Assessment and verification: The producer shall provide a declaration completed with documentation on the test methods performed by the accredited institution and the test results.
(b) Maintenance
Maintenance of products shall be possible without organic based solvents.
The manufacturer shall guarantee the possibility of acquiring spare part (original functional items or items fulfilling equivalent functions) upon request throughout the actual period of their industrial manufacturing and for a period of 5 years as of the date when production of the relevant range is stopped.
Assessment and verification: The applicant and/or his supplier shall provide a declaration completed with documents showing that this criterion is met.
(c) Recycling and waste
The product must be easily recyclable. A detailed description of the best ways to dispose of the product (reuse, recycling, take back initiative by the applicant, energy production) shall be given to the consumer, ranking them according to their impact on the environment. For each option the precautions to be taken to limit the impact on the environment will have to be clearly stated.
Assessment and verification: The applicant and/or his supplier shall provide a sample of the information which will be supplied and a justification of the recommendations.
(d) Consumer information
The following information shall be supplied with the Ecolabelled product:

— | Information on the fitness for purpose, on the basis of domestic or contract use (light or heavy, indoor or outdoor);
— | Information on cleaning and care;
— | Instruction for the replacement of glass (if any) upon request in case of damage or breakage from manufacturer or retailer;
— | Instruction that the local authorities should be contacted on the best way to dispose of old furniture and materials;
— | Instruction for assembly;
— | Best use from an ergonomic point of view, where relevant;
— | Name of the species of solid wood;
— | Indicate any treatments or preservatives that have been used on outdoor products (chemical, biological or physical);
— | Recommendation that the consumer use EU Ecolabelled products for future preservation of the furniture.Assessment and verification: The applicant shall provide a sample of the information material supplied with the eco-labelled product.
(e) Packaging of the final product
Packaging must fulfil the following requirements:

(i) | Made out of one of the following:—easily recyclable material;—materials taken from renewable resources;—materials intended to be reusable, such as textile coverings. | — | easily recyclable material; | — | materials taken from renewable resources; | — | materials intended to be reusable, such as textile coverings.
— | easily recyclable material;
— | materials taken from renewable resources;
— | materials intended to be reusable, such as textile coverings.
(ii) | All materials shall be easily separable by hand in recyclable parts consisting of one material (e.g. cardboard, paper, plastic, textiles).Assessment and verification: A description of the product packaging shall be provided on application, together with a corresponding declaration of compliance with these criteria.
(f) Information on the packaging
The following text shall appear on the packaging:
‘For more information as to why this product has been awarded the Flower, please visit the website: http://www.ecolabel.eu’
The following text (or equivalent text) shall also appear on the packaging and in the user manual:
‘For more information visit the European Eco-label website. Additional information can be obtained at: name/address of the consumer department of the applicant’.
Assessment and verification: The applicant shall provide a sample of the product’s packaging and user manual and of the information supplied with the product, together with a declaration of compliance with each part of this criterion.
(g) Information appearing on the eco-label
Box 2 of the Eco-label shall contain the following text:

— | Wood from well managed forests;
— | restricted hazardous substances;
— | product tested for durability.Assessment and verification: The applicant shall provide a sample of the product packaging showing the label, together with a declaration of compliance with this criterion.

(1)
OJ 196, 16.8.1967, p. 1.
(2)
OJ L 200, 30.7.1999, p. 1.
(3)
OJ L 353, 31.12.2008, p. 1.
(4)
OJ L 33, 8.2.1979, p. 36.
(5)
OJ L 262, 27.9.1976, p. 201.
(6)
OJ L 85, 29.3.1999, p. 1.
(7)
OJ L 123, 24.4.1998, p. 1.

Appendix
Limit values of elements and substances allowed in recycled wood fibres for the production of wood-based materials

Elements and compounds | Limit values(mg/kg recycled wood-based material)
Arsenic | 25
Cadmium | 50
Chromium | 25
Copper | 40
Lead | 90
Mercury | 25
Fluorine | 100
Chlorine | 1 000
Pentachlorophenol (PCP) | 5
Tar oils (benzo(a)pyrene) | 0,5

Pending: 32009D0563

28.7.2009 EN Official Journal of the European Union L 196/27
(1) Under Regulation (EC) No 1980/2000 the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) It also provides that the review of the eco-label criteria, as well as of the assessment and verification requirements related to those criteria, is to take place in due time before the end of the period of validity of the criteria specified for the product group concerned.
(4) Pursuant to Regulation (EC) No 1980/2000, a timely review has been carried out of the ecological criteria, as well as of the related assessment and verification requirements established by Commission Decision 2002/231/EC of 18 March 2002 establishing revised ecological criteria for the award of the Community eco-label to footwear and amending Decision 1999/179/EC(2). Those ecological criteria and the related assessment and verification requirements are valid until 31 March 2010.
(5) In the light of that review, it is appropriate, in order to take account of scientific and market developments, to modify the definition of the product group and to establish new ecological criteria.
(6) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(7) Decision 2002/231/EC should therefore be replaced.
(8) A transitional period should be allowed for producers whose products have been awarded the eco-label for footwear based on the criteria contained in Decision 2002/231/EC, so that they have sufficient time to adapt their products to comply with the revised criteria and requirements. Producers should also be allowed to submit applications set out under the criteria set in Decision 2002/231/EC or set out under the criteria set in this Decision until the lapse of validity of that Decision.
(9) Measures provided for in this Decision are in accordance with the opinion of the Committee instituted by Article 17 of Regulation (EC) No 1980/2000,
— limiting the levels of toxic residues,
— limiting the emissions of volatile organic compounds, and,
— promoting a more durable product,
(a) For shoes made of leather, there shall be no Chromium VI in the final product.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report, using test method EN ISO 17075 (detection limit 3 ppm). The sample preparation must follow the indications of the EN ISO 4044.(Note:difficulties in measurement due to interferences may be encountered when analysing certain coloured leather)
(b) There shall be no Arsenic, Cadmium and Lead in the materials used for the product assembly or in the final product.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report using one of the following EN 14602 test methods:—testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product,—testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.For leather products the sample preparation shall follow EN ISO 4044. — testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product, — testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.
— testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product,
— testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.
— testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product,
— testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.
(c) The amount of free and hydrolysed formaldehyde of the components of the footwear shall not exceed the following limits:—textile: not detectable,—leather: 150 ppm.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report, using the following test methods: Textiles: EN ISO 14184-1 (detection limit: 20 ppm); Leather: EN ISO 17226-1 or 2.
(a) If the waste waters from leather tanning sites and from the textile industries are released directly into fresh waters the content of COD shall not exceed 250 mg COD/l of water discharged.If the waste waters from leather tanning sites are released into a municipal waste water treatment plant/facility, then this criterion shall not apply, as long as it can be demonstrated:—that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and,—that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).Assessment and verification:the applicant shall provide a test report and complementary data, using the following test method: COD: ISO 6060 — Water quality, determination of chemical oxygen demand.Where the waste water is discharged into a municipal waste water treatment facility, documentation must be provided from the relevant authority showing that the discharge is authorised and that that municipal plant is operational and that it meets the minimum requirements of Directive 91/271/EEC. — that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and, — that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).
— that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and,
— that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).
— that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and,
— that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).
(b) Tannery waste water after treatment shall contain less than 1 mg Chromium (III)/l.Assessment and verification:the applicant shall provide a test report and complementary data, using the following test methods: ISO 9174 or EN 1233 or EN ISO 11885 for Cr.
(a) Pentachlorophenol (PCP) and Tetrachlorophenol (TCP) and its salts and esters shall not be used.Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that the materials do not contain such chlorophenols along with a test report using the following test methods: Leather, EN ISO 17070 (limit of detection 0,1 ppm); Textile, XP G 08-015 (limit of detection 0,05 ppm)
(b) No azo dyes shall be used that may cleave to any of the following aromatic amines:—4-aminodiphenyl(92-67-1)—benzidine(92-87-5)—4-chloro-o-toluidine(95-69-2)—2-naphthylamine(91-59-8)—o-amino-azotoluene(97-56-3)—2-amino-4-nitrotoluene(99-55-8)—p-chloroaniline(106-47-8)—2,4-diaminoanisol(615-05-4)—4,4′-diaminodiphenylmethane(101-77-9)—3,3′-dichlorobenzidine(91-94-1)—3,3′-dimethoxybenzidine(119-90-4)—3,3′-dimethylbenzidine(119-93-7)—3,3′-dimethyl-4,4_-diaminodiphenylmethane(838-88-0)—p-cresidine(120-71-8)—4,4′-methylene-bis-(2-chloraniline)(101-14-4)—4,4′-oxydianiline(101-80-4)—4,4′-thiodianiline(139-65-1)—o-toluidine(95-53-4)—2,4-diaminotoluene(95-80-7)—2.4,5-trimethylaniline(137-17-7)—4-aminoazobenzene(60-09-3)—o-anisidine(90-04-0)Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that such azo dyes have not been used. Should a verification of this declaration be carried out, the following test methods shall be used: Leather — CEN ISO TS 17234; Textile — EN 14362 1 or 2.Textiles limit 30 ppm (note:false positives are possible for 4-aminoazobenzene and confirmation is therefore recommended);Leather limit 30 ppm (note:false positives are possible for 4-aminoazobenzene, 4-aminodiphenyl and 2-naphthylamine and confirmation is therefore recommended). — 4-aminodiphenyl (92-67-1) — benzidine (92-87-5) — 4-chloro-o-toluidine (95-69-2) — 2-naphthylamine (91-59-8) — o-amino-azotoluene (97-56-3) — 2-amino-4-nitrotoluene (99-55-8) — p-chloroaniline (106-47-8) — 2,4-diaminoanisol (615-05-4) — 4,4′-diaminodiphenylmethane (101-77-9) — 3,3′-dichlorobenzidine (91-94-1) — 3,3′-dimethoxybenzidine (119-90-4) — 3,3′-dimethylbenzidine (119-93-7) — 3,3′-dimethyl-4,4_-diaminodiphenylmethane (838-88-0) — p-cresidine (120-71-8) — 4,4′-methylene-bis-(2-chloraniline) (101-14-4) — 4,4′-oxydianiline (101-80-4) — 4,4′-thiodianiline (139-65-1) — o-toluidine (95-53-4) — 2,4-diaminotoluene (95-80-7) — 2.4,5-trimethylaniline (137-17-7) — 4-aminoazobenzene (60-09-3) — o-anisidine (90-04-0)
— 4-aminodiphenyl (92-67-1)
— benzidine (92-87-5)
— 4-chloro-o-toluidine (95-69-2)
— 2-naphthylamine (91-59-8)
— o-amino-azotoluene (97-56-3)
— 2-amino-4-nitrotoluene (99-55-8)
— p-chloroaniline (106-47-8)
— 2,4-diaminoanisol (615-05-4)
— 4,4′-diaminodiphenylmethane (101-77-9)
— 3,3′-dichlorobenzidine (91-94-1)
— 3,3′-dimethoxybenzidine (119-90-4)
— 3,3′-dimethylbenzidine (119-93-7)
— 3,3′-dimethyl-4,4_-diaminodiphenylmethane (838-88-0)
— p-cresidine (120-71-8)
— 4,4′-methylene-bis-(2-chloraniline) (101-14-4)
— 4,4′-oxydianiline (101-80-4)
— 4,4′-thiodianiline (139-65-1)
— o-toluidine (95-53-4)
— 2,4-diaminotoluene (95-80-7)
— 2.4,5-trimethylaniline (137-17-7)
— 4-aminoazobenzene (60-09-3)
— o-anisidine (90-04-0)
— 4-aminodiphenyl (92-67-1)
— benzidine (92-87-5)
— 4-chloro-o-toluidine (95-69-2)
— 2-naphthylamine (91-59-8)
— o-amino-azotoluene (97-56-3)
— 2-amino-4-nitrotoluene (99-55-8)
— p-chloroaniline (106-47-8)
— 2,4-diaminoanisol (615-05-4)
— 4,4′-diaminodiphenylmethane (101-77-9)
— 3,3′-dichlorobenzidine (91-94-1)
— 3,3′-dimethoxybenzidine (119-90-4)
— 3,3′-dimethylbenzidine (119-93-7)
— 3,3′-dimethyl-4,4_-diaminodiphenylmethane (838-88-0)
— p-cresidine (120-71-8)
— 4,4′-methylene-bis-(2-chloraniline) (101-14-4)
— 4,4′-oxydianiline (101-80-4)
— 4,4′-thiodianiline (139-65-1)
— o-toluidine (95-53-4)
— 2,4-diaminotoluene (95-80-7)
— 2.4,5-trimethylaniline (137-17-7)
— 4-aminoazobenzene (60-09-3)
— o-anisidine (90-04-0)
(c) The following N-Nitrosamines shall not be detected in rubber:—N-nitrosodimethylamine (NDMA)—N-nitrosodiethylamine (NDEA)—N-nitrosodipropylamine (NDPA)—N-nitrosodibutylamine (NDBA)—N-nitrosopiperidine (NPIP)—N-nitrosopyrrolidine (NPYR)—N-nitrosomorpholine (NMOR)—N-nitroso N-methyl N-phenylamine (NMPhA)—N-nitroso N-ethyl N-phenylamine (NEPhA)Assessment and verification:the applicant shall provide a test report, using test method EN 12868 (1999-12) or EN 14602. — N-nitrosodimethylamine (NDMA) — N-nitrosodiethylamine (NDEA) — N-nitrosodipropylamine (NDPA) — N-nitrosodibutylamine (NDBA) — N-nitrosopiperidine (NPIP) — N-nitrosopyrrolidine (NPYR) — N-nitrosomorpholine (NMOR) — N-nitroso N-methyl N-phenylamine (NMPhA) — N-nitroso N-ethyl N-phenylamine (NEPhA)
— N-nitrosodimethylamine (NDMA)
— N-nitrosodiethylamine (NDEA)
— N-nitrosodipropylamine (NDPA)
— N-nitrosodibutylamine (NDBA)
— N-nitrosopiperidine (NPIP)
— N-nitrosopyrrolidine (NPYR)
— N-nitrosomorpholine (NMOR)
— N-nitroso N-methyl N-phenylamine (NMPhA)
— N-nitroso N-ethyl N-phenylamine (NEPhA)
— N-nitrosodimethylamine (NDMA)
— N-nitrosodiethylamine (NDEA)
— N-nitrosodipropylamine (NDPA)
— N-nitrosodibutylamine (NDBA)
— N-nitrosopiperidine (NPIP)
— N-nitrosopyrrolidine (NPYR)
— N-nitrosomorpholine (NMOR)
— N-nitroso N-methyl N-phenylamine (NMPhA)
— N-nitroso N-ethyl N-phenylamine (NEPhA)
(d) C10-C13 chloralkanes shall not be used in leather, rubber or textile components.Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that such chloralkanes have not been used.
(e) No dyes meeting the criteria for classification as carcinogenic, mutagenic toxic to reproduction, hazardous/dangerous to the environment with the following R-phrases: R40, R45, R49, R50, R51, R52, R53, R60, R61, R62, R63 or R68 (or any combination), shall be used. (Classification rules as according to Council Directive 67/548/EEC(3)or Directive 1999/45/EC of the European Parliament and of the Council(4).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008 of the European Parliament and of the Council(5). In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with the following hazard statements (or combinations thereof): H351, H350, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341.Assessment and verification:the applicant shall provide a declaration of non-use of such dyes.
(f) Alkylphenol ethoxylate (APE), and Perfluorooctane sulfonate (PFOS) shall not be used.Assessment and verification:the applicant shall provide a declaration of non-use of such substances.
(g) No dyes meeting the criteria for classification as sensitising to skin (R43) shall be used. (Classification rules as according to Directive 67/548/EEC or Directive 1999/45/EC).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008. In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with the following hazard statement: H317.Assessment and verification:The applicant shall provide a declaration of non-use of these dyes.
(h) Phthalates: Only phthalates that at the time of application have been risk assessed and have not been classified with the phrases (or combinations thereof): R60, R61, R62, R50, R51, R52, R53, R50/53, R51/53, R52/53, in accordance with Directive 67/548/EEC, may be used in the product (if applicable). Additionally DNOP (di-n-octyl phthalate), DINP (di-isononyl phthalate), DIDP (di-isodecyl phthalate) are not permitted in the product.Assessment and verification:The applicant shall provide a declaration of compliance with this criterion.
(i) Biocides: Only biocidal products containing biocidal active substances included in Annex IA of the Directive 98/8/EC of the European Parliament and of the Council(6), and authorised for use in footwear, shall be allowed for use.Assessment and verification:The applicant shall provide a declaration that the requirements of this criterion have been met along with a list of biocidal products used.
— ‘These shoes have been treated to improve their water resistance. They do not require further treatment.’ (This criterion is applicable only to footwear that has been water-resistant treated)
— ‘Where possible, repair your footwear rather than throw them away. This is less damaging to the environment.’
— ‘When disposing of footwear, please use appropriate local recycling facilities where these are available.’
— low air and water pollution,
— harmful substances reduced.
— EN 13512 — Upper — Flex resistance,
— EN 13571 — Upper — Tear strength,
— EN 17707 — Outsoles — Flex resistance,
— EN 12770 — Outsoles — Abrasion resistance,
— EN 17708 — Whole sole — Sole adhesion,
— EN 12771 — Outsoles — Tear strength,
— EN ISO 17700 — Test methods for uppers, linings and in socks — Colour fastness to rubbing.
General sports School footwear Casual Men's town Cold weather footwear Women's town Fashion Infants Indoor
Uppers flex resistant:(kc without visible damage) Dry = 100Wet = 20 Dry = 100Wet = 20 Dry = 80Wet = 20 Dry = 80Wet = 20 Dry = 100Wet = 20– 20° = 30 Dry = 50Wet = 10 Dry = 15 Dry = 15 Dry = 15
Uppers tear strength:(Average tear force, N)
Leather ≥ 80 ≥ 60 ≥ 60 ≥ 60 ≥ 60 ≥ 40 ≥ 30 ≥ 30 ≥ 30
Other materials ≥ 40 ≥ 40 ≥ 40 ≥ 40 ≥ 40 ≥ 40 ≥ 30 ≥ 30 ≥ 30
Outsoles flex resistance:
Cut growth (mm) ≤ 4 ≤ 4 ≤ 4 ≤ 4 ≤ 4 ≤ 4
Nsc = no spontaneous crack Nsc Nsc Nsc Nsc Nsc at – 10 °C Nsc
Outsoles abrasion resistance:
D ≥ 0,9 g/cm3(mm3) ≤ 200 ≤ 200 ≤ 250 ≤ 350 ≤ 200 ≤ 400 ≤ 450
D < 0,9 g/cm3(mg) ≤ 150 ≤ 150 ≤ 170 ≤ 200 ≤ 150 ≤ 250 ≤ 300
Uppersole adhesion: (N/mm) ≥ 4,0 ≥ 4,0 ≥ 3,0 ≥ 3,5 ≥ 3,5 ≥ 3,0 ≥ 2,5 ≥ 3,0 ≥ 2,5
Outsoles tear strength:(Average strength, N/mm)
D ≥ 0,9 g/cm3 8 8 8 6 8 6 5 6 5
D < 0,9 g/cm3 6 6 6 4 6 4 4 5 4
Colour fastness of the inside of the footwear (lining or inner face of the upper). Grey scale on the felt after 50 cycles wet ≥ 2/3 ≥ 2/3 ≥ 2/3 ≥ 2/3 ≥ 2/3 ≥ 2/3 ≥ 2/3 ≥ 2/3
On the basis of the overall daily production of shoes of the plant:—MJdp= average energy used per day in production of shoes [electricity + fossil fuels] (calculated on an annual basis),—N= average number of pair of shoes produced per day (calculated on a annual basis),
On the basis of the production of eco-labelled shoes of the plant:—MJep= average energy used per day in production of eco-labelled shoes [electricity + fossil fuels] (calculated on an annual basis),—Nep= average number of pairs of eco-labelled shoes produced per day (calculated on an annual basis),
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1980/2000 of the European Parliament and of the Council of 17 July 2000 on a revised Community eco-label award scheme(1), and in particular the second subparagraph of Article 6(1) thereof,
After consulting the European Union Eco-labelling Board,
(1) Under Regulation (EC) No 1980/2000 the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) It also provides that the review of the eco-label criteria, as well as of the assessment and verification requirements related to those criteria, is to take place in due time before the end of the period of validity of the criteria specified for the product group concerned.
(4) Pursuant to Regulation (EC) No 1980/2000, a timely review has been carried out of the ecological criteria, as well as of the related assessment and verification requirements established by Commission Decision 2002/231/EC of 18 March 2002 establishing revised ecological criteria for the award of the Community eco-label to footwear and amending Decision 1999/179/EC(2). Those ecological criteria and the related assessment and verification requirements are valid until 31 March 2010.
(5) In the light of that review, it is appropriate, in order to take account of scientific and market developments, to modify the definition of the product group and to establish new ecological criteria.
(6) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(7) Decision 2002/231/EC should therefore be replaced.
(8) A transitional period should be allowed for producers whose products have been awarded the eco-label for footwear based on the criteria contained in Decision 2002/231/EC, so that they have sufficient time to adapt their products to comply with the revised criteria and requirements. Producers should also be allowed to submit applications set out under the criteria set in Decision 2002/231/EC or set out under the criteria set in this Decision until the lapse of validity of that Decision.
(9) Measures provided for in this Decision are in accordance with the opinion of the Committee instituted by Article 17 of Regulation (EC) No 1980/2000,
HAS ADOPTED THIS DECISION:

Article 1
The product group ‘footwear’ shall comprise all articles of clothing designed to protect or cover the foot, with a fixed outer sole which comes into contact with the ground. Footwear shall not contain any electric or electronic components.

Article 2
In order to be awarded the Community eco-label for products falling within the product group footwear under Regulation (EC) No 1980/2000 (hereinafter ‘the eco-label’), footwear shall comply with the criteria set out in the Annex to this Decision.

Article 3
The ecological criteria for the product group ‘footwear’, as well as the related assessment and verification requirements, shall be valid for four years from the date of adoption of this Decision.

Article 4
For administrative purposes the code number assigned to the product group ‘footwear’ shall be ‘017’.

Article 5
Decision 2002/231/EC is repealed.

Article 6
1. Applications for the eco-label for products falling within the product group footwear submitted before the date of adoption of this Decision shall be evaluated in accordance with the conditions laid down in Decision 2002/231/EC.
2. Applications for the eco-label for products falling within the product group footwear submitted from the date of adoption of this Decision but by 31 March 2010 at the latest may be based either on the criteria set out in Decision 2002/231/EC or on the criteria set out in this Decision.
Those applications shall be evaluated pursuant to the criteria on which they are based.
3. Where the eco-label is awarded on the basis of an application evaluated according to the criteria set out in Decision 2002/231/EC, that eco-label may be used for twelve months from the date of adoption of this Decision.

Article 7
This Decision is addressed to the Member States.

THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1980/2000 of the European Parliament and of the Council of 17 July 2000 on a revised Community eco-label award scheme(1), and in particular the second subparagraph of Article 6(1) thereof,
After consulting the European Union Eco-labelling Board,
(1) Under Regulation (EC) No 1980/2000 the Community eco-label may be awarded to a product possessing characteristics which enable it to contribute significantly to improvements in relation to key environmental aspects.
(2) Regulation (EC) No 1980/2000 provides that specific eco-label criteria, drawn up on the basis of the criteria drafted by the European Union Eco-labelling Board, are to be established according to product groups.
(3) It also provides that the review of the eco-label criteria, as well as of the assessment and verification requirements related to those criteria, is to take place in due time before the end of the period of validity of the criteria specified for the product group concerned.
(4) Pursuant to Regulation (EC) No 1980/2000, a timely review has been carried out of the ecological criteria, as well as of the related assessment and verification requirements established by Commission Decision 2002/231/EC of 18 March 2002 establishing revised ecological criteria for the award of the Community eco-label to footwear and amending Decision 1999/179/EC(2). Those ecological criteria and the related assessment and verification requirements are valid until 31 March 2010.
(5) In the light of that review, it is appropriate, in order to take account of scientific and market developments, to modify the definition of the product group and to establish new ecological criteria.
(6) The ecological criteria, as well as the related assessment and verification requirements, should be valid for four years from the date of adoption of this Decision.
(7) Decision 2002/231/EC should therefore be replaced.
(8) A transitional period should be allowed for producers whose products have been awarded the eco-label for footwear based on the criteria contained in Decision 2002/231/EC, so that they have sufficient time to adapt their products to comply with the revised criteria and requirements. Producers should also be allowed to submit applications set out under the criteria set in Decision 2002/231/EC or set out under the criteria set in this Decision until the lapse of validity of that Decision.
(9) Measures provided for in this Decision are in accordance with the opinion of the Committee instituted by Article 17 of Regulation (EC) No 1980/2000,
HAS ADOPTED THIS DECISION:
The product group ‘footwear’ shall comprise all articles of clothing designed to protect or cover the foot, with a fixed outer sole which comes into contact with the ground. Footwear shall not contain any electric or electronic components.
In order to be awarded the Community eco-label for products falling within the product group footwear under Regulation (EC) No 1980/2000 (hereinafter ‘the eco-label’), footwear shall comply with the criteria set out in the Annex to this Decision.
The ecological criteria for the product group ‘footwear’, as well as the related assessment and verification requirements, shall be valid for four years from the date of adoption of this Decision.
For administrative purposes the code number assigned to the product group ‘footwear’ shall be ‘017’.
Decision 2002/231/EC is repealed.
1. Applications for the eco-label for products falling within the product group footwear submitted before the date of adoption of this Decision shall be evaluated in accordance with the conditions laid down in Decision 2002/231/EC.
2. Applications for the eco-label for products falling within the product group footwear submitted from the date of adoption of this Decision but by 31 March 2010 at the latest may be based either on the criteria set out in Decision 2002/231/EC or on the criteria set out in this Decision.
Those applications shall be evaluated pursuant to the criteria on which they are based.
3. Where the eco-label is awarded on the basis of an application evaluated according to the criteria set out in Decision 2002/231/EC, that eco-label may be used for twelve months from the date of adoption of this Decision.
This Decision is addressed to the Member States.

FRAMEWORK

ANNEX
The aims of the criteria
These criteria aim in particular at:

— | limiting the levels of toxic residues,
— | limiting the emissions of volatile organic compounds, and,
— | promoting a more durable product,The criteria are set at levels that promote the labelling of footwear which has a lower environmental impact.

Assessment and verification requirements
The specific assessment and verification requirements are indicated within each criterion.
Where appropriate, test methods other than those indicated for each criterion may be used if their equivalence is accepted by the competent body assessing the application.
The functional unit is one pair of shoes. Requirements are based on shoe size 40 Paris point. For children’s shoes the requirements apply for a size 32 Paris point (or the largest size in the case of maximum sizes smaller than 32 Paris point).
Any upper shoe components weighing less than 3 % of the whole upper part shall not be taken into account for the application of the criteria. Any sole shoe components weighing less than 3 % of the whole outer sole shall not be taken into account for the application of the criteria.
Where appropriate, competent bodies may require supporting documentation and may carry out independent verifications.
The competent bodies are recommended to take into account the implementation of recognised environmental management schemes, such as EMAS or ISO 14001, when assessing applications and monitoring compliance with the criteria (note:it is not required to implement such management schemes).

CRITERIA
1. Dangerous substances in the final product

| (a) | For shoes made of leather, there shall be no Chromium VI in the final product.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report, using test method EN ISO 17075 (detection limit 3 ppm). The sample preparation must follow the indications of the EN ISO 4044.(Note:difficulties in measurement due to interferences may be encountered when analysing certain coloured leather)
| (b) | There shall be no Arsenic, Cadmium and Lead in the materials used for the product assembly or in the final product.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report using one of the following EN 14602 test methods:—testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product,—testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.For leather products the sample preparation shall follow EN ISO 4044. | — | testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product, | — | testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.
— | testing the materials for the product assembly. The substances specified in the criterion shall not be detectable in any of the materials used for the manufacturing of the final product,
— | testing the final product. The substances specified in the criterion shall not be detectable in either the upper or lower components of the footwear following separation and complete grinding.
| (c) | The amount of free and hydrolysed formaldehyde of the components of the footwear shall not exceed the following limits:—textile: not detectable,—leather: 150 ppm.Assessment and verification:the applicant and/or his supplier(s) shall provide a test report, using the following test methods: Textiles: EN ISO 14184-1 (detection limit: 20 ppm); Leather: EN ISO 17226-1 or 2.2. Reduction of water consumption (only for the tanning of hides and skins)
The following limits to water consumption for the tanning of hide and skin(1)shall not be exceeded:
—Hides: 35 m3/t,
—Skins: 55 m3/t,
Assessment and verification:the applicant and/or his supplier(s) shall provide appropriate documentation that the mentioned limits have not been exceeded.
3. Emissions from the production of material

| (a) | If the waste waters from leather tanning sites and from the textile industries are released directly into fresh waters the content of COD shall not exceed 250 mg COD/l of water discharged.If the waste waters from leather tanning sites are released into a municipal waste water treatment plant/facility, then this criterion shall not apply, as long as it can be demonstrated:—that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and,—that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).Assessment and verification:the applicant shall provide a test report and complementary data, using the following test method: COD: ISO 6060 — Water quality, determination of chemical oxygen demand.Where the waste water is discharged into a municipal waste water treatment facility, documentation must be provided from the relevant authority showing that the discharge is authorised and that that municipal plant is operational and that it meets the minimum requirements of Directive 91/271/EEC. | — | that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and, | — | that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).
— | that the discharge of waste water from the tanning site into the municipal waste water supply is authorised and,
— | that the municipal waste water treatment facility is operational and that the subsequent discharge of treated water into the fresh water system is in line with minimum Community requirements according to Council Directive 91/271/EEC(2).
| (b) | Tannery waste water after treatment shall contain less than 1 mg Chromium (III)/l.Assessment and verification:the applicant shall provide a test report and complementary data, using the following test methods: ISO 9174 or EN 1233 or EN ISO 11885 for Cr.4. Use of hazardous substances (up until purchase)

| (a) | Pentachlorophenol (PCP) and Tetrachlorophenol (TCP) and its salts and esters shall not be used.Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that the materials do not contain such chlorophenols along with a test report using the following test methods: Leather, EN ISO 17070 (limit of detection 0,1 ppm); Textile, XP G 08-015 (limit of detection 0,05 ppm)
| (b) | No azo dyes shall be used that may cleave to any of the following aromatic amines:—4-aminodiphenyl(92-67-1)—benzidine(92-87-5)—4-chloro-o-toluidine(95-69-2)—2-naphthylamine(91-59-8)—o-amino-azotoluene(97-56-3)—2-amino-4-nitrotoluene(99-55-8)—p-chloroaniline(106-47-8)—2,4-diaminoanisol(615-05-4)—4,4′-diaminodiphenylmethane(101-77-9)—3,3′-dichlorobenzidine(91-94-1)—3,3′-dimethoxybenzidine(119-90-4)—3,3′-dimethylbenzidine(119-93-7)—3,3′-dimethyl-4,4_-diaminodiphenylmethane(838-88-0)—p-cresidine(120-71-8)—4,4′-methylene-bis-(2-chloraniline)(101-14-4)—4,4′-oxydianiline(101-80-4)—4,4′-thiodianiline(139-65-1)—o-toluidine(95-53-4)—2,4-diaminotoluene(95-80-7)—2.4,5-trimethylaniline(137-17-7)—4-aminoazobenzene(60-09-3)—o-anisidine(90-04-0)Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that such azo dyes have not been used. Should a verification of this declaration be carried out, the following test methods shall be used: Leather — CEN ISO TS 17234; Textile — EN 14362 1 or 2.Textiles limit 30 ppm (note:false positives are possible for 4-aminoazobenzene and confirmation is therefore recommended);Leather limit 30 ppm (note:false positives are possible for 4-aminoazobenzene, 4-aminodiphenyl and 2-naphthylamine and confirmation is therefore recommended). | — | 4-aminodiphenyl | (92-67-1) | — | benzidine | (92-87-5) | — | 4-chloro-o-toluidine | (95-69-2) | — | 2-naphthylamine | (91-59-8) | — | o-amino-azotoluene | (97-56-3) | — | 2-amino-4-nitrotoluene | (99-55-8) | — | p-chloroaniline | (106-47-8) | — | 2,4-diaminoanisol | (615-05-4) | — | 4,4′-diaminodiphenylmethane | (101-77-9) | — | 3,3′-dichlorobenzidine | (91-94-1) | — | 3,3′-dimethoxybenzidine | (119-90-4) | — | 3,3′-dimethylbenzidine | (119-93-7) | — | 3,3′-dimethyl-4,4_-diaminodiphenylmethane | (838-88-0) | — | p-cresidine | (120-71-8) | — | 4,4′-methylene-bis-(2-chloraniline) | (101-14-4) | — | 4,4′-oxydianiline | (101-80-4) | — | 4,4′-thiodianiline | (139-65-1) | — | o-toluidine | (95-53-4) | — | 2,4-diaminotoluene | (95-80-7) | — | 2.4,5-trimethylaniline | (137-17-7) | — | 4-aminoazobenzene | (60-09-3) | — | o-anisidine | (90-04-0)
— | 4-aminodiphenyl | (92-67-1)
— | benzidine | (92-87-5)
— | 4-chloro-o-toluidine | (95-69-2)
— | 2-naphthylamine | (91-59-8)
— | o-amino-azotoluene | (97-56-3)
— | 2-amino-4-nitrotoluene | (99-55-8)
— | p-chloroaniline | (106-47-8)
— | 2,4-diaminoanisol | (615-05-4)
— | 4,4′-diaminodiphenylmethane | (101-77-9)
— | 3,3′-dichlorobenzidine | (91-94-1)
— | 3,3′-dimethoxybenzidine | (119-90-4)
— | 3,3′-dimethylbenzidine | (119-93-7)
— | 3,3′-dimethyl-4,4_-diaminodiphenylmethane | (838-88-0)
— | p-cresidine | (120-71-8)
— | 4,4′-methylene-bis-(2-chloraniline) | (101-14-4)
— | 4,4′-oxydianiline | (101-80-4)
— | 4,4′-thiodianiline | (139-65-1)
— | o-toluidine | (95-53-4)
— | 2,4-diaminotoluene | (95-80-7)
— | 2.4,5-trimethylaniline | (137-17-7)
— | 4-aminoazobenzene | (60-09-3)
— | o-anisidine | (90-04-0)
| (c) | The following N-Nitrosamines shall not be detected in rubber:—N-nitrosodimethylamine (NDMA)—N-nitrosodiethylamine (NDEA)—N-nitrosodipropylamine (NDPA)—N-nitrosodibutylamine (NDBA)—N-nitrosopiperidine (NPIP)—N-nitrosopyrrolidine (NPYR)—N-nitrosomorpholine (NMOR)—N-nitroso N-methyl N-phenylamine (NMPhA)—N-nitroso N-ethyl N-phenylamine (NEPhA)Assessment and verification:the applicant shall provide a test report, using test method EN 12868 (1999-12) or EN 14602. | — | N-nitrosodimethylamine (NDMA) | — | N-nitrosodiethylamine (NDEA) | — | N-nitrosodipropylamine (NDPA) | — | N-nitrosodibutylamine (NDBA) | — | N-nitrosopiperidine (NPIP) | — | N-nitrosopyrrolidine (NPYR) | — | N-nitrosomorpholine (NMOR) | — | N-nitroso N-methyl N-phenylamine (NMPhA) | — | N-nitroso N-ethyl N-phenylamine (NEPhA)
— | N-nitrosodimethylamine (NDMA)
— | N-nitrosodiethylamine (NDEA)
— | N-nitrosodipropylamine (NDPA)
— | N-nitrosodibutylamine (NDBA)
— | N-nitrosopiperidine (NPIP)
— | N-nitrosopyrrolidine (NPYR)
— | N-nitrosomorpholine (NMOR)
— | N-nitroso N-methyl N-phenylamine (NMPhA)
— | N-nitroso N-ethyl N-phenylamine (NEPhA)
| (d) | C10-C13 chloralkanes shall not be used in leather, rubber or textile components.Assessment and verification:the applicant and/or his supplier(s) shall provide a declaration that such chloralkanes have not been used.
| (e) | No dyes meeting the criteria for classification as carcinogenic, mutagenic toxic to reproduction, hazardous/dangerous to the environment with the following R-phrases: R40, R45, R49, R50, R51, R52, R53, R60, R61, R62, R63 or R68 (or any combination), shall be used. (Classification rules as according to Council Directive 67/548/EEC(3)or Directive 1999/45/EC of the European Parliament and of the Council(4).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008 of the European Parliament and of the Council(5). In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with the following hazard statements (or combinations thereof): H351, H350, H350i, H400, H410, H411, H412, H413, H360F, H360D, H361f, H361d H360FD, H361fd, H360Fd, H360Df, H341.Assessment and verification:the applicant shall provide a declaration of non-use of such dyes.
| (f) | Alkylphenol ethoxylate (APE), and Perfluorooctane sulfonate (PFOS) shall not be used.Assessment and verification:the applicant shall provide a declaration of non-use of such substances.
| (g) | No dyes meeting the criteria for classification as sensitising to skin (R43) shall be used. (Classification rules as according to Directive 67/548/EEC or Directive 1999/45/EC).Alternatively, classification may be considered according to Regulation (EC) No 1272/2008. In this case no substances or preparations may be added to the raw materials that are assigned, or may be assigned at the time of application, with the following hazard statement: H317.Assessment and verification:The applicant shall provide a declaration of non-use of these dyes.
| (h) | Phthalates: Only phthalates that at the time of application have been risk assessed and have not been classified with the phrases (or combinations thereof): R60, R61, R62, R50, R51, R52, R53, R50/53, R51/53, R52/53, in accordance with Directive 67/548/EEC, may be used in the product (if applicable). Additionally DNOP (di-n-octyl phthalate), DINP (di-isononyl phthalate), DIDP (di-isodecyl phthalate) are not permitted in the product.Assessment and verification:The applicant shall provide a declaration of compliance with this criterion.
| (i) | Biocides: Only biocidal products containing biocidal active substances included in Annex IA of the Directive 98/8/EC of the European Parliament and of the Council(6), and authorised for use in footwear, shall be allowed for use.Assessment and verification:The applicant shall provide a declaration that the requirements of this criterion have been met along with a list of biocidal products used.5. Use of volatile organic compounds (VOCs) during final assembly of shoes
VOCs are any organic compound having at 293,15 K a vapour pressure of 0,01 kPa or more, or having a corresponding volatility under the particular conditions of use.
The total use of VOCs during final footwear production shall not exceed, on average, 20 gram VOC/pair.
Assessment and verification:the applicant shall provide a calculation of the total use of VOCs during final shoe production, together with supporting data, test results and documentation as appropriate, with the calculation made using EN 14602. (Registration of purchased leather, adhesives, finishes and production of footwear during at least the last six months is required.)
6. Energy Consumption
The energy consumption at the manufacturing stage shall be declared.
Assessment and verification:the applicant is requested to provide the relevant information according to the Technical appendix A1.
7. Packaging of the final product
Where cardboard boxes are used for the final packaging of footwear, they shall be made of 100 % recycled material. Where plastic bags are used for the final packaging of footwear, they shall be made of, at least, 75 % recycled material or they shall be biodegradable or compostable, in agreement with the definitions provided by the EN 13432(7).
Assessment and verification:a sample of the product packaging shall be provided on application, together with a corresponding declaration of compliance with this criterion. Only primary packaging, as defined in the Directive 94/62/EC of the European Parliament and the Council(8), is subject to the criterion.
8. Information on the packaging
(a) User InstructionsThe following information (or equivalent text) shall be supplied with the product:

— | ‘These shoes have been treated to improve their water resistance. They do not require further treatment.’ (This criterion is applicable only to footwear that has been water-resistant treated)
— | ‘Where possible, repair your footwear rather than throw them away. This is less damaging to the environment.’
— | ‘When disposing of footwear, please use appropriate local recycling facilities where these are available.’(b) Information about the eco-labelThe following text (or equivalent text) shall appear on the packaging:
‘For more information visit the EU Ecolabel website: http://www.ecolabel.eu’
(c) Information to consumersAn information box in which the applicant explains its approach to environmental sustainability should be put on the packaging.
Assessment and verification:the applicant shall provide a sample of the product packaging and of the information supplied with the product, together with a declaration of compliance with each part of this criterion.
9. Information appearing on the eco-label
Box 2 of the eco-label shall contain the following text:

— | low air and water pollution,
— | harmful substances reduced.Assessment and verification:the applicant shall provide a sample of the product packaging showing the label, together with a declaration of compliance with this criterion.
10. Parameters contributing to durability
Occupational and safety footwear shall carry the EC mark (in accordance with Council Directive 89/686/EEC(9)).
All other footwear shall meet the requirements indicated in the table overleaf.
Assessment and verification:the applicant shall provide a test report corresponding to the parameters indicated in the table overleaf, using the following test methods:

— | EN 13512 — Upper — Flex resistance,
— | EN 13571 — Upper — Tear strength,
— | EN 17707 — Outsoles — Flex resistance,
— | EN 12770 — Outsoles — Abrasion resistance,
— | EN 17708 — Whole sole — Sole adhesion,
— | EN 12771 — Outsoles — Tear strength,
— | EN ISO 17700 — Test methods for uppers, linings and in socks — Colour fastness to rubbing.
| General sports | School footwear | Casual | Men’s town | Cold weather footwear | Women’s town | Fashion | Infants | Indoor
Uppers flex resistant:(kc without visible damage) | Dry = 100Wet = 20 | Dry = 100Wet = 20 | Dry = 80Wet = 20 | Dry = 80Wet = 20 | Dry = 100Wet = 20– 20° = 30 | Dry = 50Wet = 10 | Dry = 15 | Dry = 15 | Dry = 15
Uppers tear strength:(Average tear force, N)
Leather | ≥ 80 | ≥ 60 | ≥ 60 | ≥ 60 | ≥ 60 | ≥ 40 | ≥ 30 | ≥ 30 | ≥ 30
Other materials | ≥ 40 | ≥ 40 | ≥ 40 | ≥ 40 | ≥ 40 | ≥ 40 | ≥ 30 | ≥ 30 | ≥ 30
Outsoles flex resistance:
Cut growth (mm) | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 4 | | |
Nsc = no spontaneous crack | Nsc | Nsc | Nsc | Nsc | Nsc at – 10 °C | Nsc | | |
Outsoles abrasion resistance:
D ≥ 0,9 g/cm3(mm3) | ≤ 200 | ≤ 200 | ≤ 250 | ≤ 350 | ≤ 200 | ≤ 400 | | | ≤ 450
D < 0,9 g/cm3(mg) | ≤ 150 | ≤ 150 | ≤ 170 | ≤ 200 | ≤ 150 | ≤ 250 | | | ≤ 300
Uppersole adhesion: (N/mm) | ≥ 4,0 | ≥ 4,0 | ≥ 3,0 | ≥ 3,5 | ≥ 3,5 | ≥ 3,0 | ≥ 2,5 | ≥ 3,0 | ≥ 2,5
Outsoles tear strength:(Average strength, N/mm)
D ≥ 0,9 g/cm3 | 8 | 8 | 8 | 6 | 8 | 6 | 5 | 6 | 5
D < 0,9 g/cm3 | 6 | 6 | 6 | 4 | 6 | 4 | 4 | 5 | 4
Colour fastness of the inside of the footwear (lining or inner face of the upper). Grey scale on the felt after 50 cycles wet | ≥ 2/3 | ≥ 2/3 | ≥ 2/3 | ≥ 2/3 | ≥ 2/3 | ≥ 2/3 | | ≥ 2/3 | ≥ 2/3
(1) Hide is defined as ‘the outer covering or a mature or fully-grown animal of the larger kind, e.g. cattle, horses, camels, elephants, etc. …’. Skin is defined as ‘the outer covering of an animal of the smaller kinds, e.g. sheep and goats, or of the immature animals of the larger species, e.g. calves. Pigs, reptiles, birds and fish are included under skins’. (International Glossary of Leather Terms, ICT).
(2)
OJ L 135, 30.5.1991, p. 40.
(3)
OJ 196, 16.8.1967, p. 1.
(4)
OJ L 200, 30.7.1999, p. 1.
(5)
OJ L 353, 31.12.2008, p. 1.
(6)
OJ L 123, 24.4.1998, p. 1.
(7) EN 13432 ‘Requirements for packaging recoverable through composting and biodegradation — Testing scheme and evaluation criteria for the final acceptance of packaging’.
(8)
OJ L 365, 31.12.1994, Article 3(1)(a), p. 10.: ‘sales packaging or primary packaging, i.e. packaging conceived so as to constitute a sales unit to the final user or consumer at the point of purchase’.
(9)
OJ L 399, 30.12.1989, p. 18.

Pending: 32008D0185

4.3.2008 EN Official Journal of the European Union L 59/19
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
1. Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2. a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3. with regard to the holding of origin of the pigs:(a)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;(b)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;(c)vaccination against Aujeszky’s disease has not been carried out for at least 12 months;(d)the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;(e)no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results; (a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question; (b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question; (c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months; (d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies; (e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
(a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
(a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4. the pigs to be moved:(a)have not been vaccinated;(b)have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;(c)must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding;(d)have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (a) have not been vaccinated; (b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented; (c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding; (d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(a) have not been vaccinated;
(b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(a) have not been vaccinated;
(b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
1. Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2. a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3. all the pigs in question must be transported directly to the slaughterhouse of destination and either:(a)they come from a holding which fulfils the conditions laid down in Article 1(3); or(b)they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or(c)they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (a) they come from a holding which fulfils the conditions laid down in Article 1(3); or (b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(a) they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
(a) they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
1. come from Member States or regions listed in Annex I; or
2. come from:(a)Member States or regions listed in Annex II; and(b)a holding which fulfils the requirements of Article 1(3); or (a) Member States or regions listed in Annex II; and (b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
3. fulfil the following conditions:(a)Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;(b)a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);(c)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;(d)the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;(e)the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;(f)the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days. (a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin; (b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2); (c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question; (d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented; (e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs; (f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
1. come from Member States or regions listed in Annex I; or
2. come from:(a)Member States or regions listed in Annex II; and(b)a holding which fulfils the requirements of Article 1(3); or (a) Member States or regions listed in Annex II; and (b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
3. fulfil the following conditions:(a)Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;(b)a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);(c)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;(d)a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;(e)the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out. (a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin; (b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2); (c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question; (d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment; (e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b) in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c) the compliance of the pigs in question with the conditions laid down in this Decision.
(a) in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b) in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.
ISO code Member State Regions
CZ Czech Republic All regions
DK Denmark All regions
DE Germany All regions
FR France The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
CY Cyprus Whole territory
LU Luxembourg All regions
AT Austria Whole territory
SK Slovakia All regions
FI Finland All regions
SE Sweden All regions
UK United Kingdom All regions in England, Scotland and Wales
ISO code Member State Regions
BE Belgium Whole territory.
ES Spain The territory of the Autonomous Communities of Galicia, País Vasco, Asturias, Cantabria, Navarra, La Rioja.The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in the Autonomous Community of Castilla y León.The territory of the province of Las Palmas in the Canary Islands.
FR France The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.
IT Italy The Province of Bolzano.
NL Netherlands Whole territory.
1. The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a), (b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test and the examination in 2(c), at least, must thereafter be carried out on each batch.
2. Standardisation, sensitivity and specificity of the test.(a)The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F.(b)The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q.(c)For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.(d)The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika (a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F. (b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q. (c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative. (d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
(a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
(b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
(c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
(a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
(b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
(c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
1. Member State: …
2. Date: …
3. Reporting period: …
4. Number of holdings where AD has been detected by means of clinical, serological or virological investigations: …
5. Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached table):RegionNumber of pig holdingsNumber of pig holdings under an AD-pogramme(1)Number of AD not-infected pig holdings(with vaccination)(2)Number of AD free pig holdings(without vaccination)(3)Total Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3) Total
Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3)
Total
Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3)
Total
6. Further information on serological monitoring in Artificial Insemination Centres, for export purposes, in the framework of other surveillance schemes, etc.: …………
Commission Decision 2001/618/EC(OJ L 215, 9.8.2001, p. 48).
Commission Decision 2001/746/EC(OJ L 278, 23.10.2001, p. 41). Only as regards the reference to Decision 2001/618/EC in Article 1
Commission Decision 2001/905/EC(OJ L 335, 19.12.2001, p. 22). Only as regards the reference to Decision 2001/618/EC in Article 2
Commission Decision 2002/270/EC(OJ L 93, 10.4.2002, p. 7). Only Article 3
Commission Decision 2003/130/EC(OJ L 52, 27.2.2003, p. 9).
Commission Decision 2003/575/EC(OJ L 196, 2.8.2003, p. 41).
Commission Decision 2004/320/EC(OJ L 102, 7.4.2004, p. 75). Only Article 2 and Annex II
Commission Decision 2005/768/EC(OJ L 290, 4.11.2005, p. 27).
Commission Decision 2006/911/EC(OJ L 346, 9.12.2006, p. 41). Only as regards the reference to Decision 2001/618/EC in Article 1 and point 12 of the Annex
Commission Decision 2007/603/EC(OJ L 236, 8.9.2007, p. 7).
Commission Decision 2007/729/EC(OJ L 294, 13.11.2007, p. 26). Only as regards the reference to Decision 2001/618/EC in Article 1 and point 10 of the Annex
Decision 2001/618/EC This Decision
Article 1(a) and (b) Article 1, points 1 and 2
Article 1(c) first to fifth indent Article 1, point 3(a) to (e)
Article 1(d) first to fourth indent Article 1, point 4(a) to (d)
Article 2(a) and (b) Article 2, points 1 and 2
Article 2(c) first to third indent Article 2, point 3(a) to (c)
Article 3(a) Article 3, point 1
Article 3(b) first and second indent Article 3, point 2(a) and (b)
Article 3(c) first to sixth indent Article 3, point 3(a) to (f)
Article 4(a) Article 4, point 1
Article 4(b) first and second indent Article 4, point 2(a) and (b)
Article 4(c) first to fifth indent Article 4, point 3(a) to (e)
Articles 5 to 8 Articles 5 to 8
Article 9 —
Article 10 —
— Article 9
Article 11 Article 10
Annexes I to IV Annexes I to IV
— Annex V
— Annex VI
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine(1), and in particular Article 8, Article 9(2) and Article 10(2) thereof,
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:

Article 1
The dispatching of pigs intended for breeding or production destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3.
with regard to the holding of origin of the pigs:
(a)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c)
vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d)
the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e)
no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4.
the pigs to be moved:
(a)
have not been vaccinated;
(b)
have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c)
must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:
(i)
30 days, in the case of pigs intended for production;
(ii)
90 days, in the case of pigs intended for breeding;
(d)
have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:
(i)
2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii)
0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
However, the first of the two tests shall not be necessary if:
(i)
in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii)
the pigs to be moved have lived in the holding of origin since birth;
(iii)
no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.

Article 2
The dispatching of pigs intended for slaughter destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex, is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3.
all the pigs in question must be transported directly to the slaughterhouse of destination and either:
(a)
they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b)
they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:
(i)
in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii)
they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c)
they have not been vaccinated and they proceed from a holding where:
(i)
in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii)
vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii)
they have lived for at least 90 days before dispatch.

Article 3
Pigs intended for breeding destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e)
the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f)
the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.

Article 4
Pigs intended for production destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e)
the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.

Article 5
The serological tests carried out to monitor or detect Aujeszky’s disease in pigs in accordance with this Decision must meet the standards laid down in Annex III.

Article 6
Without prejudice to Article 10(3) of Directive 64/432/EEC, information on the occurrence of Aujeszky’s disease, including details of the monitoring and eradication programmes in operation in the Member States listed in Annex II and in the other Member States or regions not listed in that Annex where monitoring and eradication programmes are in place, must be provided at least annually by each Member State in accordance with the uniform criteria laid down in Annex IV.

Article 7
1. Without prejudice to the provisions laid down in Community legislation concerning health certificates, before the completion, for animals of the porcine species destined for Member States or regions listed in Annex I or II, of section C of the health certificate required by Directive 64/432/EEC, the official veterinarian shall ascertain:
(a)
the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b)
in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c)
the compliance of the pigs in question with the conditions laid down in this Decision.
2. For animals of the porcine species destined for Member States or regions listed in Annex I or II, the certification under paragraph 4 of Section C of the health certificate referred to in paragraph 1 shall be completed and supplemented as follows:
(a)
in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b)
in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.

Article 8
Member States must ensure that when pigs destined for Member States or regions listed in Annex I or II are transported, they shall not come in contact with pigs of different or unknown status, as regards Aujeszky’s disease, during transport or transit.

Article 9
Decision 2001/618/EC is repealed.
References to the repealed Decision shall be construed as references to this Decision and shall be read in accordance with the correlation table in Annex VI.

Article 10
This Decision is addressed to the Member States.

THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine(1), and in particular Article 8, Article 9(2) and Article 10(2) thereof,
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:
The dispatching of pigs intended for breeding or production destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3.
with regard to the holding of origin of the pigs:
(a)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c)
vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d)
the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e)
no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4.
the pigs to be moved:
(a)
have not been vaccinated;
(b)
have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c)
must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:
(i)
30 days, in the case of pigs intended for production;
(ii)
90 days, in the case of pigs intended for breeding;
(d)
have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:
(i)
2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii)
0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
However, the first of the two tests shall not be necessary if:
(i)
in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii)
the pigs to be moved have lived in the holding of origin since birth;
(iii)
no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
The dispatching of pigs intended for slaughter destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex, is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3.
all the pigs in question must be transported directly to the slaughterhouse of destination and either:
(a)
they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b)
they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:
(i)
in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii)
they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c)
they have not been vaccinated and they proceed from a holding where:
(i)
in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii)
vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii)
they have lived for at least 90 days before dispatch.
Pigs intended for breeding destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e)
the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f)
the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
Pigs intended for production destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e)
the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
The serological tests carried out to monitor or detect Aujeszky’s disease in pigs in accordance with this Decision must meet the standards laid down in Annex III.
Without prejudice to Article 10(3) of Directive 64/432/EEC, information on the occurrence of Aujeszky’s disease, including details of the monitoring and eradication programmes in operation in the Member States listed in Annex II and in the other Member States or regions not listed in that Annex where monitoring and eradication programmes are in place, must be provided at least annually by each Member State in accordance with the uniform criteria laid down in Annex IV.
1. Without prejudice to the provisions laid down in Community legislation concerning health certificates, before the completion, for animals of the porcine species destined for Member States or regions listed in Annex I or II, of section C of the health certificate required by Directive 64/432/EEC, the official veterinarian shall ascertain:
(a)
the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b)
in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c)
the compliance of the pigs in question with the conditions laid down in this Decision.
2. For animals of the porcine species destined for Member States or regions listed in Annex I or II, the certification under paragraph 4 of Section C of the health certificate referred to in paragraph 1 shall be completed and supplemented as follows:
(a)
in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b)
in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.
Member States must ensure that when pigs destined for Member States or regions listed in Annex I or II are transported, they shall not come in contact with pigs of different or unknown status, as regards Aujeszky’s disease, during transport or transit.
Decision 2001/618/EC is repealed.
References to the repealed Decision shall be construed as references to this Decision and shall be read in accordance with the correlation table in Annex VI.
This Decision is addressed to the Member States.
ANNEX IMember States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited
ISO code | Member State | Regions
CZ | Czech Republic | All regions
DK | Denmark | All regions
DE | Germany | All regions
FR | France | The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
CY | Cyprus | Whole territory
LU | Luxembourg | All regions
AT | Austria | Whole territory
SK | Slovakia | All regions
FI | Finland | All regions
SE | Sweden | All regions
UK | United Kingdom | All regions in England, Scotland and Wales
ANNEX IIMember States or regions thereof where approved Aujeszky’s disease control programmes are in place
ISO code | Member State | Regions
BE | Belgium | Whole territory.
ES | Spain | The territory of the Autonomous Communities of Galicia, País Vasco, Asturias, Cantabria, Navarra, La Rioja.The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in the Autonomous Community of Castilla y León.The territory of the province of Las Palmas in the Canary Islands.
FR | France | The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.
IT | Italy | The Province of Bolzano.
NL | Netherlands | Whole territory.

Standards for Aujeszky’s disease serological tests — Protocol for the enzyme linked immunosorbent assay (ELISA) for detecting antibodies to Aujeszky’s disease virus (whole virus), to glycoprotein B (ADV-gB), to glycoprotein D (ADV-gD) or to glycoprotein E (ADV-gE)

ANNEX III
| 1. | The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a), (b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test and the examination in 2(c), at least, must thereafter be carried out on each batch.
| 2. | Standardisation, sensitivity and specificity of the test.(a)The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F.(b)The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q.(c)For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.(d)The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | (a) | The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. | — | Community reference serum ADV 1 at 1:8 dilution, | — | Community reference serum ADV-gE A, | — | Community reference serum ADV-gE B, | — | Community reference serum ADV-gE C, | — | Community reference serum ADV-gE D, | — | Community reference serum ADV-gE E, | — | Community reference serum ADV-gE F. | (b) | The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. | — | Community reference serum ADV-gE G, | — | Community reference serum ADV-gE H, | — | Community reference serum ADV-gE J, | — | Community reference serum ADV-gE K, | — | Community reference serum ADV-gE L, | — | Community reference serum ADV-gE M, | — | Community reference serum ADV-gE N, | — | Community reference serum ADV-gE O, | — | Community reference serum ADV-gE P, | — | Community reference serum ADV-gE Q. | (c) | For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative. | (d) | The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected] | BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia | CZ | — | DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200 | DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave | EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected] | ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected] | FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350 | FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan | UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046 | GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903 | HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected] | IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare | IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia | LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius | LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected] | MT | — | NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad | PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected] | PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa | SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67 | SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana | SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
(a) | The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. | — | Community reference serum ADV 1 at 1:8 dilution, | — | Community reference serum ADV-gE A, | — | Community reference serum ADV-gE B, | — | Community reference serum ADV-gE C, | — | Community reference serum ADV-gE D, | — | Community reference serum ADV-gE E, | — | Community reference serum ADV-gE F.
— | Community reference serum ADV 1 at 1:8 dilution,
— | Community reference serum ADV-gE A,
— | Community reference serum ADV-gE B,
— | Community reference serum ADV-gE C,
— | Community reference serum ADV-gE D,
— | Community reference serum ADV-gE E,
— | Community reference serum ADV-gE F.
(b) | The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. | — | Community reference serum ADV-gE G, | — | Community reference serum ADV-gE H, | — | Community reference serum ADV-gE J, | — | Community reference serum ADV-gE K, | — | Community reference serum ADV-gE L, | — | Community reference serum ADV-gE M, | — | Community reference serum ADV-gE N, | — | Community reference serum ADV-gE O, | — | Community reference serum ADV-gE P, | — | Community reference serum ADV-gE Q.
— | Community reference serum ADV-gE G,
— | Community reference serum ADV-gE H,
— | Community reference serum ADV-gE J,
— | Community reference serum ADV-gE K,
— | Community reference serum ADV-gE L,
— | Community reference serum ADV-gE M,
— | Community reference serum ADV-gE N,
— | Community reference serum ADV-gE O,
— | Community reference serum ADV-gE P,
— | Community reference serum ADV-gE Q.
(c) | For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) | The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected] | BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia | CZ | — | DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200 | DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave | EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected] | ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected] | FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350 | FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan | UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046 | GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903 | HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected] | IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare | IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia | LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius | LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected] | MT | — | NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad | PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected] | PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa | SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67 | SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana | SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ | —
DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT | —
NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika

Criteria on the information to be provided on the occurrence of Aujeszky’s disease (AD) and on plans for the monitoring and eradication of this disease, to be provided in accordance with Article 8 of Council Directive 64/432/EEC

ANNEX IV
| 1. | Member State: …
| 2. | Date: …
| 3. | Reporting period: …
| 4. | Number of holdings where AD has been detected by means of clinical, serological or virological investigations: …
| 5. | Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached table):RegionNumber of pig holdingsNumber of pig holdings under an AD-pogramme(1)Number of AD not-infected pig holdings(with vaccination)(2)Number of AD free pig holdings(without vaccination)(3)Total | Region | Number of pig holdings | Number of pig holdings under an AD-pogramme(1) | Number of AD not-infected pig holdings(with vaccination)(2) | Number of AD free pig holdings(without vaccination)(3) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | | |
Region | Number of pig holdings | Number of pig holdings under an AD-pogramme(1) | Number of AD not-infected pig holdings(with vaccination)(2) | Number of AD free pig holdings(without vaccination)(3)
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total | | | |
| 6. | Further information on serological monitoring in Artificial Insemination Centres, for export purposes, in the framework of other surveillance schemes, etc.: …………
(1) Programme under the supervision of the competent authority.
(2) Pig holdings where serological tests for AD have been carried out with negative results in accordance with an official AD programme and where vaccination has been applied during the previous 12 months.
(3) Pig holdings which fulfil the conditions of Article 1(3).
ANNEX VREPEALED DECISION WITH LIST OF ITS SUCCESSIVE AMENDMENTS
Commission Decision 2001/618/EC(OJ L 215, 9.8.2001, p. 48). |
Commission Decision 2001/746/EC(OJ L 278, 23.10.2001, p. 41). | Only as regards the reference to Decision 2001/618/EC in Article 1
Commission Decision 2001/905/EC(OJ L 335, 19.12.2001, p. 22). | Only as regards the reference to Decision 2001/618/EC in Article 2
Commission Decision 2002/270/EC(OJ L 93, 10.4.2002, p. 7). | Only Article 3
Commission Decision 2003/130/EC(OJ L 52, 27.2.2003, p. 9). |
Commission Decision 2003/575/EC(OJ L 196, 2.8.2003, p. 41). |
Commission Decision 2004/320/EC(OJ L 102, 7.4.2004, p. 75). | Only Article 2 and Annex II
Commission Decision 2005/768/EC(OJ L 290, 4.11.2005, p. 27). |
Commission Decision 2006/911/EC(OJ L 346, 9.12.2006, p. 41). | Only as regards the reference to Decision 2001/618/EC in Article 1 and point 12 of the Annex
Commission Decision 2007/603/EC(OJ L 236, 8.9.2007, p. 7). |
Commission Decision 2007/729/EC(OJ L 294, 13.11.2007, p. 26). | Only as regards the reference to Decision 2001/618/EC in Article 1 and point 10 of the Annex
ANNEX VICorrelation table
Decision 2001/618/EC | This Decision
Article 1(a) and (b) | Article 1, points 1 and 2
Article 1(c) first to fifth indent | Article 1, point 3(a) to (e)
Article 1(d) first to fourth indent | Article 1, point 4(a) to (d)
Article 2(a) and (b) | Article 2, points 1 and 2
Article 2(c) first to third indent | Article 2, point 3(a) to (c)
Article 3(a) | Article 3, point 1
Article 3(b) first and second indent | Article 3, point 2(a) and (b)
Article 3(c) first to sixth indent | Article 3, point 3(a) to (f)
Article 4(a) | Article 4, point 1
Article 4(b) first and second indent | Article 4, point 2(a) and (b)
Article 4(c) first to fifth indent | Article 4, point 3(a) to (e)
Articles 5 to 8 | Articles 5 to 8
Article 9 | —
Article 10 | —
— | Article 9
Article 11 | Article 10
Annexes I to IV | Annexes I to IV
— | Annex V
— | Annex VI

Pending: 32008D0185

4.3.2008 EN Official Journal of the European Union L 59/19
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
1. Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2. a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3. with regard to the holding of origin of the pigs:(a)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;(b)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;(c)vaccination against Aujeszky’s disease has not been carried out for at least 12 months;(d)the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;(e)no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results; (a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question; (b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question; (c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months; (d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies; (e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
(a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
(a) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c) vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d) the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e) no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4. the pigs to be moved:(a)have not been vaccinated;(b)have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;(c)must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding;(d)have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (a) have not been vaccinated; (b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented; (c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding; (d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(a) have not been vaccinated;
(b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(a) have not been vaccinated;
(b) have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c) must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:(i)30 days, in the case of pigs intended for production;(ii)90 days, in the case of pigs intended for breeding; (i) 30 days, in the case of pigs intended for production; (ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(i) 30 days, in the case of pigs intended for production;
(ii) 90 days, in the case of pigs intended for breeding;
(d) have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:(i)2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;(ii)0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.However, the first of the two tests shall not be necessary if:(i)in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;(ii)the pigs to be moved have lived in the holding of origin since birth;(iii)no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation. (i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production; (ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding. (i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies; (ii) the pigs to be moved have lived in the holding of origin since birth; (iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
(i) 2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii) 0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
(i) in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii) the pigs to be moved have lived in the holding of origin since birth;
(iii) no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
1. Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2. a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3. all the pigs in question must be transported directly to the slaughterhouse of destination and either:(a)they come from a holding which fulfils the conditions laid down in Article 1(3); or(b)they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or(c)they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (a) they come from a holding which fulfils the conditions laid down in Article 1(3); or (b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(a) they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
(a) they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b) they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:(i)in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;(ii)they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or (i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months; (ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(i) in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii) they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c) they have not been vaccinated and they proceed from a holding where:(i)in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;(ii)vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);(iii)they have lived for at least 90 days before dispatch. (i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months; (ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2); (iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
(i) in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii) vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii) they have lived for at least 90 days before dispatch.
1. come from Member States or regions listed in Annex I; or
2. come from:(a)Member States or regions listed in Annex II; and(b)a holding which fulfils the requirements of Article 1(3); or (a) Member States or regions listed in Annex II; and (b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
3. fulfil the following conditions:(a)Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;(b)a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);(c)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;(d)the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;(e)the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;(f)the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days. (a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin; (b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2); (c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question; (d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented; (e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs; (f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e) the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f) the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
1. come from Member States or regions listed in Annex I; or
2. come from:(a)Member States or regions listed in Annex II; and(b)a holding which fulfils the requirements of Article 1(3); or (a) Member States or regions listed in Annex II; and (b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
(a) Member States or regions listed in Annex II; and
(b) a holding which fulfils the requirements of Article 1(3); or
3. fulfil the following conditions:(a)Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;(b)a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);(c)no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;(d)a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;(e)the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out. (a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin; (b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2); (c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question; (d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment; (e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b) a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c) no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d) a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e) the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
(a) the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b) in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c) the compliance of the pigs in question with the conditions laid down in this Decision.
(a) in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b) in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.
ISO code Member State Regions
CZ Czech Republic All regions
DK Denmark All regions
DE Germany All regions
FR France The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
CY Cyprus Whole territory
LU Luxembourg All regions
AT Austria Whole territory
SK Slovakia All regions
FI Finland All regions
SE Sweden All regions
UK United Kingdom All regions in England, Scotland and Wales
ISO code Member State Regions
BE Belgium Whole territory.
ES Spain The territory of the Autonomous Communities of Galicia, País Vasco, Asturias, Cantabria, Navarra, La Rioja.The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in the Autonomous Community of Castilla y León.The territory of the province of Las Palmas in the Canary Islands.
FR France The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.
IT Italy The Province of Bolzano.
NL Netherlands Whole territory.
1. The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a), (b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test and the examination in 2(c), at least, must thereafter be carried out on each batch.
2. Standardisation, sensitivity and specificity of the test.(a)The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F.(b)The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q.(c)For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.(d)The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika (a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F. (b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q. (c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative. (d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
(a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
(b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
(c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
(a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. — Community reference serum ADV 1 at 1:8 dilution, — Community reference serum ADV-gE A, — Community reference serum ADV-gE B, — Community reference serum ADV-gE C, — Community reference serum ADV-gE D, — Community reference serum ADV-gE E, — Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
— Community reference serum ADV 1 at 1:8 dilution,
— Community reference serum ADV-gE A,
— Community reference serum ADV-gE B,
— Community reference serum ADV-gE C,
— Community reference serum ADV-gE D,
— Community reference serum ADV-gE E,
— Community reference serum ADV-gE F.
(b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. — Community reference serum ADV-gE G, — Community reference serum ADV-gE H, — Community reference serum ADV-gE J, — Community reference serum ADV-gE K, — Community reference serum ADV-gE L, — Community reference serum ADV-gE M, — Community reference serum ADV-gE N, — Community reference serum ADV-gE O, — Community reference serum ADV-gE P, — Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
— Community reference serum ADV-gE G,
— Community reference serum ADV-gE H,
— Community reference serum ADV-gE J,
— Community reference serum ADV-gE K,
— Community reference serum ADV-gE L,
— Community reference serum ADV-gE M,
— Community reference serum ADV-gE N,
— Community reference serum ADV-gE O,
— Community reference serum ADV-gE P,
— Community reference serum ADV-gE Q.
(c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected] BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia CZ — DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200 DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected] ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected] FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350 FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046 GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903 HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected] IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected] MT — NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected] PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67 SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
AT AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. +43 (0) 505 55-38112 Fax +43 (0) 505 55-38108 E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ —
DE Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. +34 916 290 300 Fax +34 916 290 598 E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [email protected] Tel. +358 20 772 003 (exchange) Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. (44-1932) 341111 Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. +36 1 460-6300 Fax +36 1 252-5177 E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. +371 7620526 Fax +371 7620434 E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT —
NL Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. +48 81 889 30 00 Fax +48 81 886 25 95 E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. (46-18) 67 40 00 Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika
1. Member State: …
2. Date: …
3. Reporting period: …
4. Number of holdings where AD has been detected by means of clinical, serological or virological investigations: …
5. Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached table):RegionNumber of pig holdingsNumber of pig holdings under an AD-pogramme(1)Number of AD not-infected pig holdings(with vaccination)(2)Number of AD free pig holdings(without vaccination)(3)Total Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3) Total
Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3)
Total
Region Number of pig holdings Number of pig holdings under an AD-pogramme(1) Number of AD not-infected pig holdings(with vaccination)(2) Number of AD free pig holdings(without vaccination)(3)
Total
6. Further information on serological monitoring in Artificial Insemination Centres, for export purposes, in the framework of other surveillance schemes, etc.: …………
Commission Decision 2001/618/EC(OJ L 215, 9.8.2001, p. 48).
Commission Decision 2001/746/EC(OJ L 278, 23.10.2001, p. 41). Only as regards the reference to Decision 2001/618/EC in Article 1
Commission Decision 2001/905/EC(OJ L 335, 19.12.2001, p. 22). Only as regards the reference to Decision 2001/618/EC in Article 2
Commission Decision 2002/270/EC(OJ L 93, 10.4.2002, p. 7). Only Article 3
Commission Decision 2003/130/EC(OJ L 52, 27.2.2003, p. 9).
Commission Decision 2003/575/EC(OJ L 196, 2.8.2003, p. 41).
Commission Decision 2004/320/EC(OJ L 102, 7.4.2004, p. 75). Only Article 2 and Annex II
Commission Decision 2005/768/EC(OJ L 290, 4.11.2005, p. 27).
Commission Decision 2006/911/EC(OJ L 346, 9.12.2006, p. 41). Only as regards the reference to Decision 2001/618/EC in Article 1 and point 12 of the Annex
Commission Decision 2007/603/EC(OJ L 236, 8.9.2007, p. 7).
Commission Decision 2007/729/EC(OJ L 294, 13.11.2007, p. 26). Only as regards the reference to Decision 2001/618/EC in Article 1 and point 10 of the Annex
Decision 2001/618/EC This Decision
Article 1(a) and (b) Article 1, points 1 and 2
Article 1(c) first to fifth indent Article 1, point 3(a) to (e)
Article 1(d) first to fourth indent Article 1, point 4(a) to (d)
Article 2(a) and (b) Article 2, points 1 and 2
Article 2(c) first to third indent Article 2, point 3(a) to (c)
Article 3(a) Article 3, point 1
Article 3(b) first and second indent Article 3, point 2(a) and (b)
Article 3(c) first to sixth indent Article 3, point 3(a) to (f)
Article 4(a) Article 4, point 1
Article 4(b) first and second indent Article 4, point 2(a) and (b)
Article 4(c) first to fifth indent Article 4, point 3(a) to (e)
Articles 5 to 8 Articles 5 to 8
Article 9 —
Article 10 —
— Article 9
Article 11 Article 10
Annexes I to IV Annexes I to IV
— Annex V
— Annex VI
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine(1), and in particular Article 8, Article 9(2) and Article 10(2) thereof,
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:

Article 1
The dispatching of pigs intended for breeding or production destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3.
with regard to the holding of origin of the pigs:
(a)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c)
vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d)
the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e)
no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4.
the pigs to be moved:
(a)
have not been vaccinated;
(b)
have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c)
must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:
(i)
30 days, in the case of pigs intended for production;
(ii)
90 days, in the case of pigs intended for breeding;
(d)
have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:
(i)
2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii)
0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
However, the first of the two tests shall not be necessary if:
(i)
in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii)
the pigs to be moved have lived in the holding of origin since birth;
(iii)
no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.

Article 2
The dispatching of pigs intended for slaughter destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex, is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3.
all the pigs in question must be transported directly to the slaughterhouse of destination and either:
(a)
they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b)
they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:
(i)
in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii)
they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c)
they have not been vaccinated and they proceed from a holding where:
(i)
in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii)
vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii)
they have lived for at least 90 days before dispatch.

Article 3
Pigs intended for breeding destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e)
the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f)
the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.

Article 4
Pigs intended for production destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e)
the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.

Article 5
The serological tests carried out to monitor or detect Aujeszky’s disease in pigs in accordance with this Decision must meet the standards laid down in Annex III.

Article 6
Without prejudice to Article 10(3) of Directive 64/432/EEC, information on the occurrence of Aujeszky’s disease, including details of the monitoring and eradication programmes in operation in the Member States listed in Annex II and in the other Member States or regions not listed in that Annex where monitoring and eradication programmes are in place, must be provided at least annually by each Member State in accordance with the uniform criteria laid down in Annex IV.

Article 7
1. Without prejudice to the provisions laid down in Community legislation concerning health certificates, before the completion, for animals of the porcine species destined for Member States or regions listed in Annex I or II, of section C of the health certificate required by Directive 64/432/EEC, the official veterinarian shall ascertain:
(a)
the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b)
in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c)
the compliance of the pigs in question with the conditions laid down in this Decision.
2. For animals of the porcine species destined for Member States or regions listed in Annex I or II, the certification under paragraph 4 of Section C of the health certificate referred to in paragraph 1 shall be completed and supplemented as follows:
(a)
in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b)
in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.

Article 8
Member States must ensure that when pigs destined for Member States or regions listed in Annex I or II are transported, they shall not come in contact with pigs of different or unknown status, as regards Aujeszky’s disease, during transport or transit.

Article 9
Decision 2001/618/EC is repealed.
References to the repealed Decision shall be construed as references to this Decision and shall be read in accordance with the correlation table in Annex VI.

Article 10
This Decision is addressed to the Member States.

THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine(1), and in particular Article 8, Article 9(2) and Article 10(2) thereof,
(1) Commission Decision 2001/618/EC of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC(2)has been substantially amended several times(3). In the interests of clarity and rationality the said Decision should be codified.
(2) The International Office of Epizootic Diseases (OIE) is the international organisation designated under the Agreement on the Application of Sanitary and Phytosanitary Measures in application of GATT 1994 which is responsible for the establishment of international animal health rules for trade in animals and animal products. These rules are published in the International Animal Health Code.
(3) The chapter of the International Animal Health Code on Aujeszky’s disease has been substantially amended.
(4) It is appropriate to modify the additional guarantees required in intra-Community trade of pigs in relation to Aujeszky’s disease in order to ensure their consistency with the international rules on this disease and better control in the Community.
(5) Criteria must be established on the information to be provided by the Member States on Aujeszky’s disease, in accordance with Article 8 of Directive 64/432/EEC.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:
The dispatching of pigs intended for breeding or production destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease, fulfilling the criteria laid down in Article 9(1) of Directive 64/432/EEC, must be in place in the Member State or regions of origin under the supervision of the competent authority. Appropriate measures on pig transport and movements must be in place according to this plan for preventing a spread of disease between holdings of a different status;
3.
with regard to the holding of origin of the pigs:
(a)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding in question;
(b)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holdings located in an area of 5 km surrounding the holding of origin of the pigs; however, this provision shall not apply if, in these latter holdings, disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority and in accordance with the eradication plan referred to in point (2), and these measures have effectively prevented any spread of disease to the holding in question;
(c)
vaccination against Aujeszky’s disease has not been carried out for at least 12 months;
(d)
the pigs have been subjected on at least two occasions at an interval of at least four months to a serological survey for the presence of ADV-gE or ADV-gB or ADV-gD antibody or to the whole Aujeszky’s disease virus. This survey must have shown the absence of Aujeszky’s disease and that vaccinated pigs have been free from gE antibodies;
(e)
no pigs have been introduced from holdings of a lower animal health status as regards Aujeszky’s disease in the previous 12 months, unless they have been tested for Aujeszky’s disease with negative results;
4.
the pigs to be moved:
(a)
have not been vaccinated;
(b)
have been kept isolated in accommodation approved by the competent authority, during the 30 days prior to movement, and in such a way that any risk of spreading Aujeszky’s disease to these pigs is prevented;
(c)
must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least:
(i)
30 days, in the case of pigs intended for production;
(ii)
90 days, in the case of pigs intended for breeding;
(d)
have been subjected with negative results to at least two serological tests for ADV-gB or ADV-gD or the whole Aujeszky’s disease virus, at a distance of at least 30 days between each test. However, in case of pigs less than four months old, the serological test for ADV-gE may also be used. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested in the isolation unit must be sufficient to detect:
(i)
2 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for production;
(ii)
0,1 % seroprevalence with 95 % confidence in the isolation unit in case of pigs intended for breeding.
However, the first of the two tests shall not be necessary if:
(i)
in the framework of the plan referred to in point (2), a serological survey has been carried out in the holding of origin between 45 and 170 days prior to shipment, demonstrating the absence of Aujeszky’s disease antibodies and that vaccinated pigs have been free from gE antibodies;
(ii)
the pigs to be moved have lived in the holding of origin since birth;
(iii)
no pigs have moved on to the holding of origin while the pigs to be moved have been kept in isolation.
The dispatching of pigs intended for slaughter destined for the Member States or regions free of Aujeszky’s disease listed in Annex I and coming from any other Member State or region not listed in that Annex, is authorised subject to the following conditions:
1.
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
2.
a plan for the control and eradication of Aujeszky’s disease is in place in the Member State or regions of origin of the pigs, fulfilling the criteria laid down in Article 1(2);
3.
all the pigs in question must be transported directly to the slaughterhouse of destination and either:
(a)
they come from a holding which fulfils the conditions laid down in Article 1(3); or
(b)
they have been vaccinated against Aujeszky’s disease at least 15 days prior to their shipment and come from a holding of origin where:
(i)
in the framework of the plan referred to in point (2), Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority for the previous 12 months;
(ii)
they had remained for at least 30 days before dispatch and where no clinical or pathological evidence of this disease has been detected at the moment of completion of the health certificate referred to in Article 7; or
(c)
they have not been vaccinated and they proceed from a holding where:
(i)
in the framework of the plan referred to in point 2, Aujeszky’s disease monitoring and eradication measures have been regularly applied under the supervision of the competent authority in the previous 12 months and no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous six months;
(ii)
vaccination against Aujeszky’s disease and introduction of vaccinated pigs have been forbidden by the competent authority, since the holding is in the process of reaching the highest status as regards Aujeszky’s disease in accordance to the plan referred to in point (2);
(iii)
they have lived for at least 90 days before dispatch.
Pigs intended for breeding destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1(2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
the pigs must have been isolated in accommodation approved by the competent authority for the 30 days immediately prior to movement and kept isolated in such a way that any risk of spreading of Aujeszky’s disease is prevented;
(e)
the pigs must have been subjected, with negative results, to a serological test for the presence of gE antibodies. Sampling for the last test must be performed within 15 days prior to shipment. The number of pigs tested must be sufficient to detect 2 % seroprevalence with 95 % confidence in these pigs;
(f)
the pigs must have lived in the holding of origin or in a holding of an equivalent status since birth, and have remained in the holding of origin for at least 90 days.
Pigs intended for production destined for the Member States or regions listed in Annex II, where approved Aujeszky’s disease eradication programmes are in place, must either:
1.
come from Member States or regions listed in Annex I; or
2.
come from:
(a)
Member States or regions listed in Annex II; and
(b)
a holding which fulfils the requirements of Article 1(3); or
3.
fulfil the following conditions:
(a)
Aujeszky’s disease must be compulsorily notifiable in the Member State of origin;
(b)
a plan for the control and eradication of Aujeszky’s disease is in place in the Member States or region of origin, which fulfils the criteria laid down in Article 1 point (2);
(c)
no clinical, pathological or serological evidence of Aujeszky’s disease has been recorded in the previous 12 months in the holding of origin of the pigs in question;
(d)
a serological survey for Aujeszky’s disease, demonstrating its absence and that vaccinated pigs have been free from gE antibodies, has been carried out in the holding of origin and between 45 and 170 days prior to shipment;
(e)
the pigs must either have lived in the holding of origin since birth or have remained in such holdings for at least 30 days after introduction from a holding of an equivalent status, where a serological survey equivalent to the one referred to in point (d) has been carried out.
The serological tests carried out to monitor or detect Aujeszky’s disease in pigs in accordance with this Decision must meet the standards laid down in Annex III.
Without prejudice to Article 10(3) of Directive 64/432/EEC, information on the occurrence of Aujeszky’s disease, including details of the monitoring and eradication programmes in operation in the Member States listed in Annex II and in the other Member States or regions not listed in that Annex where monitoring and eradication programmes are in place, must be provided at least annually by each Member State in accordance with the uniform criteria laid down in Annex IV.
1. Without prejudice to the provisions laid down in Community legislation concerning health certificates, before the completion, for animals of the porcine species destined for Member States or regions listed in Annex I or II, of section C of the health certificate required by Directive 64/432/EEC, the official veterinarian shall ascertain:
(a)
the status of the holding and of the Member State or region of origin of the pigs in question as regards Aujeszky’s disease;
(b)
in case the pigs are not originating from a Member State or a region free of the disease, the status of the holding and of the Member State or regions of destination for the pigs in question as regards Aujeszky’s disease;
(c)
the compliance of the pigs in question with the conditions laid down in this Decision.
2. For animals of the porcine species destined for Member States or regions listed in Annex I or II, the certification under paragraph 4 of Section C of the health certificate referred to in paragraph 1 shall be completed and supplemented as follows:
(a)
in the first indent, after the word ‘disease’ the word ‘Aujeszky’ must be added;
(b)
in the second indent, reference shall be made to this Decision. In the same line, the number of the Article of this Decision, which is relevant for the pigs in question, shall be quoted between brackets.
Member States must ensure that when pigs destined for Member States or regions listed in Annex I or II are transported, they shall not come in contact with pigs of different or unknown status, as regards Aujeszky’s disease, during transport or transit.
Decision 2001/618/EC is repealed.
References to the repealed Decision shall be construed as references to this Decision and shall be read in accordance with the correlation table in Annex VI.
This Decision is addressed to the Member States.
ANNEX IMember States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited
ISO code | Member State | Regions
CZ | Czech Republic | All regions
DK | Denmark | All regions
DE | Germany | All regions
FR | France | The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
CY | Cyprus | Whole territory
LU | Luxembourg | All regions
AT | Austria | Whole territory
SK | Slovakia | All regions
FI | Finland | All regions
SE | Sweden | All regions
UK | United Kingdom | All regions in England, Scotland and Wales
ANNEX IIMember States or regions thereof where approved Aujeszky’s disease control programmes are in place
ISO code | Member State | Regions
BE | Belgium | Whole territory.
ES | Spain | The territory of the Autonomous Communities of Galicia, País Vasco, Asturias, Cantabria, Navarra, La Rioja.The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in the Autonomous Community of Castilla y León.The territory of the province of Las Palmas in the Canary Islands.
FR | France | The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.
IT | Italy | The Province of Bolzano.
NL | Netherlands | Whole territory.

Standards for Aujeszky’s disease serological tests — Protocol for the enzyme linked immunosorbent assay (ELISA) for detecting antibodies to Aujeszky’s disease virus (whole virus), to glycoprotein B (ADV-gB), to glycoprotein D (ADV-gD) or to glycoprotein E (ADV-gE)

ANNEX III
| 1. | The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a), (b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test and the examination in 2(c), at least, must thereafter be carried out on each batch.
| 2. | Standardisation, sensitivity and specificity of the test.(a)The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F.(b)The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q.(c)For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.(d)The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | (a) | The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. | — | Community reference serum ADV 1 at 1:8 dilution, | — | Community reference serum ADV-gE A, | — | Community reference serum ADV-gE B, | — | Community reference serum ADV-gE C, | — | Community reference serum ADV-gE D, | — | Community reference serum ADV-gE E, | — | Community reference serum ADV-gE F. | (b) | The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. | — | Community reference serum ADV-gE G, | — | Community reference serum ADV-gE H, | — | Community reference serum ADV-gE J, | — | Community reference serum ADV-gE K, | — | Community reference serum ADV-gE L, | — | Community reference serum ADV-gE M, | — | Community reference serum ADV-gE N, | — | Community reference serum ADV-gE O, | — | Community reference serum ADV-gE P, | — | Community reference serum ADV-gE Q. | (c) | For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative. | (d) | The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected] | BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia | CZ | — | DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200 | DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave | EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected] | ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected] | FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350 | FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan | UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046 | GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903 | HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected] | IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare | IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia | LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius | LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected] | MT | — | NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad | PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected] | PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa | SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67 | SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana | SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
(a) | The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:—Community reference serum ADV 1 at 1:8 dilution,—Community reference serum ADV-gE A,—Community reference serum ADV-gE B,—Community reference serum ADV-gE C,—Community reference serum ADV-gE D,—Community reference serum ADV-gE E,—Community reference serum ADV-gE F. | — | Community reference serum ADV 1 at 1:8 dilution, | — | Community reference serum ADV-gE A, | — | Community reference serum ADV-gE B, | — | Community reference serum ADV-gE C, | — | Community reference serum ADV-gE D, | — | Community reference serum ADV-gE E, | — | Community reference serum ADV-gE F.
— | Community reference serum ADV 1 at 1:8 dilution,
— | Community reference serum ADV-gE A,
— | Community reference serum ADV-gE B,
— | Community reference serum ADV-gE C,
— | Community reference serum ADV-gE D,
— | Community reference serum ADV-gE E,
— | Community reference serum ADV-gE F.
(b) | The specificity of the test must be of such a level that the following Community reference sera are scored negative:—Community reference serum ADV-gE G,—Community reference serum ADV-gE H,—Community reference serum ADV-gE J,—Community reference serum ADV-gE K,—Community reference serum ADV-gE L,—Community reference serum ADV-gE M,—Community reference serum ADV-gE N,—Community reference serum ADV-gE O,—Community reference serum ADV-gE P,—Community reference serum ADV-gE Q. | — | Community reference serum ADV-gE G, | — | Community reference serum ADV-gE H, | — | Community reference serum ADV-gE J, | — | Community reference serum ADV-gE K, | — | Community reference serum ADV-gE L, | — | Community reference serum ADV-gE M, | — | Community reference serum ADV-gE N, | — | Community reference serum ADV-gE O, | — | Community reference serum ADV-gE P, | — | Community reference serum ADV-gE Q.
— | Community reference serum ADV-gE G,
— | Community reference serum ADV-gE H,
— | Community reference serum ADV-gE J,
— | Community reference serum ADV-gE K,
— | Community reference serum ADV-gE L,
— | Community reference serum ADV-gE M,
— | Community reference serum ADV-gE N,
— | Community reference serum ADV-gE O,
— | Community reference serum ADV-gE P,
— | Community reference serum ADV-gE Q.
(c) | For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.
(d) | The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.ATAGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsCYState Veterinary LaboratoryVeterinary Services1417 AthalassaNicosiaCZ—DEFriedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200DKNational Veterinary Institute, Technical University of DenmarkLindholmDK-4771 KalvehaveEEVeterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350FRLaboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 PloufraganUKVeterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046GRCentre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903HUMezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. KildareITCentro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 BresciaLTNational Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 VilniusLUCODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 BrusselsLVNacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected]—NLCentraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA LelystadPLLaboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected]ório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 LisboaSEStatens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67SIUniverza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 LjubljanaSKŠtátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected] | BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia | CZ | — | DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200 | DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave | EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected] | ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected] | FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350 | FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan | UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046 | GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903 | HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected] | IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare | IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia | LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius | LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels | LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected] | MT | — | NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad | PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected] | PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa | SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67 | SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana | SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
AT | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)Robert Koch-Gasse 17A-2340 MödlingTel. +43 (0) 505 55-38112Fax +43 (0) 505 55-38108E-mail: [email protected] | AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) | Robert Koch-Gasse 17 | A-2340 Mödling | Tel. +43 (0) 505 55-38112 | Fax +43 (0) 505 55-38108 | E-mail: [email protected]
AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: [email protected]
BE | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
CY | State Veterinary LaboratoryVeterinary Services1417 AthalassaNicosia | State Veterinary Laboratory | Veterinary Services | 1417 Athalassa | Nicosia
State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia
CZ | —
DE | Friedrich-Loeffler-InstitutBundesforschungsinstitut für TiergesundheitStandort WusterhausenSeestraße 55D-16868 WusterhausenTel. + 49 33979 80-0Fax + 49 33979 80-200 | Friedrich-Loeffler-Institut | Bundesforschungsinstitut für Tiergesundheit | Standort Wusterhausen | Seestraße 55 | D-16868 Wusterhausen | Tel. + 49 33979 80-0 | Fax + 49 33979 80-200
Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200
DK | National Veterinary Institute, Technical University of DenmarkLindholmDK-4771 Kalvehave | National Veterinary Institute, Technical University of Denmark | Lindholm | DK-4771 Kalvehave
National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave
EE | Veterinaar- ja ToidulaboratooriumKreutzwaldi 30, 51006 Tartu, EstoniaTel. + 372 7 386 100Faks: + 372 7 386 102E-mail: [email protected] | Veterinaar- ja Toidulaboratoorium | Kreutzwaldi 30, 51006 Tartu, Estonia | Tel. + 372 7 386 100 | Faks: + 372 7 386 102 | E-mail: [email protected]
Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: [email protected]
ES | Laboratorio Central de Sanidad Animal de AlgeteCarretera de Algete, km 8Algete 28110 (Madrid)Tel. +34 916 290 300Fax +34 916 290 598E-mail: [email protected] | Laboratorio Central de Sanidad Animal de Algete | Carretera de Algete, km 8 | Algete 28110 (Madrid) | Tel. +34 916 290 300 | Fax +34 916 290 598 | E-mail: [email protected]
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: [email protected]
FI | Finnish Food Safety AuthorityAnimal Diseases and Food Safety ResearchMustialankatu 3FI-00790 Helsinki, FinlandE-mail: [email protected]. +358 20 772 003 (exchange)Fax +358 20 772 4350 | Finnish Food Safety Authority | Animal Diseases and Food Safety Research | Mustialankatu 3 | FI-00790 Helsinki, Finland | E-mail: [email protected] | Tel. +358 20 772 003 (exchange) | Fax +358 20 772 4350
Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: [email protected]
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350
FR | Laboratoire d’études et de recherches avicoles, porcines et piscicolesAFSSA site de Ploufragan/Brest —LERAPPBP 5322440 Ploufragan | Laboratoire d’études et de recherches avicoles, porcines et piscicoles | AFSSA site de Ploufragan/Brest — | LERAPP | BP 53 | 22440 Ploufragan
Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan
UK | Veterinary Laboratories AgencyNew Haw, Addlestone, WeybridgeSurrey KT15 3NB, UKTel. (44-1932) 341111Fax (44-1932) 347046 | Veterinary Laboratories Agency | New Haw, Addlestone, Weybridge | Surrey KT15 3NB, UK | Tel. (44-1932) 341111 | Fax (44-1932) 347046
Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046
GR | Centre of Athens Veterinary Institutes25 Neapoleos Street,GR-153 10 Agia Paraskevi AttikiTel. +30 2106010903 | Centre of Athens Veterinary Institutes | 25 Neapoleos Street, | GR-153 10 Agia Paraskevi Attiki | Tel. +30 2106010903
Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903
HU | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai IgazgatóságCentral Agricultural Office, Veterinary Diagnostic DirectorateAddress: 1149 Budapest, Tábornok u. 2.Mailing Address: 1581 Budapest, 146. Pf. 2.Tel. +36 1 460-6300Fax +36 1 252-5177E-mail: [email protected] | Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság | Central Agricultural Office, Veterinary Diagnostic Directorate | Address: 1149 Budapest, Tábornok u. 2. | Mailing Address: 1581 Budapest, 146. Pf. 2. | Tel. +36 1 460-6300 | Fax +36 1 252-5177 | E-mail: [email protected]
Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: [email protected]
IE | Virology DivisionCentral Veterinary Research LaboratoryDepartment of Agriculture and Food LaboratoriesBackweston CampusStacumny LaneCelbridgeCo. Kildare | Virology Division | Central Veterinary Research Laboratory | Department of Agriculture and Food Laboratories | Backweston Campus | Stacumny Lane | Celbridge | Co. Kildare
Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare
IT | Centro di referenza nazionale per la malattia di Aujeszky —Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,Via Bianchi, 9;25124 Brescia | Centro di referenza nazionale per la malattia di Aujeszky — | Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, | Via Bianchi, 9; | 25124 Brescia
Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia
LT | National Veterinary Laboratory(Nacionalinė veterinarijos laboratorija)J. Kairiūkščio 10LT-08409 Vilnius | National Veterinary Laboratory | (Nacionalinė veterinarijos laboratorija) | J. Kairiūkščio 10 | LT-08409 Vilnius
National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius
LU | CODA — CERVA — VARVeterinary and Agrochemical Research CentreGroeselenberg 99B-1180 Brussels | CODA — CERVA — VAR | Veterinary and Agrochemical Research Centre | Groeselenberg 99 | B-1180 Brussels
CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels
LV | Nacionālais diagnostikas centrs(National Diagnostic Centre)Lejupes iela 3, Rīga, LV-1076Tel. +371 7620526Fax +371 7620434E-mail: [email protected] | Nacionālais diagnostikas centrs | (National Diagnostic Centre) | Lejupes iela 3, Rīga, LV-1076 | Tel. +371 7620526 | Fax +371 7620434 | E-mail: [email protected]
Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: [email protected]
MT | —
NL | Centraal Instituut voor Dierziekte ControleCIDC-LelystadHoofdvestiging: Houtribweg 39Nevenvestiging: Edelhertweg 15Postbus 20048203 AA Lelystad | Centraal Instituut voor Dierziekte Controle | CIDC-Lelystad | Hoofdvestiging: Houtribweg 39 | Nevenvestiging: Edelhertweg 15 | Postbus 2004 | 8203 AA Lelystad
Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad
PL | Laboratory Departement of Swine DiseasesPaństwowy Instytut Weterynaryjny – Państwowy InstytutBadawczyal. Partyzantów 57, 24-100 PuławyTel. +48 81 889 30 00Fax +48 81 886 25 95E-mail: [email protected] | Laboratory Departement of Swine Diseases | Państwowy Instytut Weterynaryjny – Państwowy Instytut | Badawczy | al. Partyzantów 57, 24-100 Puławy | Tel. +48 81 889 30 00 | Fax +48 81 886 25 95 | E-mail: [email protected]
Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: [email protected]
PT | Laboratório Nacional de Investigação Veterinária (LNIV)Estrada de Benfica, 701P-1549-011 Lisboa | Laboratório Nacional de Investigação Veterinária (LNIV) | Estrada de Benfica, 701 | P-1549-011 Lisboa
Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa
SE | Statens veterinärmedicinska anstaltDepartment of VirologyS-751 89 UppsalaTel. (46-18) 67 40 00Fax (46-18) 67 44 67 | Statens veterinärmedicinska anstalt | Department of Virology | S-751 89 Uppsala | Tel. (46-18) 67 40 00 | Fax (46-18) 67 44 67
Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67
SI | Univerza v LjubljaniVeterinarska fakultetaNacionalni veterinarski inštitutGerbičeva 60,SI-1000 Ljubljana | Univerza v Ljubljani | Veterinarska fakulteta | Nacionalni veterinarski inštitut | Gerbičeva 60, | SI-1000 Ljubljana
Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana
SK | Štátny veterinárny ústavPod dráhami 918960 86 ZvolenSlovenska republika | Štátny veterinárny ústav | Pod dráhami 918 | 960 86 Zvolen | Slovenska republika
Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika

Criteria on the information to be provided on the occurrence of Aujeszky’s disease (AD) and on plans for the monitoring and eradication of this disease, to be provided in accordance with Article 8 of Council Directive 64/432/EEC

ANNEX IV
| 1. | Member State: …
| 2. | Date: …
| 3. | Reporting period: …
| 4. | Number of holdings where AD has been detected by means of clinical, serological or virological investigations: …
| 5. | Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached table):RegionNumber of pig holdingsNumber of pig holdings under an AD-pogramme(1)Number of AD not-infected pig holdings(with vaccination)(2)Number of AD free pig holdings(without vaccination)(3)Total | Region | Number of pig holdings | Number of pig holdings under an AD-pogramme(1) | Number of AD not-infected pig holdings(with vaccination)(2) | Number of AD free pig holdings(without vaccination)(3) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | | |
Region | Number of pig holdings | Number of pig holdings under an AD-pogramme(1) | Number of AD not-infected pig holdings(with vaccination)(2) | Number of AD free pig holdings(without vaccination)(3)
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total | | | |
| 6. | Further information on serological monitoring in Artificial Insemination Centres, for export purposes, in the framework of other surveillance schemes, etc.: …………
(1) Programme under the supervision of the competent authority.
(2) Pig holdings where serological tests for AD have been carried out with negative results in accordance with an official AD programme and where vaccination has been applied during the previous 12 months.
(3) Pig holdings which fulfil the conditions of Article 1(3).
ANNEX VREPEALED DECISION WITH LIST OF ITS SUCCESSIVE AMENDMENTS
Commission Decision 2001/618/EC(OJ L 215, 9.8.2001, p. 48). |
Commission Decision 2001/746/EC(OJ L 278, 23.10.2001, p. 41). | Only as regards the reference to Decision 2001/618/EC in Article 1
Commission Decision 2001/905/EC(OJ L 335, 19.12.2001, p. 22). | Only as regards the reference to Decision 2001/618/EC in Article 2
Commission Decision 2002/270/EC(OJ L 93, 10.4.2002, p. 7). | Only Article 3
Commission Decision 2003/130/EC(OJ L 52, 27.2.2003, p. 9). |
Commission Decision 2003/575/EC(OJ L 196, 2.8.2003, p. 41). |
Commission Decision 2004/320/EC(OJ L 102, 7.4.2004, p. 75). | Only Article 2 and Annex II
Commission Decision 2005/768/EC(OJ L 290, 4.11.2005, p. 27). |
Commission Decision 2006/911/EC(OJ L 346, 9.12.2006, p. 41). | Only as regards the reference to Decision 2001/618/EC in Article 1 and point 12 of the Annex
Commission Decision 2007/603/EC(OJ L 236, 8.9.2007, p. 7). |
Commission Decision 2007/729/EC(OJ L 294, 13.11.2007, p. 26). | Only as regards the reference to Decision 2001/618/EC in Article 1 and point 10 of the Annex
ANNEX VICorrelation table
Decision 2001/618/EC | This Decision
Article 1(a) and (b) | Article 1, points 1 and 2
Article 1(c) first to fifth indent | Article 1, point 3(a) to (e)
Article 1(d) first to fourth indent | Article 1, point 4(a) to (d)
Article 2(a) and (b) | Article 2, points 1 and 2
Article 2(c) first to third indent | Article 2, point 3(a) to (c)
Article 3(a) | Article 3, point 1
Article 3(b) first and second indent | Article 3, point 2(a) and (b)
Article 3(c) first to sixth indent | Article 3, point 3(a) to (f)
Article 4(a) | Article 4, point 1
Article 4(b) first and second indent | Article 4, point 2(a) and (b)
Article 4(c) first to fifth indent | Article 4, point 3(a) to (e)
Articles 5 to 8 | Articles 5 to 8
Article 9 | —
Article 10 | —
— | Article 9
Article 11 | Article 10
Annexes I to IV | Annexes I to IV
— | Annex V
— | Annex VI